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ABSTRACT 
Up to 70% of somatic cell nuclear transfer (SCNT)–derived bovine pregnancies are lost during 
the peri-implantation period of gestation. Given the physiology of blastocyst implantation and 
clinico-pathological features that characterize SCNT pregnancies, we hypothesized that insulin-
like growth factor (IGF) signaling, epidermal growth factor (EGF) signaling, and cell adhesion 
are perturbed in bovine SCNT pregnancies during the peri-implantation period. To test this 
hypothesis, we analyzed transcriptomes of endometrial tissue and extra-embryonic tissue (EET) 
collected from gestation day (GD)-18 and GD-34 bovine pregnancies (SCNT and artificial 
insemination-derived pregnancies) using RNAseq, and endometrial transcription of 16 
preselected genes using quantitative real time-PCR and/or in situ hybridization. Findings of our 
study suggest that IGF signaling, EGF signaling and cell adhesion are perturbed in SCNT 
pregnancies during the peri-implantation period. Findings of this study also extend our current 
knowledge on temporal regulation of these molecular functions during the peri-implantation 
period in cattle. On the basis of functional ontology enrichment analysis, integrin signaling, 
IGF1R signaling, EGFR/ERBB signaling, and PI3K/AKT and ERK1/2 signaling, two signal 
transduction pathways induced by integrin clustering and IGF1R and EGFR/ERBB activation, 
were significantly affected by both implantation and SCNT. In addition, expression levels of 
genes related to cell cycle G1/S transition, apoptosis/survival, glucose uptake, protein synthesis 
and energy metabolism, cellular functions regulated by growth factor and/or integrin signaling, 
were also affected by SCNT and/or implantation. Implantation-associated gene expression 
differences were observed in all tissues while SCNT-associated gene expression differences were 
observed mainly in GD-18 EET and GD-34 inter-caruncular tissues.  Our findings on aberrant 
transcript levels of genes related to cell adhesion, IGF signaling and EGF signaling in SCNT 
pregnancies suggest that perturbations in these molecular functions may contribute to the high 
embryo mortalities and other clinico-pathological features observed during the peri-
implantation period in cattle.  
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Chapter 1: Literature review 
Implantation and placentation 
Early mammals were monotremes (GD-18 vs GD-34 comparison; differentially 
expressed genes; DEG; FDR P<0.05; Miller 2010) whose embryos developed within an egg and 
were nourished by yolk (lecithotrophy; Carter 2008). Later, mammals developed viviparity, “a 
momentous stage in evolution” (Dey 2010), which provided better protection from predators 
and environmental adversity, and better nutrition (Huppertz and Peeters 2005) for their unborn 
young through a placenta (matrotrophy; Carter 2008). 
Three different types of placentation exist among eutherian mammals: (i) Epithelio-
chorial, (ii) Endothelio-chorial, and (iii) Hemo-chorial (Carter and Enders 2004; Moffett and 
Loke 2006). The epithelio-chorial placenta of ruminants has two distinct features that make it 
different from other animals with the same type of placentation. Firstly, 15 to 20 percent of the 
trophoblast (Tr) cell population is binucleated due to acytokinetic mitosis (Spencer et al. 2007; 
Wooding 1984) and thus sometimes referred to as a synepitheliochorial placenta. These 
binucleate cells (BNC) synthesize the placental lactogen hormone (chorionic 
somatomammotropin hormone 1; CSH1) and other glycoproteins, migrate through tight 
junctions to fuse with a uterine epithelial cell to form fetomaternal hybrid trinucleate cells, and 
release their granules to the endometrium (Wooding and Beckers 1987; Wooding et al. 1997). 
Secondly, it is a cotyledonary type of placentation (Chavatte-Palmer and Guillomot 2007) with 
specialized focal areas known as cotyledons whose development commences ~GD-35 in cattle 
(Chavatte-Palmer et al. 2012a). Cotyledonary villi that develop on them ~GD-60 interdigitate 
with complementary endometrial caruncular crypts giving rise to placentomes (Dantzer and 
Leiser 2006). As few as 26 or as many as 126 placentomes have been reported in bovine 
placentae (Laven and Peters 2001). The inter-placentomal areas remain free of such 
cotyledonary villi-maternal crypt type attachments; however, the luminal epithelium of both the 
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caruncular (CAR) and intercaruncular (ICAR) regions becomes attached to the chorion by 
microvillous interdigitation to form the placenta. Development of CAR commences prenatally; 
prominent pedunculated nodules have been demonstrated in fetal uteri of newborn sheep 
(Atkinson et al. 1984), from which CAR develop with sexual maturity. Therefore, it is believed 
that the number of placentomes formed is a function of establishment of appropriate 
interactions between maternal caruncles and fetal cotyledons during the peri-implantation 
period (Chavatte-Palmer et al. 2012a; Lee et al. 2004). 
It has been suggested that “Implantation and placentation are intimately linked and 
cannot be dissociated either in time or in space” (Merviel et al. 2004). Implantation, not only 
initiates the intimate and firm contact between the conceptus and the uterine food source 
(Wooding et al. 1982), but also serves to initiate placentation (Armant 2005; Blomberg et al. 
2010). Successful implantation, an “absolute requirement” for reproduction (van Mourik et al. 
2009), is a highly complex and orchestrated process.  
A key feature of the ruminant Tr is the extensive proliferation and elongation it 
undergoes prior to implantation (Wintenberger-Torres and Flechon 1974). As a result, the Tr 
spreads to and occupies both uterine horns even in monotocus species such as cattle. In cattle, 
implantation begins close to the embryo at ~GD 19 - 20 on the ipsi-lateral horn and gradually 
proceeds distally towards the two extremities of the conceptus (Dantzer and Leiser 2006). The 
process of implantation was initially described in three phases (Enders and Schlafke 1967) and 
later elaborated to include five phases (Chavatte-Palmer and Guillomot 2007): (i) shedding of 
the zona pellucida (zp), (ii) precontact and blastocyst orientation, (iii) apposition, (iv) adhesion, 
and (v) invasion. 
Shedding the zp is necessary for successful implantation due to its inherent non-adhesive 
qualities. The loss of zp takes place as a result of mechanical rupture due to increasing 
hydrostatic pressure from the growing blastocyst (McLaren 1970) and enzymatic degradation by 
uterine and/or embryonic proteases (Perona and Wassarman 1986). After the loss of the zp 
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(GD-9 - 10 in cattle; Maddox-Hyttel et al. 2003), the blastocyst is relatively immobile and 
oriented centrally (e.g. ruminants) or eccentrically (e.g. rodents and human) inside the uterine 
cavity (Chavatte-Palmer and Guillomot 2007). 
It is during the stage of apposition that the first cell-cell contacts take place between cells 
of the Tr and the luminal epithelium (LE). Apposition is achieved by interdigitation of microvilli 
of Tr and LE cells (Enders and Schlafke 1967; Reinius 1967; Tachi et al. 1970; Wang and Dey 
2006). In addition, in ruminants, invasion of endometrial glandular ducts by transitory 
trophoblastic villi has been observed during this stage of gestation (GD 15 – 18). These villi may 
play a role in anchorage and/or absorption of uterine glandular secretions (Chavatte-Palmer and 
Guillomot 2007). In most species, a reduction in apical microvilli has also been observed 
(Spencer et al. 2004a). In addition, in mice, the same modification has been observed on LE as 
well allowing an even closer association between the two layers of cells (Enders and Schlafke 
1969). Another important observation made during this phase of implantation is the reduction 
or removal of the glycocalyx of LE which would also allow close apposition between the two cell 
layers (Chavatte-Palmer and Guillomot 2007; Enders and Schlafke 1972; Spencer et al. 2004a). 
In ruminants, the phase of apposition coincides with commencement of gastrulation whereas in 
mice and humans, gastrulation is a post-implantation event (Chavatte-Palmer and Guillomot 
2007; Eakin and Behringer 2004; Table 1.1). 
During adhesion, cell-cell contacts between the Tr and LE become closer (<200Å; 
Schlafke and Enders 1975). Interdigitation between microvilli from the two compartments is 
seen on both CAR and ICAR. A variety of cell adhesion molecules, including integrins, have been 
implicated in cell-cell and cell-matrix interactions during blastocyst implantation (Kimber and 
Spanswick 2000). Binucleated cells can be observed in the Tr by this phase; however it is 
believed that only mono-nucleated cells actually adhere to cells of the LE. In cattle, a BNC fuses 
with a single LE cell to give rise to a tri-nucleate syncytial cell. In contrast, in sheep, continued 
migration and fusion of BNC with tri-nucleate cells gives rise to syncytial plaques linked by tight 
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junctions (Chavatte-Palmer and Guillomot 2007). Due to this syncytial formation, the ruminant 
placenta has been re-classified as a synepitheliochorial placenta to differentiate it from the true 
epithelio-chorial type of placentation seen in species such as swine.   
In species with endothelio-chorial and hemo-chorial types of placentation, implantation 
extends to the invasion phase. Three types of invasion are described depending on the type of 
endometrial penetration by the Tr (Schlafke and Enders 1975): (i) intrusive invasion where the 
Tr migrates along the intercellular spaces without causing primary cellular lysis (e.g. human), 
(ii) displacement invasion where the Tr phagocytose uterine cells (e.g. mouse), and (iii) fusion 
invasion where the syncytiotrophoblast fuses with uterine cells giving rise to a syncytium 
containing both fetal and maternal nuclei (e.g. rabbit). In contrast, in species with an epithelio-
chorial placentation such as cattle, Tr cells do not invade the maternal endometrium. 
Conceptus nutrition 
Prior to implantation and placentation, conceptus growth and development is dependent 
on the endometrial glandular secretion, histiotroph, a complex mixture of enzymes, growth 
factors, cytokines, lymphokines, hormones, transport proteins and other substances, in all 
mammals (Bazer 1975; Spencer and Bazer 2004b; Wathes et al. 1998; Wimsatt 1950). However, 
in domestic animals with an epitheliochorial (pig) or synepitheliochorial (sheep, cattle, and 
goat) placenta, the requirement for histiotroph remains critical even after placentation (Spencer 
and Bazer 2004b) and continues to provide an important source of nutrients to the developing 
fetus throughout gestation (Moffatt et al. 1987; Roberts and Bazer 1988).  
In sheep (Spencer and Bazer 2004a; Stewart et al. 2000), cattle (King et al. 1981), and 
pigs (Sinowatz and Friess 1983), endometrial glands undergo extensive hyperplasia and 
hypertrophy during pregnancy, presumably in response to increasing demands by the 
developing conceptus for uterine histiotroph (Samuel et al. 1977; Stewart et al. 2000). It has 
been estimated that in ewes, ICAR endometrial glands grow substantially in length (4-fold) and 
width (10-fold) and establish additional side-branchings with initial hyperplasia (GD-15 – GD-
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50) followed by hypertrophy to increase surface area in order to maximize production of 
histiotroph (Spencer and Bazer 2004a). This process requires site-specific alterations in cell 
proliferation and ECM remodeling as well as paracrine cell-cell and cell-ECM interactions that 
support the actions of specific hormones and growth factors (Gray et al. 2001a). Results from 
studies of neonatal ovine (Gray et al. 2000; Taylor et al. 2000), porcine (Tarleton et al. 1998), 
and rodent (OGASAWARA et al. 1983) uteri suggest that uterine gland morphogenesis is 
regulated through interactions between glandular epithelia (GE) and surrounding stroma (Gray 
et al. 2001a) and are facilitated by paracrine and autocrine pathways that involve peptide growth 
factors (e.g. IGFs and EGFs) and their receptors (Kurita et al. 1998).  
Results of studies carried out on the human endometrium during the proliferative phase 
(Giudice and Saleh 1995), where proliferation of endometrial glands is highest, also suggest that 
growth factors such as IGF1, IGF2, and EGF are likely involved in endometrial gland hyperplasia 
(Gray et al. 2001a). In the peri-implantation phase of ewes, peak expression of IGF1R was 
observed on GE while the surrounding stroma expressed IGF1 (Reynolds et al. 1997). In 
pregnant mares too, a marked increase of EGF expression in GE has been demonstrated 
coincident with implantation (Lennard et al. 1998). At estrus, IGF1R mRNA was observed on 
both endometrial LE and GE (Stevenson et al. 1994) and later shifted to a predominantly deep 
expression in the GE during the luteal phase (Reynolds et al. 1997) where the expression 
continued throughout gestation (Wathes et al. 1998). In the same study, highest levels of 
expression of IGF1 mRNA (GD-22) were recorded in the stroma surrounding deep endometrial 
glands (Reynolds et al. 1997). It was also shown that IGF1R mRNA expression in the oviductal 
mucosa, whose secretions are important for embryo transport to the uterus, peaks on 2nd – 3rd 
day of the cycle coincident with the period of embryo transit (Wathes et al. 1998). Wathes et al. 
(1998) argue that these spatial and temporal changes of IGF1R mRNA and its localization to the 
two secretory epithelia (oviductal mucosa and deep GE) collectively suggest a role for IGFs in 
regulating their secretory activity. Therefore, IGF/EGF signaling can be particularly important 
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in conceptus nutrition during the peri-implantation period in animals with an epithelio-chorial 
placenta such as cattle. 
After establishment of a functional placenta, matrotrophic nutrition commences (Carter 
2008). Fetal cotyledonary villi and maternal caruncular crypts are rich in capillary networks 
where exchange of nutrients/waste products between the two compartments takes place. Fetal 
vessels assume a conical villous tree-like shape inside cotyledonary villi and maternal vessels 
assume a complementary septa-like shape around them. At the terminal level, loops of septal 
capillaries are arranged around fetal villous capillaries in a honeycomb-like fashion (Pfarrer et 
al. 2001). However, it should be emphasized that, in species with epitheliochorial placentation, 
histiotrophic nutrition from endometrial glands continues to play an important role throughout 
gestation (Moffatt et al. 1987; Roberts and Bazer 1988).  
Somatic cell nuclear transfer 
Cloning via somatic cell nuclear transfer (SNCT) has the potential to contribute 
significantly to agriculture, biotechnology, and biomedicine (Ross & Cibelli 2010). It can be a 
valuable tool for multiplication of elite livestock (Campbell et al. 1996), generation of organs for 
xenotransplantation (Schneider and Seebach 2011), development of transgenic animals for 
production of recombinant proteins (Moura et al. 2011), preservation of endangered species 
(Wells and Misica 1998), and studying genetic and epigenetic mechanisms associated with 
development, aging, and carcinogenesis (Meissner and Jaenisch 2006). 
Nuclear transfer, first envisioned by the Nobel laureate embryologist Hans Spemann in 
1938 (Spemann 1938) as a method to study cell differentiation, is a two-part process: removal of 
the nucleus from an ovum, and transferring a donor nucleus into the enucleated ovum. A genetic 
clone of the donor cell is produced when the ovum starts to divide. Spemann, using a relatively 
crude technique, carried out the first documented nuclear transfer. A newly fertilized 
salamander egg was constricted using a strand of hair grossly separating its nucleus and 
cytoplasm. After four divisions, the constriction was loosened allowing the transfer of a single 
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nucleus into the side with the separated cytoplasm. Cell division commenced on the side with 
the transferred nucleus and the two embryos were completely separated by further tightening 
the hair loop. A normal salamander embryo grew from the cell with the transferred nucleus 
demonstrating that the nucleus from a 16-cell embryo can lead to the growth of a complete 
organism. Spemann envisaged that transferring an older nucleus into an egg would be a 
"fantastical experiment".  
A 1952 publication reported that donor nuclei from blastocyst and gastrula stage Rana 
pipiens embryos were successfully transferred to enucleated ova of the same species (Farin et al. 
2006). The authors also developed a technique where donor cell nuclei are collected by suction 
applied through a glass pipette and subsequently injected into enucleated ova. In 1958, John 
Gurdon and colleagues reported producing sexually mature clones by transferring donor nuclei 
from more advanced stages of development (up to pre-hatching tadpole stage) in Xenopus laevis 
(Ahnert and Kirsten 2007). Four years later, the same group reported producing clones from 
intestinal epithelial cells from swimming tadpoles (Bryant et al. 2004). However, their later 
attempts at nuclear transfer using donor nuclei from adult keratinized skin cells did not support 
development of adult clones (Gurdon et al. 1975). 
It was not until 1986 that the first successful mammalian live births from nuclear 
transfer were reported. Blastomeres from 8- or 16-cell stage ovine embryos were used as nuclear 
donor cells and enucleated metaphase II ovine oocytes were used as recipient cytoplasts 
(Willadsen 1986). Within the next several years, successful nuclear transfer resulting in live 
births of full-term offspring was demonstrated in cattle (Prather et al. 1987; Robl et al. 1987) 
and pigs (Prather, Sims et al. 1989) as well. The researchers used pronuclear embryos or 2- to 
32-cell stage embryos as nuclear donor cells and enucleated zygotes and/or metaphase II 
oocytes as recipient cytoplasts (Prather et al. 1989; Robl et al. 1987). However, when using early 
embryos as nuclear donors, the number of identical animals that could be produced becomes 
limited by the number of cells in the embryos and further aggravated by the low efficiency of the 
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procedure (Campbell et al. 2005). Therefore developing a nuclear donor cell type that could be 
grown and maintained in culture was important. A 1994 publication reported producing bovine 
calves by using an inner cell mass derived cell line as nuclear donors. Several studies carried out 
during this period also showed that the donor cell-cycle stage affects the chromatin structure 
and development of nuclear transfer-derived embryos (Cheong et al. 1993; Collas et al. 1992). 
These studies showed that development was greater if donor cells were in mitosis or G1 phase of 
the cell-cycle than in the G2 or S phases. Dividing cells could be induced to go into quiescence 
using serum starvation. Subsequent nuclear transfer experiments, including the one that 
resulted in the first mammalian adult somatic cell-derived clone (Dolly; Wilmut et al. 1997), 
were carried out using such growth cycle arrested cells as nuclear donors. The donor nuclei for 
cloning of Dolly came from an adult mammary epithelium derived cell line. To-date, the basic 
technology of SCNT continues to be the same as that used for generating Dolly (Moura et al. 
2011). 
Since Dolly, viable offspring have been obtained by SCNT in other ungulates (goat; 
Baguisi et al. 1999; cattle; Cibelli et al. 1998; horse; Galli et al. 2003; mouflan; Loi et al. 2001; 
pig; Polejaeva et al. 2000), rodents (mouse; Wakayama et al. 1998; rat; Zhou et al. 2003) , 
lagomorphs (rabbit; Chesne et al. 2002), and carnivores (dog; Lee et al. 2005; cat; Shin et al. 
2002). However, even 15 years after the birth of the first successful mammalian offspring by 
SCNT, it is still considered an inefficient process (Hashizume et al. 2002; Hill et al. 2000; 
Panarace et al. 2007; Ross and Cibelli 2010; Wakayama and Yanagimachi 1999; Wilmut et al. 
2002), despite considerable improvements in the last decade (Arnold et al. 2008). Bovine 
pregnancies derived from cloning technologies are characterized by high pregnancy losses 
throughout gestation (Wilmut and Peterson 2002), high incidences of protracted gestations and 
dystocia (Chavatte-Palmer et al. 2002; Kruip and den Daas 1997), and an array of clinico-
pathological features such as larger but fewer placentomes, irregularly shaped placentomes, 
placental edema, placentomegaly, hydroallantois, increased umbilical vessel diameters, 
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thickened and edematous umbilical vessel walls, ascites, pulmonary hypertension, elevated 
systemic venous pressure, cardiac enlargement, hepatic congestion, hepatic steatosis,  renal 
lesions, respiratory distress and increased fetal/birth weight (Chavatte-Palmer et al. 2002; 
Constant et al. 2006; De Sousa et al. 2001; Hill et al. 1999; Miglino et al. 2007; Wells et al. 
1999). 
In contrast to the average calving rate of 55% (King 1991) in artificial insemination (AI) -
derived bovine pregnancies (hereafter denoted AI pregnancies), SCNT-derived bovine 
pregnancies (hereafter denoted SCNT pregnancies) have a modest average calving rate of 9% 
(Panarace et al. 2007), which is the cumulative result of inefficiencies at each stage of gestation 
(Wilmut et al. 2002). Pregnancy losses are particularly high during the pre- and early post-
implantation periods and may be up to 70% in SCNT derived bovine pregnancies. Observations 
from many studies implicate placental pathologies as the major cause of pregnancy losses 
during the first trimester and placental pathologies along with hydrallantois and fetal 
overgrowth as the major causes of pregnancy losses during the 2nd and 3rd trimesters in SCNT 
pregnancies (Constant et al. 2006; Hill et al. 2000; Palmieri et al. 2008).  
During the period of initiation of placentome formation (GD-35 - 50), some researchers 
reported impaired cotyledon formation (Hill et al. 2000) while others reported advanced 
cotyledon development and vascularization (Lee et al. 2004). Overall, placentome numbers and 
morphology are far more variable in SCNT pregnancies compared to AI controls, suggesting a 
dysregulation of placental development (Chavatte-Palmer et al. 2012a). Regardless of whether 
the number of placentomes is decreased or not, the total placental mass is increased in SCNT 
pregnancies (Constant et al. 2006; Lee et al. 2004). The reduced number of placentomes is 
believed to be a result of failure of establishment of appropriate interactions between maternal 
caruncles and fetal cotyledons (Chavatte-Palmer et al. 2012a; Lee et al. 2004). The major 
histologic finding of placentae collected from various stages of gestation in bovine and ovine 
SCNT pregnancies is severely reduced placental vascular development (De Sousa et al. 2001; 
  
10 
 
Hashizume et al. 2002; Hill et al. 2000; Lee et al. 2004; Ravelich et al. 2004). In ovine SCNT 
term placentae with fetuses delivered alive and healthy, the density of capillaries was lower 
(50.7/mm2) than that of control placentae (503/mm2). Moreover, vessels of SCNT placental villi 
were relatively immature compared to those from AI placental villi (Palmieri et al. 2007). 
According to this study, overall placental vasculogenesis was significantly reduced in SCNT 
pregnancies as indicated by the lack of CD34 expression by individual fetal blood vessels 
(Palmieri et al. 2007).  
Common lesions reported in the trophoblast of ovine and bovine SCNT pregnancies 
include hypoplasia, increased apoptosis and shedding of trophoblast epithelial cells, and 
reduced numbers of BNC (Fletcher et al. 2007; Hashizume et al. 2002; Loi et al. 2006; Palmieri 
et al. 2007). In contrast, others have reported an increase in placental BNC in bovine SCNT 
pregnancies at GD-50, -100 and -150 (Ravelich et al. 2004; Ravelich et al. 2006). The increased 
numbers of BNC were associated with increased numbers of fetal trophectodermal 
mononucleate cells and maternal uterine epithelial cells (Ravelich et al. 2006). Stromal 
components of the placenta are also altered in bovine and ovine SCNT pregnancies: for example, 
in GD-60 SCNT bovine pregnancies, disruption and irregular arrangement of chorionic villi and 
caruncular septa were observed. The same study also reported reduced procollagen type I and 
collagen type III fibers in SCNT placentomal stroma (Hashizume et al. 2002). These changes 
were attributed to increased expression of heparanase, an extracellular matrix-degrading 
enzyme in ICAR areas (Hashizume et al. 2002; Kizaki et al. 2001). In sheep at term with alive 
and healthy fetuses, the subtrophoblastic basement membrane and capillary basal lamina 
showed increased thickness, lamellation, and deposition of collagen fibrils (Palmieri et al. 
2007). Such changes are attributed to increased deposition of basement membrane components 
associated with hypoxia (Palmieri et al. 2008). It has also been shown in placentomes harvested 
from SCNT pregnancies that the proportion of fetal connective tissues is increased while that of 
the maternal epithelial height is decreased. The overall mean surface area of the placentomes is 
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also increased in SCNT pregnancies (Batchelder et al. 2007; Bertolini et al. 2004). These 
structural modifications may be physiological adaptations to increase the efficiency of materno-
fetal exchange (Constant et al. 2006; Miglino et al. 2007). 
Underlying cause/s of these pathologies in SCNT pregnancies have not been elucidated 
yet. However, the general consensus is that incomplete epigenetic reprogramming of the donor 
somatic cell genome by the oocyte cytoplasm gives rise to the observed pathologies (Kang et al. 
2001; Ohgane et al. 2004). Epigenetic marks of somatic cell nuclei need to be erased for them to 
acquire totipotency and to become functionally equivalent to a zygote (Takahashi 2004). This 
process of dedifferentiation of a somatic cell nucleus requires global epigenetic changes, 
including erasure of the somatic pattern of DNA methylation marks and its progressive 
reestablishment throughout development.  
Mammalian somatic cells show elevated methylation levels compared to gametes, with 
sperm DNA being more methylated than oocyte DNA (Howlett and Reik 1991). In cattle, soon 
after fertilization, DNA of both the sperm and oocyte undergo passive demethylation followed by 
de novo methylation. In the case of natural fertilization, the ICM and trophoblast attain 
different levels of methylation with the latter typically being hypomethylated compared to the 
former. However, in the case of SCNT, methylation levels of the ICM and trophoblast are 
indistinguishable (Santos and Dean 2004) suggesting that epigenetic reprogramming of the 
somatic cell nucleus may be aberrant. Trophoblast, but not ICM from SCNT conceptuses are 
hypermethylated compared to respective tissues derived from natural fertilization suggesting 
that epigenetic reprogramming in the embryonic lineage may be relatively normal while that of 
the extraembryonic lineage may be aberrant (Yang et al. 2007). Reports indicating a multitude 
of gene expression perturbations (Everts et al. 2008) together with gross/histological 
pathological changes (Hill et al. 2000) in SCNT placentae compared to the relatively normal 
nuclear transfer-derived embryonic stem cells (Wakayama et al. 2006) are consistent with this 
hypothesis (Yang et al. 2007). 
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Insulin-like growth factor (IGF) signaling 
The lack of structural variation of insulin and IGFs throughout phylogeny emphasizes 
their importance in regulating growth and metabolism in multi-cellular organisms (Maki 2010). 
Expression of IGF-related genes in the feto-placental unit has been extensively studied and has 
been implicated in conceptus-placental pathologies observed in SCNT pregnancies (Moore et al. 
2007; Ravelich et al. 2004; Yang et al. 2005).  
The family of IGFs consist of the two ligands IGF1 and IGF2; two receptors IGF1R 
(Ullrich et al. 1986) and IGF2R (Morgan et al. 1987); IGF binding proteins –BP1-6 (Baxter and 
Saunders 1992; Grimberg and Cohen 2000; Jones and Clemmons 1995) and IGF2 mRNA 
binding proteins (IGF2BP1-3; Nielsen et al. 1999). IGF1 and IGF2 exert their actions via 
endocrine, paracrine, or autocrine mechanisms (Clemmons 1997; Hwa et al. 1999) by binding 
IGF1R, while only IGF2 binds to IGF2R, a scavenger receptor that does not appear to have the 
ability to activate downstream signaling (mice; Liu et al. 1993; human; Maki 2010; cattle; Spicer 
and Aad 2007; Walters et al. 2006). IGF1 may alternatively signal through INSR (Jones and 
Clemmons 1995). IGF signaling is further regulated by IGFBP1-6 and IGF2BP1-3. IGFBPs 
generally compete for activity of IGFs at the receptor level and antagonize IGF function 
(Grimberg and Cohen 2000); however exceptions have been reported. For example, IGFBP3 
and IGFBP4 are generally known to have anti-proliferative/growth inhibitory functions by 
sequestering IGF1 and subsequently limiting ligand-receptor interactions. However, with both 
IGFBP3 and IGFBP4, growth stimulatory effects have also been demonstrated in certain tissues. 
Such growth stimulatory effects are thought to be brought out by means of IGFBPs binding IGF 
ligands and concentrating around a particular location and/or by a slow-release mechanism 
(reviewed by Mazerbourg et al. 2004; Yamada and Lee 2009). IGFBPs have been proposed to 
modulate IGF actions by different mechanisms: (i) increasing half-life, (ii) transporting and 
localizing the IGFs in specific tissues and (iii) modulating IGF binding to surface receptors 
(Clemmons 1997). The spatiotemporal gene expression of IGFBPs in endometria of mice 
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(Henemyre and Markoff 1998; Kapur et al. 1992; Markoff et al. 1995) and ruminants (Reynolds 
et al. 1997; Robinson et al. 2000) during the peri-implantation period suggests their 
involvement in implantation. In GD-16 cows, IGFBP2 mRNA was observed in the SES 
underlying the luminal epithelium (Robinson et al. 2000). Reynolds and co-workers (1997) 
reported a similar expression pattern for IGFBP2 and IGFBP4 mRNA in GD-29 ewes and 
suggested that this pattern of expression might serve as a barrier that blocks the transport of 
IGF2 into the endometrium from the adjacent cotyledon (Reynolds et al. 1997). The same group 
also went on to show that IGFBP3 was predominantly expressed on blood vessel walls 
suggesting that it may play a role in transferring the IGFs from the circulation to the target 
tissue. In mice, Markoff and co-workers (1995) showed that expression of IGFBP4 mRNA 
coincided with the peri-implantation period and implantation sites (Markoff et al. 1995). 
IGFs are anabolic and regulate feto-placental growth. IGFs are metabolically anabolic 
(Fowden 2003; Jones and Clemmons 1995) and recapitulate many of the activities of insulin, 
such as increase in glucose metabolism in fat, increase in glucose transport, inhibition of 
lipolysis, and increasing lipid, glycogen, and protein synthesis, but with only 1% to 2% the 
potency of insulin. IGFs have been shown to regulate cellular uptake of glucose and amino acids, 
cellular metabolism of carbohydrates and proteins (Chi et al. 2000; Fowden and Forhead 2009; 
Maki 2010), and cellular replication and differentiation by functioning as a progression factor in 
the cell cycle (Jones and Clemmons 1995). Stimulation by growth factors such as IGF1 is 
necessary for the cell cycle to progress up to the restriction point in late G1 phase, beyond which 
the cell is committed to completing cell division (Grimberg 2003).  
In the placenta, IGFs promote mitosis, cell differentiation, migration, aggregation and 
inhibition of apoptosis (Ravelich et al. 2004). Synthesis of most components of the IGF system 
can be regulated through nutrition (Thissen et al. 1994) making IGF1 and IGF2 suitable 
intermediaries that match growth and development of an animal to its nutritional status 
(Wathes et al. 1998). Further, it has been suggested that IGF1 acts as a nutrient sensor that 
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ensures fetal growth is commensurate with the maternal nutrient supply and IGF2 as a driver of 
feto-placental mass accumulation (Fowden 2003). 
IGFs are important for conceptus-placental growth throughout gestation. The 
importance of IGF signaling in conceptus-placental development (Baker et al. 1993; Constancia 
et al. 2002) throughout gestation (Fowden 2003) has been demonstrated. For example, IGF1 
and/or IGF2 have been shown to: (i) improve post-fertilization embryo development in bovine 
(Narula et al. 1996; Palma et al. 1997; Sirisathien and Brackett 2003; Wang et al. 2009), murine 
(Rappolee et al. 1992), swine (Xia et al. 1994) and other (Herrler et al. 1998) species, (ii) affect 
carbohydrate and/or protein metabolism of conceptuses/placentae both in vitro (Chi et al. 
2000; Fang et al. ; Karl 1995) and in vivo (Fowden and Forhead 2009), (iii) improve pre-
implantation embryo development by decreasing apoptosis and increasing cell proliferation in 
mice (Doherty et al. 1994) and rabbits (Herrler et al. 1998), and (iv) alter transfer of glucose and 
amino acids across placenta in fetal sheep (Harding et al. 1994). Further, short-term (10 days) 
and long-term (46 days) administration of IGF1 to ovine fetuses increased the weight of specific 
organs (Lok et al. 1996) and total BW (Kimble et al. 1999) respectively, a probable effect of the 
anabolic actions of IGF-I (Fowden 2003). A positive correlation between fetal plasma IGF1 
concentration and feto-placental weight in mid-gestation ewes has also been reported (Gadd et 
al. 2000).  
Gene knockout studies of mice involving IGF-related genes have provided striking data 
regarding the role of IGFs in feto-placental growth regulation: disruption of Igf1 (60% of normal 
body weight; BW), Igf2 (60% of normal BW) or Igf1r (45% of normal BW) alone or in 
combination (Igf1r with Igf1r or Igf2; 30% of normal BW) retarded fetal growth, whereas 
disruption of Igf1r (130% the normal BW) or over-expression of Igf2 enhanced fetal growth 
(reviewed by (Gicquel and Le Bouc 2006) and (Fowden 2003)). Deletion of the placenta-specific 
Igf2 transcript initially retarded placental growth followed by fetal growth secondary to 
decreased materno-fetal nutrient transfer (Constancia et al. 2002), whereas increasing Igf2 
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exposure by imprint relaxation or deletion of the Igf2r gene resulted in placentomegaly with 
placental weight doubling in cases of extreme Igf2 exposure (Fowden and Forhead 2009).  
Both autocrine and paracrine modes of growth factor action have been postulated in 
mediating conceptus-placental growth (Schultz and Heyner 1993; Simmen and Simmen 1991). 
Thus IGFs from the endometrium can potentially regulate mitogenic and metabolic activities 
not only on the uterus, but also on the conceptus even prior to implantation (Korgun et al. 2003; 
Simmen and Simmen 1991). The role of IGFs on feto-placental growth has been reviewed in 
detail elsewhere (Fowden 2003). 
IGFs during the peri-implantation period. The IGF system appears to play an important 
role during implantation and establishment of pregnancy in all species studied (Henemyre and 
Markoff 1998; Markoff et al. 1995; Nayak and Giudice 2003). Both IGF1 (GD-17; Kirby et al. 
1996) and IGF2 (GD-15 and -18; Geisert et al. 1991) endometrial mRNA levels were reportedly 
higher in pregnant cows than in cyclic cows from corresponding stages of the estrus cycle. 
Similar observations were reported for endometrial IGF1 levels of sows (Ko et al. 1994; Ko et al. 
1991; Simmen et al. 1992). Post-implantation declines in mRNA levels have been reported for 
IGF-related genes: IGF1R in sheep (Reynolds et al. 1997); IGF1 in mice (Kapur et al. 1992) and 
pig (Geisert et al. 1991). Collectively, these observations suggest that expression of IGF-related 
genes on the endometrium may be regulated by the implanting mammalian embryo (Ko et al. 
1994).  
Findings from peri-implantation stage ovine and bovine pregnancies showed spatio-
temporally regulated expression of IGF-related genes in CAR and ICAR. In early pregnant ewes, 
Reynolds and co-workers (1997) observed that expression of IGF1 was highest in the stroma 
surrounding deep endometrial glands while expression of IGF1R was highest in the deep 
endometrial glands. In contrast, levels of expression of the two genes were relatively low in the 
superficial stroma and glands (Reynolds et al. 1997). In cattle too, strongest expression of IGF1R 
mRNA was observed in deep glands at GD-16 (Robinson et al. 2000). This pattern suggests that 
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the IGF system may play a role in secretion of uterine histiotroph (Wathes et al. 1998) and 
thereby regulate growth of the conceptus (Nayak and Giudice 2003). In sheep, before inter-
digitating with fetal villi, low expression levels were detected in CAR stroma; however, after 
inter-digitating with fetal villi, mRNA for IGF1 and IGF1R could not be detected in CAR (Wathes 
et al. 1998). The authors argue that this spatio-temporal pattern during the peri-implantation 
period suggests a role for the IGF system in blastocyst implantation. 
Expression of insulin (protein or mRNA) on the pre-implantation conceptus has not 
been demonstrated in laboratory animals (Kaye and Harvey 1995; Korgun et al. 2003). 
Therefore it is currently believed that it is maternal insulin that mediates these growth effects 
during pre-implantation development (Korgun et al. 2003). However, expression of insulin 
receptors (INSR) on conceptuses has been demonstrated from compacting 8 cell stage onwards 
in mice (Harvey et al. 1995; Rosenblum et al. 1986). Investigations from Korgun and co-workers 
(2003) suggest that insulin may play a role in preparing the endometrium for implantation 
(Korgun et al. 2003). 
IGF1R activation and downstream signal transduction pathways. The tyrosine kinase 
receptor IGF1R is a hetero-tetrameric protein, consisting of two identical extracellular α-
subunits with a IGF-binding site, and two transmembrane β-subunits with intrinsic tyrosine 
kinase activity (Laviola et al. 2005). IGF1R is activated by IGFs present in the extracellular 
milieu, derived from endocrine, paracrine or autocrine sources (Riedemann and Macaulay 
2006). Ligand binding to the α-subunits leads to activation of the intrinsic tyrosine kinases and 
subsequent autophosphorylation of intrinsic tyrosines on the β-subunits (Vincent and Feldman 
2002). IGF1R activation is followed by recruitment of specific docking intermediates including 
insulin-receptor substrate family of proteins (IRS1-4), src homology and collagen domain 
protein (SHC), and 14-3-3 proteins (Chitnis et al. 2008) which in turn activate ERK/MAPK and 
PI3K/AKT signal transduction pathways.  
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PI3K/AKT signal transduction pathway 
PI3K/AKT pathway is a crucial mediator of various cellular processes such as apoptosis, 
regulation of cell cycle, protein synthesis and regulation of metabolism (Figure 1.1). AKT 
pathway is not exclusive to IGF/insulin receptor signaling; it may be activated downstream of 
multiple classes of growth factor receptors, from receptor tyrosine kinases to cytokine receptors 
and integrins (Plas and Thompson 2005). The pathway is initiated by tyrosine phosphorylated 
IRSs recruiting and activating class IA Phosphoinositide 3-Kinase (PI3K; Fasshauer et al. 2000). 
PI3Ks are heterodimeric molecules composed of a regulatory subunit (PIK3R1, PIK3R2 and 
PIK3R3) and a catalytic subunit (PIK3CA, PIK3CB and PIK3CD). Binding of a regulatory 
subunit to a catalytic subunit inhibits its catalytic activity. Upon cellular stimulation, the 
regulatory subunit-mediated inhibition of the catalytic subunit is relieved, increasing the 
enzymatic activity of the catalytic subunit (reviewed by Geering et al. 2007a). Generally catalytic 
subunits and regulatory subunits exist in 1:1 ratio. Deletion of PIK3R1 lead to a decrease in the 
levels of PIK3CA and PIK3CB while loss of PIK3CA and/or PIK3CB decreased the levels of 
PIK3Rs (however, exceptions have been reported; Geering et al. 2007b). Phosphatase and tensin 
homolog (PTEN), dephosphorylates PIP3 negatively regulating PI3K signaling and switching off 
PI3K/AKT mediated proliferative and antiapoptotic signals (Himpe and Kooijman 2009). It was 
also shown that PIK3R1 binds and positively regulates lipid phosphatase activity of PTEN 
maintaining PI3K/PTEN balance (Chagpar et al. 2010). Activation of PI3K leads to an increase 
in the levels of phosphatidylinositol 3,4,5-triphosphate (PIP3), which in turn leads to 
recruitment and activation of AKT/protein kinase b and phosphoinositide-dependent kinase-1 
(PDK1), which then phosphorylates and activates other protein kinases including p90Rsk and 
protein kinase C (Fasshauer et al. 2000). 
A substantial amount of data indicates that PI3K/AKT activity mediates a wide range of 
insulin/IGF effects (Chibalin et al. 2000; Yuan and Cantley 2008). For example, PI3K/AKT (i) 
enhances glucose uptake by inducing membrane translocation of the glucose transporters 
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GLUT1 and GLUT4 (Clarke et al. 1994), (ii) promotes glycogen synthesis through 
phosphorylation and inactivation of glycogen synthase kinase 3 (GSK3), (iii) regulates cell cycle 
G1/S transition by inhibiting GSK3 mediated cyclin D degradation (Chang et al. 2003), (iv) 
promotes anti-apoptotic/pro-survival pathways and (v) enhances protein synthesis via 
phosphorylation of mammalian target of rapamycin (MTOR) and relieving the inhibition on  the 
rate limiting step on translation initiation (Shiojima and Walsh 2002; Topisirovic et al. 2005). 
Above functions (iii), (iv) and (v) are described in detail below. 
IGF1R-mediated suppression of apoptosis is imposed via 3 pathways. PI3K/AKT 
pathway is the primary anti-apoptotic pathway activated by IGF signaling. Activated AKT 
induces inhibitory phosphorylation of pro-apoptotic factors B-cell CLL/lymphoma 2 (BCL2) -
associated agonist of cell death (BAD; BAD promotes cell death by neutralizing the anti-
apoptotic effects of BCL2-like 1 and BCL2; Peruzzi et al. 1999), members of the forkhead 
transcription factor family (FOXOs), caspase 9 (Riedemann and Macaulay 2006) and other 
growth inhibitors such as p21, p27, Chk1, and GSK3 (Chitnis et al. 2008; Rössig et al. 2001). 
AKT activation also leads to increased expression of anti-apoptotic proteins BCL-2, BCL2-like 1 
(BCL-XL/BCL2L1) and NF-κB (Brazil et al. 2004). The second anti-apoptotic pathway induced 
by activated IGF1R is mediated via the three 14-3-3 family of proteins Tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein, beta, zeta and epsilon 
polypeptides (14-3-3 beta/alpha, 14-3-3 zeta/delta, and 14-3-3 epsilon). Upon interaction with 
IGF1R, they activate v-raf-1 murine leukemia viral oncogene homolog 1 (c-RAF1; Fu et al. 2000; 
Thorson et al. 1998) which then translocates to the mitochondria and phosphorylates BAD 
dissociating it from BCL2 and BCL2L1 and releasing it to the cytosol (Parvaresch et al. 2002; 
Peruzzi et al. 1999). The third mechanism through which IGF1 inhibits apoptosis is by 
phosphorylation and inhibition of Mitogen-Activated Protein Kinase Kinase Kinase 5 (ASK1 
(MAP3K5))-mediated cell death (Galvan et al. 2003). 
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In addition to having anti-apoptotic properties, AKT pathway also regulates cell cycle 
progression via cyclin D. Cyclin D complexes with and functions as a regulatory subunit of 
CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. Phosphorylation of 
cyclin D by GSK3β promotes shuttling of cyclin D from the nucleus to the cytoplasm (Alt et al. 
2000) for subsequent degradation via the 26S proteasome (Diehl et al. 1998). AKT 
phosphorylates and inhibits GSK3 and acts to increase nuclear cyclin D levels. Cyclin D 
promotes cell cycle progression by phosphorylating and inactivating the retinoblastoma protein 
(Chang et al. 2003). 
The PI3K/AKT pathway also mediates another one of IGF1R functions which is cellular 
protein synthesis. Activated AKT phosphorylates and inhibits tuberin (TSC2)-mediated 
repression of ras homolog enriched in brain (RHEB). This leads to MTOR activation which in 
turn mediates phosphorylation of ribosomal protein S6 kinase 1 (RPS6K1), ribosomal protein S6 
(RPS6) and eukaryotic translation initiation factor 4E-binding protein-1 (4E-BP1; Figure 1.1). 
4E-BP1 is an inhibitor of eIF4E and MTOR mediated phosphorylation of 4E-BP1 relives its 
inhibition on eIF4E and activates protein synthesis. eIF4E binds and recruits the mRNA to the 
translation initiation complex for protein synthesis (Gibbons et al. 2009), the rate limiting step 
in translation initiation (Topisirovic et al. 2005). However, mitogenic signal-mediated 
PI3K/AKT is not the only pathway through which MTOR is regulated. Growth factor–induced 
activation of MTOR requires sufficient nutrients in the form of glucose and amino acids. Low 
glucose/hypoxia/low ATP and low amino acid levels will prevent even activated AKT from 
activating MTOR (Carrera 2004; Peng et al. 2002).   
Under conditions of depleted cellular ATP levels, the ATP:AMP ratio increases and 
activates AMP-activated protein kinase (AMPK), a central regulator of energy-consuming 
anabolic processes in the cell that promotes the adaptation of cells to their microenvironment 
(Suzuki et al. 2004). AMPK is switched on by cellular stresses that interfere with ATP 
production (e.g. hypoxia, glucose deprivation, ischemia) or by stresses that increase ATP 
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consumption (e.g. muscle contraction). Once activated, the system switches on catabolic 
pathways that generate ATP and switches off ATP-consuming processes that are not essential 
for short-term cell survival, such as the synthesis of lipids, carbohydrates, and proteins. 
Activated AMPK inhibits protein synthesis by phosphorylation and activation of tuberin (TSC2) 
leading to inhibition of MTOR signaling which in turn reduces energy-consuming processes 
such as protein synthesis. Thus, TSC2 coordinates mitogenic signals via PI3K/AKT signaling 
and the cellular energy status via AMPK signaling. When mitogenic signals and cellular ATP are 
high, TSC2 is inactive, permitting MTOR signaling and protein synthesis. When mitogenic 
signals and cellular energy levels are low, TSC2 is active, repressing MTOR signaling and 
inhibiting protein synthesis (Hardie 2003; Lu et al. 2008). Further, it has also been shown that 
IGF1 is also able to induce AMPK-α subunit phosphorylation via ataxia telangiectasia mutated 
(ATM; Suzuki et al. 2004), an AMPK-related molecule that is activated by AKT in response to 
glucose starvation (Suzuki et al. 2003). However, it should be noted that biochemical effects of 
MTOR signaling are complex, incompletely understood and potentially context specific (Dancey 
2010). 
A recent study carried out in peri-implantation stage ewes reported the expression of 
mRNA and/or proteins of MTOR, TSC2, RHEB, EIF4EBP1 and several associated genes 
(MTOR associated protein, LST8 homolog; MLST8, regulatory associated protein of MTOR, 
complex 1; RAPTOR, RAPTOR independent companion of MTOR, complex 2; RICTOR and 
tuberous sclerosis 1; TSC1) on endometrial epithelia and trophoblast cells. They also showed 
that the expression of RHEB and EIF4EBP1 mRNAs increased with advancing days of 
pregnancy (primarily in uterine luminal and glandular epithelia) and that their transcription in 
the endometrium is regulated by progesterone and IFNτ (Gao et al. 2009). These results suggest 
that the implanting conceptus may regulate protein synthesis on maternal endometrial epithelia 
via IFNτ. Using primary ovine trophectoderm (oTr) cells isolated from GD-15 conceptuses, the 
same group showed that select nutrients, (glucose, Arg and Leu, but not Gln) coordinately 
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activate AKT1-MTOR and RPS6K-RPS6 cell signaling pathways to stimulate hypertrophy, 
hyperplasia, and migration of oTr cells. These results suggest that nutrients in histiotroph 
(select amino acids and glucose) may regulate trophoblast cell hypertrophy, hyperplasia, and 
migration in vivo (Kim et al. 2011b). Therefore, on the one hand, the conceptus regulates 
endometrial celluar protein synthesis via the MTOR pathway; on the other, endometrial 
histiotroph, a secretory product of endometrial epithelial cells, regulates trophoblast cell 
development via the MTOR pathway. Results from above studies collectively suggest that MTOR 
signaling in conceptuses and endometria, in response to a multitude of stimuli, including 
hormones, cytokines, and nutrients, likely mediates interactions between the uterus and 
conceptus that are required for growth and development during the peri-implantation period of 
pregnancy (Bazer et al. 2011; Gao et al. 2009). 
ERK1/2/MAPK signaling pathway 
Another IGF and EGF-activated signaling pathway, which is coupled mainly to mitogenic 
and transcriptional responses, is the extracellular-signal-regulated kinase (ERK) cascade (Figure 
1.2). ERK1/2 mitogen activated protein kinase (MAPK) pathway regulates cell proliferation, 
survival and differentiation. This signaling cascade is activated by many different membrane-
bound receptors including receptor tyrosine kinases, G-protein coupled receptors and integrins 
(McKay and Morrison 2007). The ERK signaling pathway is often divided into membranous and 
cytoplasmic phases for the purpose of illustration. The membranous phase involves growth 
factor receptor-mediated activation of a small GTP binding protein (RAS) by the guanine 
nucleotide exchange factor, son of sevenless homolog (SOS), via adapter protein growth factor 
receptor-bound protein 2 (GRB2) and the cytoplasmic phase involves the sequential stimulation 
of several cytoplasmic protein kinases collectively known as the mitogen-activated protein 
kinase (MAPK) signaling cascade (Seger and Krebs 1995). Typically, the ERK1/2 signal 
transduction is initiated by the growth factor-induced recruitment of the SOS-GRB2 complex to 
the plasma membrane. SHC and IRS1, activated and phosphorylated upon growth factor 
  
22 
 
receptor activation (e.g. IGF1R activation), recruits and activates the SOS-GRB2 complex which 
catalyzes the transformation of an inactive GDP-bound form of RAS (RAS-GDP) into its active 
GTP-bound form (RAS-GTP). RAS-GTP activates the protein serine kinase RAF which in turn 
activates MAPK kinases mitogen- and extracellular signal-regulated kinase-1/2 (MEK1/2). 
MEK1/2 in turn activates the ERK cascade ultimately leading to transcription of genes that drive 
proliferation (Chitnis et al. 2008; Galvan et al. 2003; Kim et al. 1998; Kuemmerle 2003). 
IGF signaling in SCNT pregnancies. Aberrant expression levels for IGF-related genes 
(mRNA and/or protein) in the bovine SCNT conceptus-placental unit during all three trimesters 
of gestation have been reported: IGF1 (GD-25; Moore et al. 2007; GD-150; Ravelich et al. 2004), 
IGF2 (full-term; Chavatte-Palmer et al. 2002; Li et al. 2007; Yang et al. 2005; GD-25; Moore et 
al. 2007; GD-60; Oishi et al. 2006; GD-15: Sawai 2009), IGF1R (full-term; Li et al. 2007; GD-15; 
Sawai 2009), IGF2R (full-term; Li et al. 2007; Long and Cai 2007; Yang et al. 2005; GD-25; 
Moore et al. 2007), IGFBP1 (GD-150; Ravelich et al. 2004), IGFBP2 (full-term; Li et al. 2007; 
GD-50 and GD-100; Ravelich et al. 2004), IGFBP3 (full-term; Li et al. 2007; GD-50, GD-100 
and GD-150; Ravelich et al. 2004; GD-15; Sawai 2009), and IGFBP4 (full-term; Li et al. 2007).  
Given the cellular functions mediated by IGF and insulin signaling, it has been suggested 
that aberrant expression of IGF-related genes in SCNT pregnancies may reflect disturbances in 
energy metabolism (Garry et al. 1996; Ravelich et al. 2004). Indeed insulin (Liu et al. 2009; 
Stump et al. 2003) and IGF (Sonntag et al. 2006; Unterluggauer et al. 2008) signaling have 
been demonstrated to affect cellular ATP levels and/or mitochondrial respiration in other 
biological systems. We and others have observed aberrant expression levels of molecules 
(mRNA or protein) related to mitochondrial oxidative phosphorylation (electron transport chain 
and tricarboxylic acid cycle) or glycolysis in SCNT pregnancies: GD-7 (Zhou et al. 2008b); GD-
18 (Bauersachs et al. 2009); GD-20 (Mansouri-Attia et al. 2009); GD-25 and GD-60 
(Hashizume et al. 2002); and full-term (Everts et al. 2008) bovine SCNT pregnancies, blastocyst 
stage (Whitworth et al. 2011); and GD-26 (Chae et al. 2006; Chae et al. 2009) porcine SCNT 
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pregnancies, and mouse SCNT derived embryos (Vassena et al. 2007). The relationship between 
disturbances in IGF signaling and energy metabolism has not been studied in SCNT 
pregnancies; however, perturbations in IGF signaling and energy metabolism can explain the 
pathogenesis of common clinico-pathological features of SCNT such as placentomegaly, 
increased fetal size, and hydroallantois on the basis of results of several studies carried out in 
sheep (Gadd et al. 2000; Kimble et al. 1999; Lok et al. 1996; Powell and Brace 1991), mice 
(Baker et al. 1993; Gicquel and Le Bouc 2006; Liu et al. 1993), and guinea pigs (Sferruzzi-Perri 
et al. 2006). For example, hydroallantois/hydroamnios and fetal edema have been 
experimentally produced in sheep by artificially elevating lactate levels (Powell and Brace 1991) 
and occluding the umbilical cord (asphyxiation) during the mid-gestation period for 30 minutes 
(Bennet et al. 1999; O'Connell et al. 2006) respectively. Lactate is a byproduct of anaerobic 
energy metabolism (Carter 2000) and high levels of plasma lactate have been demonstrated in 
neonatal SCNT calves (Batchelder et al. 2007). Consistent with this observation, another study 
reported down-regulation of transcript levels of seven genes (SDHA, NDUFB5, COX6C, PPA1, 
UQCRC2, ATP5B, NDUFA4) involved in oxidative phosphorylation (Everts et al. 2008).  
Epidermal growth factor (EGF) signaling 
EGFR activation and downstream signal transduction pathways. The family of family 
of epidermal growth factor (EGF) ligands consists of EGF, heparin binding-EGF (HB-EGF), 
amphiregulin (AREG), betacellulin (BTC), epiregulin (EREG), neuregulins (NRG1 - 4) and 
transforming growth factor α (TGFα) while the family of EGF receptors (EGFR) consists of 
ERBB1–4 (terms EGFR and ERBB1 used interchangeably to denote the same molecule; Dey et 
al. 2004; Jorissen et al. 2003). Ligand binding induces homo/heterodimerization of ERBBs, 
resulting in receptor auto-phosphorylation and trans-phosphorylation, which enhances their 
kinase activity. All ERBB receptors, except ERBB2, have their specific, partially overlapping, 
ligands. For example, it has been shown that the ligands EGF, AREG and TGFα only bind EGFR 
with high affinity; BTC, HB-EGF and EREG bind both EGFR and ERBB4; NRG1 and NRG2 bind 
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both ERBB3 and ERBB4, and that NRG3 and NRG4 bind only ERBB4 (Marmor et al. 2004; 
Schlessinger 2000; Sweeney et al. 2000). A unique feature about ERBB2 is that it does not bind 
any of the known ligands with high affinity, but it is the preferred heterodimeric partner for 
other ERBB- receptors (Marmor et al. 2004).  
Ligand binding to ERBBs generally activates multiple pathways that are often 
functionally interlinked of which PI3K/AKT, RAS/RAF/ERK1/2, and phospholipase C–protein 
kinase C (PLC/PKC) signaling pathways are the best characterized (Jorissen et al. 2003; 
Marmor et al. 2004). ERBBs can recruit the regulatory subunit of PI3K either directly (in case of 
ERBB3 and ERBB4) or via adaptor proteins (in case of EGFR and ERBB2) such as GRB2, SHC 
and Cas-Br-M (murine) ecotropic retroviral transforming sequence (c-Cbl; Jorissen et al. 2003; 
Katso et al. 2001). ERBBs activate the ERK pathway directly through recruitment of GRB2 or 
indirectly through SHC adaptor. Activated EGFR and ERBB2 can bind and phosphorylate PLCγ 
activating it. Activated PLCγ hydrolyzes PIP2 to generate diacylglycerol (DAG) and inositol 
trisphosphate (IP3). Binding of IP3 to receptors on the endoplasmic reticulum induces calcium 
release resulting in increased intracellular calcium levels. Increased calcium levels activate 
calcium/calmodulin-dependent protein kinases and phosphatases, including calcineurin. 
Further, calcium and DAG also activate PKC, resulting in the phosphorylation of a large variety 
of substrates. EGF family of growth factors exert their respective cellular functions such as cell 
proliferation and apoptosis-regulation via these signal transduction pathways (reviewed by 
Marmor et al. 2004).  
EGFs in placentation and peri-implantation period. EGF signaling regulates cell growth 
through proliferation, differentiation, and apoptosis (Bryant et al. 2004) in a variety of cell types 
(Johnstone et al. 2005; Jorissen et al. 2003) including those of the placenta (Johnstone et al. 
2005) and stimulates proliferation and/or migration of trophoblast cells in cattle (Dilly et al. 
2010) and human (Han et al. 2010; Qiu et al. 2004) and has anti-apoptotic effects on human 
trophoblast cells (Garcia-Lloret et al. 1996; Levy et al. 2000). The expression of genes related to 
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the EGF family of mitogens and/or their receptors (mRNA and/or protein) during the sexual 
cycle has been studied in humans (Chobotova et al. 2005; Chobotova et al. 2002; Ejskjær et al. 
2005), cattle (Sağsöz et al. 2011), pigs (Wollenhaupt et al. 1997), and other species (Kida et al. 
2010).  Several studies carried out in mice (Brown et al. 2004; Das et al. 1997; Das et al. 1994; 
Lim et al. 1998; Lim and Dey 2009; Paria et al. 1993; Reese et al. 1998), ewes (Tamada et al. 
2002), rabbits (Klonisch et al. 2001), rhesus monkeys (Yue et al. 2000), and humans 
(Chobotova et al. 2002; Yoo et al. 1997) suggest a role for this family of growth factors during 
the window of implantation. Data on EGF signaling of domestic animals during early pregnancy 
is sparse. One study that looked at the mRNA expression of the EGF ligand in pregnant mares 
reported a marked increase in glandular epithelium coincident with the period of implantation 
and its homogenous maintenance until GD-250. In contrast, failing donkey-in-horse 
pregnancies showed a gradually diminishing patchy expression (Lennard et al. 1998). 
In mice, expression of HB-EGF (Das et al. 1994) and AREG (Brown et al. 2004) was 
observed on LE, expression of EREG and BTC was observed on LE and SES (Das et al. 1997), 
expression of NRG4 was observed on LE and glandular epithelia (Brown et al. 2004), and 
expression of some neuregulin-1 (NRG1) isoforms (neu differentiation factor; NDF (Reese et al. 
1998) and sensory and motor neuron-derived factor; SMDF (Brown et al. 2004)) was observed 
on the SES. Out of these genes, all but NRG4 was exclusively expressed at the site of 
implantation during the peri-implantation period. In contrast, NRG4 mRNA was detected prior 
to implantation. All four ERBB receptors were expressed in the peri-implantation uterus: 
ERBB1 in the SES; ERBB2 and ERBB3 in the LE and ERBB4 on the myometrium (Lim et al. 
1998). Brown and co-workers (2004) also observed upregulation in the expression of ERBB2 
and ERBB3 from the 2-cell stage to the blastocyst stage, and localization of signal to the 
trophectoderm at the blastocyst stage.  
While the exact mode of action for each member of this family is not known, it has been 
demonstrated that some ligands are secreted, facilitating a paracrine type of signaling while 
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others exert their action while being bound to the cell membranes  (Dey et al. 2004; juxtacrine 
and/or autocrine signaling; Falls 2003). Brown and co-workers (2004) suggest that the NRG1 
expressed on the SES may bind ERBBs on the LE and exert their action in a paracrine and/or 
juxtacrine manner while NRG4 expressed in the LE may bind ERBBs on the SES in a juxtacrine 
manner or be secreted in a paracrine manner to interact with ERBBs expressed deeper in 
myometrium. They also suggest that ERBBs on the implanting blastocyst may serve as alternate 
targets of endometrial NRGs and may mediate endometrial receptivity and blastocyst activation. 
These findings collectively suggest that the family of EGF ligands and receptors may be involved 
in preparation of the endometrium for implantation as well as embryo-uterine cross-talk. 
EGF signaling in SCNT pregnancies. In contrast to the IGF system, expression 
levels/patterns of EGF-related genes have not been studied extensively with regard to SCNT 
pregnancies. Based on the microarray data from from a recent study, mRNA levels of ERBB2 
and NRG2 were affected by SCNT in endometria of GD-20 bovine pregnancies. 
Aberrant expression levels (mRNA and/or protein) for IGF and EGF-related genes have 
also been reported in other pregnancy-associated conditions characterized by pre- and/or 
postnatal growth disorders such as Beckwith–Wiedemann syndrome (BWS), and “small for 
gestational age” (SGA) and “large for gestational age” (LGA; Forbes and Westwood 2008; 
Giudice et al. 1995; Klammt et al. 2008; Sparago et al. 2004) pregnancies and implantation 
associated disorders such as placenta accreta in humans (Tseng et al. 2004), respectively. These 
findings emphasize the importance of optimal regulation of IGF and EGF signaling in conceptus 
growth. 
Integrin signaling 
Integrins are trans-membrane receptors that form structural or functional linkages 
between two adjacent cells or a cell with its surrounding extracellular matrix (ECM; Wang et al. 
2012). Integrins consist of non-covalently bound alpha and beta subunits. To-date 18 alpha and 
8 beta subunits have been identified in mammalian cells that give rise to 24 distinct heterodimer 
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combinations (Hynes 2002; Hynes 2004). In addition to their structural role in cell–cell and 
cell–ECM adhesion, integrins also mediate outside-in and inside-out signaling pathways 
through integrin-associated signaling and adaptor molecules such as integrin-linked kinase 
(ILK) and focal adhesion kinase (FAK/PTK2). By virtue of these properties, integrins are able to 
recognize environmental changes, transmit the message across the plasma membrane, and 
mediate a variety of cellular responses such as changes to cell shape, adhesion, migration, cell 
proliferation, differentiation, cytoskeletal rearrangement, and apoptosis/survival during a 
variety of physiological and pathological conditions (Miranti and Brugge 2002; Schwartz and 
Ginsberg 2002).  
Integrins can exist in low- and high-affinity states (Hynes 2002). In the resting, low-
affinity state, the extra-cellular domains of the α and β subunits are in a folded/handshake 
configuration while in the activated, high-affinity state, the distal parts of the extra-cellular 
domains swing open in a switchblade motion (Vinogradova et al. 2002; Xiao et al. 2004). This 
allosteric switch, or ‘integrin activation’, requires transmission of an ‘inside-out’ signal from the 
intra-cellular domains to the extra-cellular domains. It has been shown that this ‘inside-out’ 
signal involves binding of the cytoplasmic protein, talin, to the  intra-cellular domain of the β 
integrin (Anthis et al. 2009). Upon activation, integrins are able to bind ECM proteins such as 
fibronectin, vitronectin, collagen, laminin, thrombospondin, fibrillin, tenascin, osteopontin and 
fibrinogen or other cell adhesion molecules such as ICAMs, VCAM1, or cadherins. Activated 
integrins cluster together forming ‘focal contacts’. Two mechanisms have been proposed for 
integrin clustering: the first model suggests that the clustering involves lateral diffusion of 
integrins on the plasma membrane while the second model suggests that integrins are 
translocated to the plasma membrane where new focal contacts are formed (Kawakami et al. 
2001). Integrin clustering is followed by coclustering of a number of cytoskeletal proteins such 
as talin, paxillin, vinculin or alpha-actinin and regulatory kinases such as FAK and ILK on the 
cytoplasmic face of the plasma membrane. These focal adhesions serve to concentrate effector 
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molecules within a focal adhesion complex (FAC; reviewed by Humphries et al. 2006; Plow et al. 
2000).  
The protein complex resulting from integrin clustering serves as a structural and 
functional link between integrins and the actin cytoskeleton. The cytoplasmic tails of integrins 
serve as binding sites for α-actinin and talin which in turn recruit vinculin. Vinculin anchors to 
F-actin and thereby link the FAC to the actin cytoskeleton (Martin et al. 2002). Upon integrin-
ECM ligation, SCR mediated phosphorylation leads to activation of FAK which plays an 
important role in integrin-mediated cell adhesion, cell survival and cell cycle progression in 
association with other signaling molecules such as Src family kinases, PI3K, Grb2 and Grb7. One 
of the pathways through which integrins activate AKT is via FAK mediated phosphorylation of 
PI3K (Playford and Schaller 2004; Shen and Guan 2001; Sonoda et al. 2000). Integrin-
mediated activation of ERK1/2 signaling is also mediated through FAK via GRB2 in a SRC 
dependent manner (Schlaepfer and Hunter 1996). ILK, another important kinase activated upon 
integrin clustering, also plays a central role in the transduction of many signals initiated by cell-
matrix interactions such as cell proliferation, survival, differentiation, migration, invasion and 
angiogenesis. ILK can directly interact with integrins, paxillin and parvins which link ILK, and 
therefore integrins, to the actin cytoskeleton. One of the pathways through which integrins 
activate AKT is mediated via ILK. ILK, upon binding the beta integrin subunit, phosphorylates 
and activates AKT leading to integrin-mediated cell proliferation and survival (McDonald et al. 
2008).  
Role of integrins in blastocyst attachment to endometrial LE. Cell-cell and cell-ECM 
interactions occur in a variety of physiological events that take place during blastocyst 
implantation and placentation: (i) cell-cell adhesion between adjacent Tr cells, endometrial LE 
cells, GE cells, endothelial cells and and CAR and ICAR stromal cells (Aplin et al. 1996; Kaneko 
et al. 2011; Lessey 1997), (ii) cell-ECM interactions at the conceptus-maternal interface and 
anchoring of GE and endothelial cells to the surrounding stroma, (iii) mediation of BNC 
  
29 
 
migration and fusion with LE (MacIntyre et al. 2002), and (iv) ECM remodeling necessary for 
growth of endometrial glands, endometrial CAR and ICAR stroma,  LE, EET and 
vasculogenesis/angiogenesis. Different groups of cell adhesion-related molecules, including 
integrins, have been implicated in these events (Kimber and Spanswick 2000). For example,  
studies have demonstrated roles for integrins in endometrial receptivity(Lessey 1997), BNC 
migration (MacIntyre et al. 2002), endometrial glandular structure/function (Lessey et al. 
1996), and angiogenesis (Kim et al. 2000). Therefore, proper regulation of integrin-related gene 
expression on Tr, allantois, LE, GE, endothelia and stromal cells would be vital for successful 
implantation in SCNT pregnancies. 
Role of integrins in vasculogenesis and angiogenesis. Blood vessels develop via two 
subsequent processes, vasculogenesis and angiogenesis (Demir et al. 2010), both crucial events 
in blastocyst implantation, placentation and conceptus growth. Vasculogenesis is the formation 
of primitive capillaries by in situ differentiation of stem cells derived from pluripotent 
mesenchymal cells. Vasculogenesis is followed by angiogenesis, which is the development of new 
vessels from already existing vessels. Both these events involve extensive interplay among 
endothelial cells themselves and endothelial cells and ECM (Wang et al. 2012) which involves 
the participation of cell adhesion molecules. Certain integrin sub-units have been shown to 
directly regulate events associated with vasculogenesis and/or angiogenesis: ITGβ1, ITGβ3, and 
ITGβ4 have been shown to participate in endothelial cell apoptosis (Rice et al. 2006), while 
blockade of ITGαv or ITGα5 resulted in inhibition of angiogenesis (Kim et al. 2000). Therefore 
optimal regulation of cell adhesion molecules is important for optimal regulation of 
vasculogenesis and angiogenesis during the peri-implantation period.  
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CHAPTER 1 TABLES 
Table 1.1. Timing of implantation associated events in mouse, rat, sheep, cattle, pig and human 
(Compiled from Chavatte-Palmer and Guillomot 2007; Eakin and Behringer 2004).  
Species 
Time point in gestation (days) 
Entry to uterus Loss of zona pellucida Implantation Gastrulation 
Mouse 3 4 4.5 6 
Rat 3-4 5 5.5 6-7 
Sheep 4 8-9 15 9 
Cattle 4 9-10 19-20 13 
Pig 2 6 14 7 
Human 3-4 5 6-7 13-15 
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CHAPTER 1 FIGURES 
 
Figure 1.1. "AKT signaling" GeneGo Pathway Map 
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Figure 1.2. "ERK1/2  signaling" GeneGo Pathway Map 
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Goals of thesis research 
The objectives of the thesis research were: (i) to identify effects of somatic cell nuclear 
transfer (SCNT) on cellular localization and/or abundance of 16 preselected transcripts related 
to growth factor signaling and cell adhesion in endometria of peri-implantation stage bovine 
pregnancies, (ii) to define integrin and extracellular matrix (ECM) protein-encoding genes that 
are transcribed in endometria and EET of peri-implantation stage bovine pregnancies and to 
identify the effects of SCNT on their transcription, and (iii) to define insulin-like growth factor 
(IGF) and epidermal growth factor (EGF) signaling-related genes that are transcribed in 
endometria and extra embryonic tissues (EET) of peri-implantation stage bovine pregnancies 
and to identify the effects of SCNT on their transcription. 
For the first objective, the major hypotheses tested were: (i) endometrial transcript levels 
of IGF1, IGF1R, IGF2, IGF2R, IGFBP6, INSR, NRG2, ERBB2, ACTN4, BCAM, GRB7 and ITGB4 
are aberrant in SCNT pregnancies during the peri-implantation period, and (ii) localizations of 
ITGA3, ITGB4, ITFG3, BCAM, ACTN4, DES, FAK1, GRB7, ERBB2, NRG2, IGF1, IGF2, IGF1R, 
IGF2R, IGFBP6, and INSR transcripts are aberrant in endometria of SCNT pregnancies during 
the peri-implantation period. 
For the second objective, the major hypotheses tested were: (i) transcript levels of genes 
encoding integrins are aberrant in SCNT pregnancies, and (ii) transcript levels of genes 
encoding ECM proteins are aberrant in SCNT pregnancies.  
For the third objective, the major hypotheses tested were: (i) transcript levels of genes 
encoding ligands, receptors and binding proteins related to IGF1R activation are aberrant in 
SCNT pregnancies, (ii) transcript levels of genes encoding ligands and receptors related to 
EGFR/ERBB activation are aberrant in SCNT pregnancies, and (iii) transcript levels of genes 
related to PI3K/AKT and ERK1/2 signal transduction pathways are aberrant in SCNT 
pregnancies. 
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 Findings of this study extend current understanding of (i) the temporal regulation of 
IGF signaling, EGF signaling and cell adhesion during the peri-implantation period in cattle, 
and (ii) perturbations of IGF signaling, EGF signaling and cell adhesion in bovine SCNT 
pregnancies during the peri-implantation period. Our findings provide cues for reducing peri-
implantation losses and thereby improving cloning efficiency in cattle, and other mammals. 
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Chapter 2: Aberrant endometrial expression of select transcripts related to 
IGF signaling, EGF signaling and cell adhesion in response to somatic cell 
nuclear transfer during the peri-implantation period in cattle 
 
ABSTRACT 
Pregnancy losses during the peri-implantation period can be up to 70% in somatic cell nuclear 
transfer (SNCT)–derived bovine pregnancies. We hypothesized that cell adhesion and IGF and 
EGF growth factor-signaling are perturbed in endometria of pregnant cows carrying SCNT-
derived bovine conceptuses during the peri-implantation period. To test this hypothesis, 16 
candidate genes were selected (ITGA3, ITGB4, ITFG3, BCAM, ACTN4, DES, FAK1, GRB7, 
ERBB2, NRG2, IGF1, IGF2, IGF1R, IGF2R, IGFBP6, and INSR) and their expression tested 
using quantitative real time-PCR (qRT-PCR) and in situ hybridization on endometria collected 
from gestation day (GD)-18 (AI:N=11; SCNT:N=10) and GD-34 (AI:N=10; SCNT:N=8) bovine 
pregnancies derived from artificial insemination (AI) and SCNT. Expression levels of all genes 
quantified (N=12) decreased from GD-18 to GD-34 (FDR P<0.05) on caruncular (CAR) and/or 
inter-caruncular (ICAR) tissues of both AI and SCNT pregnancies. Five genes were aberrantly 
expressed on CAR and/or ICAR tissues from SCNT pregnancies (FDR P<0.05): (i) GD-18 CAR; 
BCAM up-regulated, (ii)  GD-18 ICAR; NRG2 down-regulated, (iii) GD-34 CAR; IGF1R and 
NRG2 up-regulated; IGFBP6 down-regulated, and (iv) GD-34 ICAR; IGF1R and ERBB2 up-
regulated; IGFBP6 down-regulated. Cellular localizations of hybridized mRNAs were not 
different between tissues from AI and SCNT pregnancies. Our findings on transcript levels of 
genes related to cell adhesion, IGF signaling and EGF signaling extend current understanding of 
temporal regulation of these molecular functions during the peri-implantation period and 
suggest that their perturbations may contribute to the high embryo mortalities and other 
clinico-pathological features observed in SCNT pregnancies during the peri-implantation period 
in cattle. 
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INTRODUCTION 
Cloning via somatic cell nuclear transfer (SNCT) is considered an inefficient process 
(Hill et al. 2000; Wakayama and Yanagimachi 1999). Bovine pregnancies derived from SNCT 
are characterized by high pregnancy losses throughout gestation (Wilmut et al. 2002), high 
incidences of protracted gestation and dystocia (Chavatte-Palmer et al. 2002; Kruip and den 
Daas 1997), and clinico-pathological features such as Large Offspring Syndrome (Chavatte-
Palmer et al. 2002; Walker et al. 1996), placentomegaly and hydroallantois (Constant et al. 
2006; Hill et al. 1999). In contrast to the average calving rate of 55% (King 1991) in artificial 
insemination (AI)-derived bovine pregnancies (hereafter denoted AI pregnancies), SCNT-
derived bovine pregnancies (hereafter denoted SCNT pregnancies) have a modest average 
calving rate of 9% (Panarace et al. 2007). 
Pregnancy losses are particularly high during the pre- and early post-implantation 
periods and may be up to 70% in SCNT derived bovine pregnancies (Chavatte-Palmer et al. 
2012b; Heyman 2005). Implantation, a complex process regulated by many molecular 
pathways, not only initiates the intimate and firm contact between the conceptus and the uterine 
food source (Wooding et al. 1982), but also serves to initiate placentation (Blomberg et al. 2010). 
Growth restriction during this phase of placentation-initiation is known to affect the number of 
placentomes formed (Wathes et al. 1998), a characteristic feature of bovine SCNT pregnancies 
(De Sousa et al. 2001; Hill et al. 1999). Considering these observations, we hypothesized that 
one or more pathways that regulate blastocyst implantation in bovine SCNT pregnancies may be 
perturbed. On the basis of results from previous studies conducted by our group (Mansouri-
Attia et al. 2009), we hypothesized that cell adhesion and insulin-like growth factor (IGF) and 
epidermal growth factor (EGF) signaling, two molecular functions important for successful 
implantation (Brown et al. 2004; Harvey et al. 1995; Johnson et al. 2001; Pandey et al. 2009; 
Schultz et al. 1997), are perturbed at the conceptus-maternal interface in SCNT pregnancies and 
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that these perturbations may be reflected on the endometrial transcriptome of surrogate 
mothers (hereafter denoted SCNT endometria). 
IGFs are metabolically anabolic (Fowden 2003; Jones and Clemmons 1995), and in 
response to changes in the nutrient supply, regulate cellular uptake of glucose and amino acids, 
cellular metabolism of carbohydrates and proteins (Chi et al. 2000; Fowden and Forhead 2009; 
Maki 2010), and cellular replication and differentiation by functioning as a progression factor in 
the cell cycle (Jones and Clemmons 1995). By virtue of these metabolic characteristics, the IGF 
system may act as a nutrient sensor (Gicquel and Le Bouc 2006; Thissen et al. 1994) that 
ensures feto-placental growth commensurate with the maternal nutrient supply (Fowden and 
Forhead 2009). EGF signaling regulates cell growth through proliferation, differentiation, and 
apoptosis (Bryant et al. 2004) in a variety of cell types including those of the placenta 
(Johnstone et al. 2005; Jorissen et al. 2003). EGF signaling also stimulates proliferation and/or 
migration of trophoblast cells in cattle (Dilly et al. 2010) and human (Han et al. 2010; Qiu et al. 
2004), and has anti-apoptotic effects on human trophoblast cells (Garcia-Lloret et al. 1996; Levy 
et al. 2000). Demonstration of spatial and/or temporal changes in endometrial expression of 
certain IGF-related genes (Geisert et al. 1991; Kirby et al. 1996; Ko et al. 1991; Simmen et al. 
1992), and EGF-related genes (Brown et al. 2004; Chobotova et al. 2002; Das et al. 1994; Lim 
and Dey 2009; Paria et al. 1993; Reese et al. 1998; Tamada et al. 2002) in several species during 
the peri-implantation period suggests a role for IGF and EGF signaling during this period. 
Because autocrine and paracrine modes of growth factor action have been postulated to mediate 
conceptus-placental growth (Schultz and Heyner 1993; Simmen and Simmen 1991), IGFs and/or 
EGFs from the endometrium can potentially regulate mitogenic and metabolic activities not only 
on the uterus, but also on the conceptus, even prior to implantation (Korgun et al. 2003; 
Simmen and Simmen 1991). Therefore, it has been suggested that the uterus may be able to 
regulate conceptus development by changing the composition of histiotroph/uterine luminal 
fluid (ULF; Bazer et al. 2011; Kim et al. 2011b; Roberts and Bazer 1988). IGF1, IGF2 and EGF 
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have been demonstrated in the ULF among other nutrients/metabolites and growth factors 
(Hempstock et al. 2004; Simmons et al. 2009).  
A variety of cell adhesion molecules, including integrins, have been implicated in cell-cell 
and cell-extra cellular matrix (ECM) interactions that take place during blastocyst implantation 
(Kimber and Spanswick 2000). Upon ligation with ECM proteins, integrins cluster together and 
form focal adhesion complexes (FAC; Rohrschneider 1980). The FAC is comprised of adapter 
proteins that bridge cytoplasmic tails of integrins to the actin cytoskeleton and cytoplasmic 
kinases that induce downstream signal transduction pathways (Bridger et al. 2008) and thereby 
regulate cellular functions critical for blastocyst implantation and placentation  (Armant 2005; 
Spencer and Bazer 2004a). Studies carried out in several species suggest a role for integrin 
signaling in blastocyst implantation (human; Coutifaris et al. 1998; sheep; Johnson et al. 2001; 
cattle; MacIntyre et al. 2002; mice; Wang et al. 2002). 
A previous study from our group showed aberrant expression of genes related to IGF and 
EGF signaling; cell surface adhesion molecules; components of the focal adhesion complex;  and 
cytoskeleton in peri-implantation stage bovine SCNT endometria (Mansouri-Attia et al. 2009). 
Aberrant expression levels (mRNA and/or protein) for IGF and EGF-related genes have also 
been reported in other pregnancy-associated conditions characterized by pre- and/or postnatal 
growth disorders such as Beckwith–Wiedemann syndrome (BWS), and “small for gestational 
age” (SGA) and “large for gestational age” (LGA; Forbes and Westwood 2008; Giudice et al. 
1995; Klammt et al. 2008; Sparago et al. 2004) pregnancies and implantation associated 
disorders such as placenta accreta in humans (Tseng et al. 2004), respectively. These findings 
emphasize the importance of optimal regulation of IGF and EGF signaling in conceptus growth. 
Considering the functions regulated by these groups of proteins during gestation, and the 
clinico-pathological features associated with SCNT pregnancies, genes related to cell adhesion 
and growth factor-signaling are attractive for studying perturbed implantation in bovine SCNT 
pregnancies. On the basis of results from previous studies conducted by our group (Mansouri-
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Attia et al. 2009), mRNA levels and/0r localization of 16 candidate genes related to above 
molecular functions were selected and tested on endometrial tissue collected from AI and SCNT 
pregnancies at gestation day (GD)-18 (pre-implantation) and GD-34 (early post-implantation). 
Our findings on aberrant transcript levels of genes related to cell adhesion, IGF signaling and 
EGF signaling in SCNT pregnancies suggest that these molecular functions are perturbed in 
SCNT endometria during the peri-implantation period. Findings of this study also support and 
extend current understanding of temporal regulation of these molecular functions during the 
peri-implantation period in cattle. 
RESULTS 
Of the SCNT pregnancies, two conceptuses were recovered from five and three 
pregnancies at GD-18 and GD-34 respectively. Of the AI pregnancies, two conceptuses were 
recovered from a single GD-34 pregnancy. All other pregnancies used for sample collection 
yielded a single conceptus. All SCNT-derived conceptuses were female while AI-derived 
conceptuses were of both sexes (GD-18: four males and three females; three sex undetermined, 
GD-34: seven males and one female; two sex undetermined). 
Localization of mRNAs is not different between AI and SCNT pregnancies. Cellular 
localization of mRNA was tested for all 16 genes. Hybridization of anti-sense probes of ITGB4, 
ACTN4, BCAM, ITFG3, DES, ERBB2, NRG2, IGF1, IGF2 and IGF1R on tissue sections produced 
cell-type-specific signals while their corresponding sense probes did not. Hybridization of anti-
sense probes of IGF2R, IGFBP6, INSR, FAK1, and GRB7 did not produce a hybridization signal 
while signals produced by anti-sense and sense probes of ITGA3 were indistinguishable. Desmin 
mRNAs did not localize to endometrial tissue (hybridization signals observed on myometrium). 
At GD-18, mRNA localization was observed on LE (all except ITFG3 and IGF2), superficial GE 
(ERBB2, NRG2, IGF1, IGF1R, ITFG3, BCAM, ACTN4, and ITGB4), deep GE (all genes expressed 
on superficial GE except BCAM), ICAR stroma (ITGB4, NRG2, and IGF1; Figure 2.1K), CAR 
stroma (ITGB4, IGF1 and IGF2), and endothelia (ITGB4, NRG2, IGF1; Figure 2.1L and IGF2) in 
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most but not all samples (Figure 2.1). In the case of BCAM and ACTN4, the intensity of the 
hybridization signal was stronger on LE than on GE. Consistent with previous reports for post-
implantation stage bovine endometria (King et al. 1981), LE was disrupted and absent in almost 
all GD-34 endometrial samples; thus we could not obtain reliable information about mRNA 
localization on LE at this stage of gestation. With the exception of the LE, mRNA localization at 
GD-34 was similar to that at GD-18. Localization of ITFG3 was unique in that it was exclusively 
expressed in GE at both time points. Expression of ITFG3 was stronger in deep GE than in 
superficial GE in several but not all samples (Figure 2.1G). None of the observed localizations 
were different between AI- and SCNT-derived tissues.  
Gene expression levels are significantly different between SCNT and AI, GD-34 and 
GD-18 and CAR and ICAR. Levels of mRNA were quantified for 12 genes (Table 2.1) and 
differences in gene expression levels tested for fixed effects (day, tissue, group, and plate), two-
way interactions (day*tissue, group*tissue and day*group), and 12 specific pair-wise 
comparisons. Expression levels of all genes were associated with at least two of the four fixed 
effects (day; all genes except IGF2R, tissue; all genes except INSR and ACTN4, group; all genes 
except IGF1, IGF2, INSR, NRG2, BCAM, and GRB7, and plate; all genes except IGF1R, ERBB2, 
BCAM, GRB7, and ITGB4). Expression levels of five genes were associated with at least one of 
the three two-way interactions (day*group; IGF1R and NRG2, day*tissue; IGF2, IGF2R, IGFBP6 
and NRG2, group*tissue; NRG2; P<0.05; Table 2.2). The results of the 12 pair-wise 
comparisons are summarized on tables 2.3 – 2.5. 
Expression levels of all 12 genes were lower at GD-34 than at GD-18 (1.26 – 3.84-fold 
decrease) in CAR and/or ICAR tissues in AI and SCNT pregnancies. All genes except IGF2R, 
IGFBP6 and NRG2 were significantly different between GD-18 and GD-34 in both CAR and 
ICAR in both AI and SCNT pregnancies. Expression levels of IGF2R and IGFBP6 were different 
in ICAR and CAR, respectively, in both AI and SCNT pregnancies. Expression of NRG2 was 
different in CAR in both AI and SCNT pregnancies and in ICAR only in AI pregnancies (FDR 
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P<0.05; Table 2.3). Expression levels of four and two genes were aberrant in SCNT endometria 
at GD-34 and GD-18, respectively (FDR P<0.05; Table 2.4). Of the four genes that were 
aberrantly expressed in SCNT endometria at GD-34, three were up-regulated (IGF1R, ERBB2 
and NRG2 1.36 – 1.52-fold increase), and one was down-regulated (IGFBP6; 1.33 – 1.39-fold 
decrease) compared to expression levels in endometria of cows carrying AI-derived conceptuses 
(hereafter denoted AI endometria). The up-regulation of IGF1R and down-regulation of IGFBP6 
in SCNT endometria were observed in both CAR and ICAR tissue while the up-regulation of 
ERBB2 and NRG2 in SCNT endometria was observed in ICAR and CAR respectively. At GD-18, 
NRG2 was down-regulated in ICAR (1.30-fold decrease) and BCAM was up-regulated in CAR 
(1.37-fold increase) of SCNT endometria (Table 2.4).  
Expression levels for all genes except INSR and ACTN4 were significantly different 
between CAR and ICAR during at least one of the two time-points. All differentially expressed 
cell adhesion-related genes were lower in CAR than in ICAR (1.49 – 3.23-fold decrease) at GD-
18 and/or GD-34. Out of the growth factor-related genes that were differentially expressed 
between CAR and ICAR, expression levels of IGF1R and ERBB2 were lower in CAR than in ICAR 
(1.56 – 2.22-fold decrease) at both time points of gestation and those of IGF1, IGF2, IGF2R, 
IGFBP6, and NRG2 were higher in CAR than in ICAR (1.32 – 3.90-fold increase; Table 2.5). 
DISCUSSION 
Sixteen candidate genes were selected to test the hypothesis that spatiotemporal 
regulation of transcription of cell adhesion and IGF and EGF signaling-related genes is 
disturbed in bovine SCNT pregnancies during the peri-implantation period of gestation. All 16 
genes were tested by ISH and additionally transcript levels of 12 of the 16 were tested by qRT-
PCR. Expression levels of all 12 genes were significantly higher at GD-18 than at GD-34 in CAR 
and/or ICAR, five were significantly different between SCNT and AI in CAR and/or ICAR, and 
10 were significantly different between CAR and ICAR at GD-18 and/or GD-34. 
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Temporal gene expression differences of IGF and EGF-related genes may reflect 
changes in metabolic/growth demands through implantation. Comparison of endometrial gene 
expression levels between the two time points showed that transcript levels of all eight growth 
factor signaling-related genes were higher at GD-18 than at GD-34 (Table 2.3). Other studies of 
mRNA/protein levels of IGF or EGF related-genes at more than one time-point during the peri-
implantation period in cattle (Geisert et al. 1991; Kirby et al. 1996), sheep (Reynolds et al. 1997), 
and other species (Brown et al. 2004; Das et al. 1997; Das et al. 1994; Kapur et al. 1992; Ko et al. 
1994; Simmen et al. 1992) also reported higher expression levels close to or at implantation 
compared to cyclic or post-implantation stages. These observations suggest that endometrial 
expression of IGF and EGF related-genes and thus IGF and EGF signaling may have an 
important role in blastocyst implantation. Implantation involves extensive remodeling of the 
endometrium which imposes acute metabolic demands on its cells (Korgun et al. 2003). 
Therefore, given the metabolic and growth functions of IGF (Fowden 2003; Harding et al. 1994) 
and EGF signaling (Johnstone et al. 2005; Jorissen et al. 2003), it is possible that the growth 
and/or metabolic demands, and in turn the physiological requirement for IGF and EGF 
signaling in the endometrium increases towards implantation and declines afterwards, and this 
is what is reflected in our findings. 
Spatial gene expression differences of IGF and EGF-related genes may reflect their 
involvement in placentome and endometrial gland formation/function. Comparison of 
endometrial gene expression levels between CAR and ICAR showed that transcript levels of 
IGF1, IGF2, IGF2R, IGFBP6 and NRG2 were higher in CAR than in ICAR at GD-18 and/or GD-
34 (1.28 – 3.90-fold increase). Given the cell proliferation/differentiation/metabolism-related 
functions of IGF (Fowden 2003; Harding et al. 1994) and EGF signaling (Johnstone et al. 2005; 
Jorissen et al. 2003), increased expression of the above genes on CAR tissue likely reflects tissue 
remodeling activities in preparation for placentome formation. Consistent with our 
observations, another study reported stronger expression of IGF2 mRNA on CAR compared to 
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ICAR in peri-implantation stage cows and the authors concluded that IGF2 may play a role in 
the growth of CAR tissue (Robinson et al. 2000). In contrast, transcript levels of IGF1R and 
ERBB2 were up-regulated in ICAR compared to CAR at both time points (1.47 – 2.22-fold 
increase; Table 2.5).  
On the basis of our ISH results, IGF1R and ERBB2 expression was observed on GE and 
LE at GD-18 and predominantly or exclusively on GE at GD-34 suggesting that they may have a 
role in endometrial gland proliferation and/or secretion. In cattle (King et al. 1981), sheep 
(Spencer and Bazer 2004a; Stewart et al. 2000), and pigs (Sinowatz and Friess 1983), 
endometrial glands undergo extensive hyperplasia and hypertrophy during pregnancy, 
presumably in response to increasing demands by the developing conceptus for uterine 
histiotroph (Samuel et al. 1977; Stewart et al. 2000). It is believed that uterine gland 
morphogenesis is regulated through interactions between GE and surrounding stroma (Gray et 
al. 2001a) via paracrine and autocrine pathways (Kurita et al. 1998), and involve IGF and/or 
(Taylor et al. 2001; Taylor et al. 2000) EGF signaling (Giudice and Saleh 1995). Proliferating 
endometrial GE of the neonatal ovine uterus expresses IGF1R while the stroma surrounding 
them expresses IGF1 and IGF2 (Taylor et al. 2001; Taylor et al. 2000) suggesting that stromal 
IGF1 and IGF2 may stimulate proliferation of IGF1R expressing GE (Gray et al. 2001a). 
Consistent with the above expression pattern, several reports have shown the expression of 
IGF1R (mid-gestation ewes; Gadd et al. 2000; GD-13 - GD-55 ewes; Reynolds et al. 1997; GD-16 
cows; Robinson et al. 2000; GD-18 and GD-34 cows; this report), ERBB2 (cyclic cows; Sağsöz et 
al. 2011; GD-18 and GD-34 cows; this report) and EGF (implantation through late gestation in 
mares; Lennard et al. 1998) in GE, and expression of IGF1 in ICAR stroma (ewes; Reynolds et al. 
1997; cattle; this report) in cyclic/pregnant animals. Therefore it is possible that 
hyperplasia/hypertrophy and/or secretory activity of GE during the peri-implantation period in 
ruminants are also governed by signaling mechanisms similar to those described for the 
neonatal ovine uterus. We specifically observed expression of IGF1 in ICAR stroma surrounding 
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GE (Figure 2.1K). Others have also argued that spatial and temporal expression patterns of 
IGF1R and/or IGF1 mRNA in peri-implantation stage cattle (Robinson et al. 2000) and ewes 
(Wathes et al. 1998) suggest a role for these genes in endometrial gland secretion. The 
importance of IGF signaling in endometrial glands was emphasized by another study that 
reported strongest endometrial expression for IGF1R, IGF2R, IGFBP1, IGFBP3, and IGFBP5 on 
GE in mid gestation ewes (Gadd et al. 2000). Considering the above observations, the 
significantly higher expression of IGF1R and ERBB2 in ICAR compared to CAR (1.47 – 2.22-fold 
increase; FDR P<0.01) and their localization on GE suggest a role for these genes in endometrial 
glandular proliferation/function in peri-implantation stage bovine pregnancies. 
Aberrant expression of IGF and EGF-related genes in SCNT endometria may reflect 
perturbed growth/metabolic demands of SCNT conceptuses. Comparison of endometrial gene 
expression levels between AI and SCNT showed that transcript levels of four of the eight IGF 
and EGF-related genes were aberrant in SCNT. Aberrant gene expression was observed for 
seven different comparisons, one and six comparisons at GD-18 and GD-34 respectively (Table 
2.4), suggesting that perturbations related to IGF and EGF signaling in SCNT endometria 
become exacerbated after implantation. Increases of IGF ligand/IGF1R levels and/or decreases 
of IGFBP levels generally result in augmentation of IGF signaling (Grimberg 2003). In GD-34 
endometria, transcript levels of IGF1R were significantly higher and that of IGFBP6 was 
significantly lower (IGFBP6 preferentially binds and sequesters IGF2; Cacalano et al. 2008; 
Gicquel and Le Bouc 2006) in SCNT compared to AI suggesting that IGF signaling may be 
augmented in SCNT endometria at GD-34. ERBB2 and NRG2 mRNA levels were also higher in 
SCNT than in AI, in ICAR and CAR respectively, suggesting that EGF signaling may also be 
augmented in SCNT endometria at GD-34. Supporting above hypotheses of augmented IGF 
signaling and EGF signaling in GD-34 SCNT endometria, IGF2 mRNA levels (1.21 fold-increase; 
FDR P<0.1) and ERBB2 mRNA levels (1.28 fold-increase; FDR P<0.06) showed a tendency to 
be up-regulated in SCNT CAR. Given the cell proliferation/differentiation/metabolism-related 
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functions of IGF (Fowden 2003; Harding et al. 1994) and EGF signaling (Johnstone et al. 2005; 
Jorissen et al. 2003), these perturbations in GD-34 SCNT endometria may reflect altered growth 
and/or metabolic demands on its cells presumably imposed by the SCNT conceptus.   
One or more of the following factors also may have contributed to the higher transcript 
levels observed for IGF1R, ERBB2 and NRG2 in SCNT endometria. First, certain studies showed 
that peri-implantation stage bovine SCNT conceptuses were developmentally delayed compared 
to control conceptuses (Alexopoulos et al. 2008). Given that the expression of all tested genes 
decreased from GD-18 to GD-34, the apparent up-regulation of above three genes in SCNT at 
GD-34 may be due to such a developmental delay in SCNT conceptuses. However, because 
transcript levels of all 12 genes significantly decreased from GD-18 to GD-34, it could be argued 
that such a delay in development should result in up-regulation of most, if not all 12 genes. 
Secondly, all SCNT-derived embryos were female while AI-derived GD-34 embyos were 
predominantly male. Sex-related differences of mRNA abundances have been reported in bovine 
blastocysts for certain genes (Bermejo-Álvarez et al. 2010). However, to our knowledge there are 
no reports indicating sex-related differences of IGF/EGF signaling during the peri-implantation 
period of gestation. Thirdly, the average number of conceptuses per pregnancy was higher in 
SCNT than in AI pregnancies. Two SCNT-derived blastocysts were transferred to each surrogate 
mother and twin conceptuses were observed in three of the eight SCNT pregnancies at GD-34. 
In contrast, of the 10 AI pregnancies, twin conceptuses were observed only in one pregnancy. 
Therefore it could be argued that the presence of twin conceptuses may impose higher 
growth/metabolic demands on SCNT endometria, and that gene expression differences 
suggestive of augmented IGF and EGF signaling in GD-34 SCNT endometria may be due to the 
different numbers of conceptuses/pregnancy in SCNT and AI gestations. However, it should also 
be noted that twin conceptuses were observed in five of the 11 GD-18 SCNT pregnancies while 
none of the GD-18 AI pregnancies yielded twin conceptuses. In spite of these differences, 
transcript levels of the genes tested by this study did not suggest augmented IGF/EGF signaling 
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on the GD-18 SCNT endometrium. Therefore, it could be argued that the differences observed in 
GD-34 SCNT endometria may not be due to the higher incidence of twin conceptuses in GD-34 
SCNT pregnancies.  
To our knowledge, only one other study examined expression of IGF-related genes on 
both pre- and post-implantation stage SCNT pregnancies(Moore et al. 2007). Moore et al. 
(2007) compared levels of IGF1, IGF2, IGF1R and IGF2R mRNAs on bovine conceptuses 
derived from AI, in vitro production, parthenogenesis and SCNT at pre-implantation (GD-7) 
and post-implantation (GD-25) time points of gestation and found no differences between SCNT 
and controls at GD-7. In contrast, post-implantation mRNA levels of IGF1, IGF2 and IGF2R 
were higher in SCNT conceptuses than in AI (Moore et al. 2007). Collectively, our findings on 
SCNT endometria and those of Moore et al. (2007) with SCNT conceptuses suggest that IGF 
signaling on both sides of the conceptus-maternal interface may be perturbed post-
implantation, presumably in response to altered growth and/or metabolic demands by the SCNT 
conceptus. In fact, perturbations in volume densities of cellular organelles associated with 
cellular metabolism has been demonstrated in in vitro produced bovine blastocysts (Crosier et 
al. 2001). Given the autocrine and paracrine modes of growth factor action at the conceptus-
maternal interface (Schultz and Heyner 1993; Simmen and Simmen 1991), it is possible that the 
changes in endometrial gene expression observed by us in relation to IGF signaling reflect 
compensatory mechanisms to altered metabolic demands from the conceptus. 
Aberrant expression of IGF1R and ERBB2 in SCNT ICAR may reflect perturbed 
endometrial glandular proliferation/function. Prior to establishment of a placenta, conceptus 
growth and development is dependent on the endometrial glandular secretion, histiotroph in all 
mammals (Bazer 1975; Spencer and Bazer 2004b; Wimsatt 1950). As discussed earlier, to meet 
the histiotroph demands of the developing conceptus, endometrial glands undergo extensive 
proliferation during this period (Samuel et al. 1977; Stewart et al. 2000). Given that IGF (Taylor 
et al. 2001; Wathes et al. 1998) and EGF (Giudice and Saleh 1995) signaling have been 
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implicated in endometrial gland proliferation (Gray et al. 2001a), and our results demonstrating 
IGF1R and ERBB2 expression predominantly on GE at GD-34, the significantly higher 
expression of IGF1R and ERBB2 in SCNT ICAR than in AI ICAR at GD-34 (1.39 - 1.41-fold; FDR 
P<0.01) appears to reflect altered endometrial glandular proliferation and/or secretory function 
in SCNT endometria.  
Findings from several studies suggest that the conceptus communicates with 
endometrial glands for its nutritional and developmental requirements during the peri-
implantation period: (i) in early-implanting ruminant pregnancies, transitory trophoblastic villi 
that invade endometrial glandular ducts (Guillomot et al. 1981), presumably involved in 
anchorage and/or absorption of histiotroph (Chavatte-Palmer and Guillomot 2007), have been 
reported, (ii) studies carried out in sheep, rabbit, and pig indicate that the conceptus signals the 
glands to enhance their development and functionality (Johnson et al. 2003b; Johnson et al. 
1999b; Spencer et al. 1999; Spencer et al. 2004b), (iii) initial attachment between the human 
conceptus and the endometrium takes place between openings of adjacent uterine glands 
(Hamilton and Boyd 1960), (iv) early gestational death of porcine SCNT embryos was caused, at 
least in part, by disruption of the developing endometrial glands as a result of impaired 
trophoblast migration and invasiveness (Kim et al. 2011a), and (v) studies using the ovine 
uterine gland knockout (UGKO) model also demonstrated that a normal glandular 
endometrium is essential for peri-implantation conceptus survival and growth (Gray et al. 
2001b). Therefore, if endometrial glandular proliferation and/or function are indeed altered in 
peri-implantation stage bovine SCNT pregnancies, as suggested by our results, it may be a 
compensatory response by the endometrium to altered nutritional and/or metabolic demands of 
the SCNT conceptus. 
Others have reported aberrant expression levels for IGF-related genes (mRNA and/or 
protein) in the bovine SCNT conceptus-placental unit during all three trimesters of gestation: 
IGF1 (GD-150; Ravelich et al. 2004), IGF2 (full-term; Chavatte-Palmer et al. 2002; Li et al. 
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2007; Yang et al. 2005; GD-60; Oishi et al. 2006; GD-15: Sawai 2009), IGF1R (full-term; Li et 
al. 2007; GD-15; Sawai 2009), IGF2R (full-term; Li et al. 2007; Long and Cai 2007; Yang et al. 
2005), IGFBP1 (GD-150; Ravelich et al. 2004), IGFBP2 (full-term; Li et al. 2007; GD-50 and 
GD-100; Ravelich et al. 2004), IGFBP3 (full-term; Li et al. 2007; GD-50, GD-100 and GD-150; 
Ravelich et al. 2004; GD-15; Sawai 2009), and IGFBP4 (full-term; Li et al. 2007). Collectively, 
these observations suggest that IGF signaling may be perturbed in SCNT pregnancies 
throughout gestation. 
Given the functions mediated by IGF and insulin signaling, some have suggested that 
aberrant expression of IGF related-genes in SCNT pregnancies likely reflects disturbances in 
energy metabolism (Garry et al. 1996; Ravelich et al. 2004). Findings from several studies 
showing aberrant expression levels of molecules (mRNA or protein) related to mitochondrial 
oxidative phosphorylation (electron transport chain and tricarboxylic acid cycle) and glycolysis 
(Table 2.6) support the hypothesis that energy metabolism may be perturbed in SCNT 
pregnancies at the cellular level. Even though the regulation of cellular ATP levels and/or 
mitochondrial respiration by insulin (Liu et al. 2009; Stump et al. 2003) and IGF (Sonntag et al. 
2006; Unterluggauer et al. 2008) signaling has been demonstrated in other biological systems, 
the same has not been studied in SCNT pregnancies to-date. Collectively, above observations 
support hypotheses by Ravelich et al. (2004) and Garry et al. (1996) that perturbed gene 
expression levels related to IGF/insulin signaling in SCNT pregnancies reflect disturbances in 
energy metabolism. Perturbations in IGF signaling and energy metabolism can explain the 
pathogenesis of common clinico-pathological features of SCNT such as placentomegaly, 
increased fetal size, and hydroallantois on the basis of results of several studies carried out in 
sheep (Gadd et al. 2000; Kimble et al. 1999; Lok et al. 1996; Powell and Brace 1991), mice 
(Baker et al. 1993; Gicquel and Le Bouc 2006; Liu et al. 1993), and guinea pigs (Sferruzzi-Perri 
et al. 2006). 
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Endometrial expression levels of cell adhesion-related genes decrease from GD-18 to 
GD-34. Comparison of endometrial gene expression levels between the two time points showed 
that transcript levels of all four cell adhesion-related genes were higher at GD-18 than at GD-34 
(Table 2.3). Similar to the decline in growth factor signaling-related genes, this may be due to a 
decline in endometrial remodeling activities post-implantation. Alternatively, it may be due to 
the loss of the LE in GD-34 samples, the cell type in which the highest expression for ITGB4, 
BCAM, and ACTN4 mRNAs was observed at GD-18 (Figure 2.1). 
Higher expression of cell adhesion-related genes in ICAR compared to CAR suggests a 
role for tested genes in endometrial gland proliferation and/or anchorage. Comparison of 
endometrial gene expression levels between CAR and ICAR showed that transcript levels of 
ITGB4, BCAM and GRB7 were higher in ICAR than in CAR at GD-18 and/or GD-34. This may be 
due to their expression on GE. Even though BCAM, ACTN4 and ITGB4 were predominantly 
expressed on LE at GD-34 (Figure 2.1), they also localized to the superficial GE on some 
samples. At GD-34, ITGB4 localized to deep GE as well in some samples. In the case of ITFG3 
(not tested by qRT-PCR), signal detection was exclusively on GE suggesting that these cell 
adhesion molecules may play a role in endometrial gland cell proliferation and/or anchoring to 
surrounding stroma. Even on the samples where a signal was not detected on GE, it is possible 
that these cell adhesion-related genes were expressed at a level below the detection threshold of 
ISH. Such an expression pattern would explain the higher expression levels of BCAM, ACTN4 
and ITGB4 on ICAR than in CAR. During this stage of gestation, ICAR is also rich in blood 
vessles (in addition to endometrial glands) while CAR is aglandular and avascular (Robinson et 
al. 2000). Angiogenesis involves extensive interplay among endothelial cells themselves and 
endothelial cells and ECM (Wang et al. 2012), and integrins have been implicated in 
angiogenesis in other systems (Kim et al. 2000; Rice et al. 2006). Therefore the observed 
differences in transcript levels of ITGB4, BCAM and GRB7 may also be related to blood vessel 
development/remodeling that takes place in ICAR during this period. 
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Aberrant endometrial expression of BCAM may reflect perturbed cell adhesion in SCNT 
pregnancies. Comparison of endometrial gene expression levels between AI and SCNT showed 
that transcript levels of BCAM were higher in SCNT compared to AI in CAR at GD-18. According 
to our knowledge, there is no data about BCAM related to pregnancy in domestic/laboratory 
animals. BCAM acts as a co-receptor with integrins for laminin 511/521 (Kikkawa and Miner 
2005) and is involved in maintenance of the basement-membrane (Rahuel et al. 2008) and 
cytoskeletal organization (Collec et al. 2011) in other systems. Aberrant transcript levels of 
BCAM in SCNT CAR may reflect perturbed cell adhesion and/or remodeling in CAR tissue. 
Given that BCAM was expressed on both LE and GE (Figure 2.1I), its aberrant expression on the 
peri-implantation stage SCNT endometrium may reflect perturbed cell adhesion at the 
conceptus-maternal interface and/or perturbed endometrial gland proliferation/function.  
In summary, our results demonstrate that endometrial expression of select genes related 
to cell adhesion and IGF and EGF signaling are affected by SCNT and implantation during the 
peri-implantation period of gestation in cattle. Expression levels of all tested genes decreased 
from GD-18 to GD-34, and may reflect a decline of metabolic/growth demands on its cells 
during the early post-implantation period. Given their predominant localization to GE at GD-34, 
significantly increased expression of IGF1R and ERBB2 in SCNT ICAR compared to AI ICAR 
may reflect altered endometrial glandular proliferation and/or secretory function. Given the 
autocrine and paracrine modes of growth factor action at the conceptus-maternal interface, we 
hypothesize that these perturbations, particularly of IGF and EGF-related genes, reflect 
compensatory mechanisms by the endometrium in response to altered growth/metabolic 
demands of the SCNT conceptus. We support the hypotheses by Ravelich et al. (2004) and Garry 
et al. (1996) that perturbed gene expression levels related to IGF/insulin signaling may reflect 
disturbances in energy metabolism, presumably initiated on the conceptus. Future studies are 
warranted emphasizing the study of the mechanisms underlying perturbed EGF and IGF 
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signaling and energy metabolism in SCNT pregnancies and the nature of signals that 
communicates the conceptus’ modified demands to the endometrium. 
MATERIALS AND METHODS 
Sample collection. Bovine pregnancies were produced from AI and SCNT (two 
blastocysts transferred to each surrogate cow at GD-7) as described previously (Smith et al. 
2005; Vignon et al. 1998), and terminated by sacrificing cows at GD-18 (pre-implantation time-
point) and GD-34 (early post-implantation time-point) for sample collection (endometrium and 
EET). Gestation day 34 cows were sacrificed upon confirmation of pregnancy by 
ultrasonography while GD-18 cows were sacrificed without confirmation of pregnancy. Artificial 
insemination-derived GD-34 pregnancies were produced and samples collected (N=10) at the 
University of Illinois at Urbana-Champaign, in accordance with guidelines set forth by the 
Institutional Animal Care and Use Committee, while the other groups of pregnancies were 
produced and samples collected (GD-18 AI: N=11; GD-18 SCNT: N=10; GD-34 SCNT: N=8) at 
the Institut National de la Recherche Agronomique, Jouy-en-Josas, France in accordance with 
guidelines set forth by the Society for the Study of Reproduction and European Convention on 
Animal Experimentation. All clones were generated using a cultured Holstein female skin 
fibroblast cell line (genotype 5538; Constant et al. 2006; Mansouri-Attia et al. 2009). The two 
sets of AI pregnancies produced in the USA and France were sired by two different bulls. A sex 
determination PCR assay using bovine amelogenin gene specific primers (Forward 5’-
AACACCACCAGCCAAACCTC-3’ and Reverse 5’-CGCTTGGTCTTGTCTGTTGC-3’) was used for 
sexing conceptuses. 
For testing by in situ hybridization (ISH), areas of endometrium containing both 
caruncular (CAR) and inter-caruncular (ICAR) regions from the pregnant uterine horn were 
dissected and transferred to 4% paraformaldehyde. For testing by quantitative real time-PCR 
(qRT-PCR), CAR and ICAR areas were dissected separately from the pregnant uterine horn and 
snap-frozen. All snap-frozen tissues were stored at -80oC until further use. 
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Candidate gene selection. Metacore™ (GeneGo; St. Joseph, MI) data mining and 
pathway analysis suite was used to analyze microarray gene expression data from a previous 
experiment conducted by our group that examined  gene expression profiles of GD-20 
endometrial tissue (Mansouri-Attia et al. 2009) from AI and SCNT pregnancies. Based on this 
analysis, 16 candidate genes related to IGF and EGF signaling and cell adhesion were selected 
for the purpose of this study: IGF1, IGF2, IGF1R, IGF2R, INSR, IGFBP6, ERBB2, NRG2, ITGA3, 
ITGB4, ITFG3, BCAM, ACTN4, DES, FAK1 and GRB7. 
Tissue fixation, probe preparation and chromogenic in situ hybridization. Two thirds of 
the samples that were transferred to 4% paraformaldehyde were processed and embedded in 
paraffin (Richard-Allan Scientific Inc., Kalamazoo, MI) while the other one third was 
cryopreserved (Tissue-Tek®, Sakura Finetek USA, Inc., Torrance, CA).  
Probes were prepared for eight cell adhesion-related genes (ITGA3, ITGB4, ITFG3, 
BCAM, ACTN4, DES, FAK1, and GRB7) and eight growth factor signaling-related genes (IGF1, 
IGF2, IGF1R, IGF2R, IGFBP6, INSR, ERBB2 and NRG2). Bovine cDNA fragments encoding 
target genes were amplified using PCR. In the case of ACTN4, BCAM, DES, FAK1, GRB7, ITGA3, 
ITGB4, ITFG3, ERBB2 and NRG2 target genes, plasmid-specific primers were used to amplify 
DNA fragments together with an adjacent RNA polymerase promoter (e.g. SP6, T3, or T7) 
directly from existing plasmid libraries. Primer pairs specific to pT7T3Pac plasmid (Degrelle et 
al. 2011) were used to amplify ITGA3 (BF044715), ITGB4 (BF046410), ITFG3 (BF043369), DES 
(BF045037), FAK1 (BF045318), GRB7 (DR697458), and NRG2 (BF043685), primer pairs 
specific to pGEMZf11 plasmid (SP6 Forward 5’-CACAGGAAACAGCTATGACC-3’, SP6 Reverse 
5’-ATTGGCCAAGTCGGCCGA-3’, T7 Forward 5’-GTAAAACGACGGCCAGTGA-3’, T7 Reverse 5’-
CTCAAGCTTAGCATGCGG-3’) were used to amplify ERBB2 (CR551755), and primer pairs 
specific to pExpress-1 plasmid (SP6 Forward 5’-CACAGGAAACAGCTATGACC-3’, SP6 Reverse 
5’-TTGGGCCCGACGTCGCATG-3’, T7 Forward 5’-GTAAAACGACGGCCAGTGA-3’, T7 Reverse 
5’-TGCAGGCGGCCGCACTAGT-3’) were used to amplify ACTN4 (DV815330) and BCAM 
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(DV916520). In the case of IGF1, IGF1R, INSR and IGFBP6 target genes, gene-specific primers 
were used (IGF1; Forward 5’-TTCTTGAAGCAGGTGAAGATGC-3’ and Reverse 5’-
TAACTCGTGCAGAGCGAAGG-3’, IGF1R; Forward 5’-ATGACATTCCTGGGCCGGTGAC-3’ and 
Reverse 5’-GGCCACGCCTTCGTAGACCAT-3’, INSR; Forward 5’-
GAGTTTTCTGGAGGCCTTCGA-3’ and Reverse 5’-GGCAGTTCAACCCCAAGATG-3’, IGFBP6; 
Forward 5’-GTGAACCGCAGAGACCAACAG-3’ and Reverse 5’-
CGTGTAGTTACCCATCACTCAACAA-3’) to amplify DNA fragments from cDNA prepared from 
endometrial samples, ligated to pGEM®-T Vector (Promega, Madison, WI), and transformed to 
chemically competent E. coli (One Shot TOP10, Invitrogen Corp., Carlsbad, CA). Finally, specific 
cDNA fragments were amplified using primer pairs specific to pGEM®-T Vector (SP6 Forward 
5’-CACAGGAAACAGCTATGACC-3’, SP6 Reverse 5’-TTGGGCCCGACGTCGCATG-3’, T7 Forward 
5’-GTAAAACGACGGCCAGTGA-3’, T7 Reverse 5’-TGCAGGCGGCCGCACTAGT-3’) together with 
an adjacent RNA polymerase promoter (e.g. SP6 or T7), sequence verified (Sanger dideoxy-
terminator sequencing; W. M. Keck Center, University of Illinois at Urbana-Champaign) and 
purified (QIAquick® PCR purification kit, QUIAGEN, Valencia, CA). One hundred nanograms of 
purified cDNA was used as template to synthesize digoxigenin (DIG)-labeled cRNA probes by in 
vitro transcription using the DIG RNA labeling mix (Roche Applied Science, Indianapolis, IN) 
and the relevant T7, T3 or SP6 polymerases, according to the manufacturer's protocol (Promega, 
Madison, WI). Anti-sense and sense probes were prepared for all 16 candidate genes and tested 
by ISH. 
For SCNT pregnancies, all samples were tested by ISH. However, for AI pregnancies, 
samples from only 5 random pregnancies were tested by ISH at each time-point. At least two 
sections (7 µm paraffin sections for IGF2 and IGF2R probes; 10 µm cryosections for all other 
probes) from each sample were tested by ISH as described previously (Cammas et al. 2005) and 
images captured using photomicrography (Nanozoomer® 2.0-HT; Hamamatsu, Bridgewater, 
NJ). Hybridizations with sense probes served as negative controls. 
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RNA extraction, cDNA synthesis and qRT-PCR. Total RNA from endometrium (CAR 
and ICAR separately) was extracted using TRIzol® (Invitrogen Corp., Carlsbad, CA) and treated 
with acid-phenol:chloroform (5:1; Ambion, Inc., Austin, TX) to minimize contamination with 
DNA. Total RNA was purified (RNeasy Mini Kit; QUIAGEN, Valencia, CA), residual DNA 
removed (RNase-Free DNase Set; QUIAGEN, Valencia, CA), concentrations and purity 
measured (NanoDrop ND-1000; NanoDrop Technologies, Wilmington, DE), RNA integrity 
(RNA Integrity Number: RIN) measured (Agilent 2100 Bio-analyzer; Agilent Technologies, Inc., 
Santa Clara, CA), and stored at –80°C until further use. cDNA was synthesized (SuperScript™ 
III Reverse Transcriptase; Invitrogen Corp., Carlsbad, CA), and target genes amplified using 
specific primers (Primer Express Software v3.0; Applied Biosystems, Foster City, CA or Primer3 
v. 0.4.0; Skaletsky 2000; Table 2.1). Bovine β-actin (ACTB) was used as an endogenous control. 
Synthesis, quality control, and relative quantification of cDNA was performed as described 
previously (Loor et al. 2005) except that the reaction was primed with oligo(dT) and random 
pentadecamers instead of random hexamers (Stangegaard et al. 2006). 
Statistical analysis of qRT-PCR data. Arbitrary expression levels of target genes were 
normalized to that of ACTB, subjected to log2 transformation, and the PROC GLM procedure of 
SAS® (v9.2; SAS Institute, Inc., Cary, NC) was used to test for differences in gene expression 
levels between different groups of samples: (i) SCNT vs AI, (ii) GD-34 vs GD-18, and (iii) CAR vs 
ICAR. The model statements included gestation length (day; GD-18 and GD-34), tissue type 
(tissue; CAR and ICAR), treatment group (group; AI and SCNT), and qPCR plate (plate; plate 1 
and 2) as fixed effects and two-way interactions (day*tissue, group*tissue and day*group). 
Given the many biologically meaningful pair-wise comparisons within each of the three main 
comparisons, 12 contrast statements were used to test differences for each specific comparison 
for each target gene: (i) SCNT vs AI - GD-18 CAR SCNT vs GD-18 CAR AI; GD-18 ICAR SCNT vs 
GD-18 ICAR AI; GD-34 CAR SCNT vs GD-34 CAR AI; and GD-34 ICAR SCNT vs GD-34 ICAR 
AI, (ii) GD-34 vs GD-18 - GD-34 CAR AI vs GD-18 CAR AI; GD-34 ICAR AI vs GD-18 ICAR AI; 
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GD-34 CAR SCNT vs GD-18 CAR SCNT; and GD-34 ICAR SCNT vs GD-18 ICAR SCNT, (iii) CAR  
vs ICAR - GD-18 CAR AI vs GD-18 ICAR AI; GD-18 CAR SCNT vs GD-18 ICAR SCNT; GD-34 
CAR AI vs GD-34 ICAR AI; and GD-34 CAR SCNT vs GD-34 ICAR SCNT. Benjamini and 
Hochberg's false discovery rate correction (FDR; Benjamini and Hochberg 1995) was used to 
correct for multiple comparisons with these 12 pair-wise comparisons, and a significance 
threshold of FDR P<0.05 was used to define differential gene expression.  
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CHAPTER 2 TABLES 
 
Table 2.1. Primers used for the relative quantitation 
Gene Sequence (5' -> 3') Length (bp) Accession No: 
ACTN4 CGGGCTCAAGCTCATGCT 
  
 
GTCCAGTGCCTTGTTCACGTT 112 NM_001098052.1 
BCAM CCACCCCAGAGTACACGTTTTT 
  
 
CCCTCAAGACTTGTTTTTAGCACAT 70 NM_174741.2 
ERBB2 GAAGGTGAAGGTGCTAGGATCTG 
  
 
TGGCTTTGGGAGATGTGTTTT 128 XR_083980.1 
GRB7 CGGGCACGAGCCTCAGT 
  
 
CGAGAAATGCGTCCATGGA 64 NM_001046014.1 
IGF1 GCTTTTATTTCAACAAGCCCACG 
  
 
TCCAGCCTCCTCAGATCACA 109 NM_001077828.1 
IGF1R CCCATTGCGGTTCTGTTGAT 
  
 
ACAGAGGCATACAGCACTCCATT 107 NM_001244612.1 
IGF2 CGTGCTGCTATGCTGCTTAC 
  
 
GTTTATGCGGCTGGATGGTC 122 NM_174087.3 
IGF2R ACAACAGTGAACTGTAAGCAGC 
  
 
CCTCCACTCGAAGTAATGCAC 126 NM_174352.2 
IGFBP6 CTCCTTCCCGGTCCAATTCT 
  
 
AGCACGGAGTCCAGATGTTTG 76 NM_001040495.1 
INSR TTGGTGTTCTGGGAGAGACAG 
  
 
TCCGACTCGAATGGTGGAGA 110 XM_002688832.1 
ITGB4 TCAGTTCTGCGAATACGACAACTT 
  
 
CACGCACTGACCCATGGA 91 NM_001193257.2 
NRG2 GTCCTGACCATCACTGGGATTT 
  
  TTCTGTCGGAGGTGGTTATGC 116 XM_003586310.1 
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Table 2.2. P values of fixed effects and two-way interactions based on qRT-PCR results 
Gene Day Group Tissue Day*Group Day*Tissue Group*Tissue 
IGF1 <0.01 *0.47 <0.01 0.52 *0.63 0.21 
IGF1R <0.01 *0.01 <0.01 0.03 *0.66 0.80 
IGF2 <0.01 *0.11 <0.01 0.89 *0.04 0.13 
IGF2R *0.05 *0.03 *0.02 0.70 *0.01 0.42 
IGFBP6 <0.01 <0.01 <0.01 0.13 <0.01 0.80 
INSR <0.01 *0.89 *0.93 0.60 *0.96 0.98 
NRG2 <0.01 *0.29 <0.01 0.01 <0.01 0.04 
ERBB2 <0.01 *0.02 <0.01 0.05 *0.96 0.52 
ACTN4 <0.01 *0.02 0.06 0.32 *0.98 0.63 
BCAM <0.01 *0.21 <0.01 0.07 *0.10 0.40 
GRB7 <0.01 *0.70 <0.01 0.33 *0.78 0.39 
ITGB4 <0.01 *0.04 <0.01 0.77 *0.22 0.86 
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Table 2.3. Fold-changes (GD-34/GD-18) based on qRT-PCR results 
 
CAR ICAR 
Gene AI SCNT AI SCNT 
IGF1 0.60** 0.53** 0.67** 0.59** 
IGF1R 0.37** 0.49** 0.35** 0.47** 
IGF2 0.53** 0.54** 0.68** 0.69** 
IGF2R 1.06** 1.02** 0.79** 0.75** 
IGFBP6 0.64** 0.52** 1.02** 0.82** 
INSR 0.53** 0.58** 0.54** 0.58** 
NRG2 0.46** 0.69** 0.76** 1.13** 
ERBB2 0.45** 0.59** 0.45** 0.59** 
ACTN4 0.51** 0.56** 0.51** 0.56** 
BCAM 0.37** 0.28** 0.49** 0.36** 
GRB7 0.26** 0.31** 0.24** 0.30** 
ITGB4 0.59** 0.62** 0.47** 0.50** 
* FDR P<0.05, ** FDR P<0.01 
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Table 2.4. Fold-changes (SCNT/AI) based on qRT-PCR results 
 
GD-18 GD-34 
Gene CAR** ICAR** CAR** ICAR** 
IGF1 1.35* 1.10** 1.19** 0.97*** 
IGF1R 1.01* 1.05** 1.36** 1.41** 
IGF2 1.19* 1.00** 1.21** 1.01** 
IGF2R 1.21* 1.10* 1.16** 1.06** 
IGFBP6 0.92** 0.89** 0.75** 0.72** 
INSR 0.95** 0.95** 1.03** 1.03** 
NRG2 1.02** 0.77** 1.52** 1.14** 
ERBB2 0.98** 1.07** 1.28** 1.39** 
ACTN4 1.09** 1.04** 1.19** 1.14** 
BCAM 1.37** 1.20** 1.02** 0.89*** 
GRB7 0.86** 1.03** 1.05** 1.26*** 
ITGB4 1.16** 1.20** 1.22** 1.26*** 
* FDR P<0.05, ** FDR P<0.01 
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Table 2.5. Fold-changes (CAR/ICAR) based on qRT-PCR results 
 
GD-18 GD-34 
Gene AI SCNT AI SCNT 
IGF1 2.30** 2.83** 2.09** 2.56** 
IGF1R 0.64** 0.62** 0.68** 0.66** 
IGF2 1.63** 1.96** 1.28** 1.54** 
IGF2R 0.98** 1.08** 1.33** 1.46** 
IGFBP6 2.02** 2.09** 1.28** 1.32** 
INSR 1.01** 1.01** 1.00** 1.00** 
NRG2 2.92** 3.90** 1.77** 2.36** 
ERBB2 0.50** 0.46** 0.49** 0.45** 
ACTN4 0.90** 0.94** 0.90** 0.94** 
BCAM 0.77** 0.88** 0.59** 0.67** 
GRB7 0.37** 0.31** 0.39** 0.33** 
ITGB4 0.43** 0.41** 0.53** 0.52** 
* FDR P<0.05, ** FDR P<0.01 
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Table 2.6. Mitochondrial energy metabolism-related molecules whose expression (mRNA/protein) is significantly affected by SCNT 
Species 
Gestation 
stage and 
tissue 
Aberrantly expressed genes/proteins Reference 
Bovine GD-7 
blastocyst 
Cytochrome c oxidase subunit Vla polypeptide 1 (Zhou et al. 2008b) 
 
Phosphoenolpyruvate carboxykinase 2 (mitochondrial) 
 
 
GD-18 
endometrium Phosphofructokinase, platelet (Bauersachs et al. 2009) 
 
GD-20 
endometrium 
Ubiquinol-cytochrome c reductase, 6.4kDa subunit (Mansouri-Attia et al. 
2009) 
 
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 
  
Cytochrome c oxidase subunit VIIa polypeptide 2 (liver) 
 
  
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon 
subunit 
 
  
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma 
polypeptide 1 
 
  
Acetyl-Coenzyme A synthetase 2 (AMP forming)-like 
 
  
Aconitase 2, mitochondrial 
 
 
Full-term 
placentomes 
Succinate dehydrogenase complex, subunit A, flavoprotein (Everts et al. 2008) 
 
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 
 
  
Cytochrome c oxidase subunit VIc 
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Table 2.6. (cont.) 
  
Pyrophosphatase (inorganic) 1 
 
  
Ubiquinol-cytochrome c reductase core protein II 
 
  
ATP synthase, H+ transporting mitochondrial F1 complex, beta 
subunit 
 
  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa 
 Porcine GD-8 
blastocyst 
Lactate dehydrogenase B (Whitworth et al. 2011) 
 
Cytochrome c oxidase subunit VA 
 
  
ATP synthase, H+ transporting mitochondrial F1 complex, beta 
subunit 
 
  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8 
 
 
GD-26 EET Pyruvate dehydrogenase (lipoamide) beta (Chae et al. 2009) 
 
GD-26 EET Alpha-enolase* (Chae et al. 2006) 
  
Malate Dehydrogenase* 
 
  
Glyceraldehyde-3-phosphate dehydrogenase* 
 
  
Lactate dehydrogenase* 
 Murine 2-cell stage Ubiquinol-cytochrome c reductase binding protein (Vassena et al. 2007) 
* In the case of molecules denoted by an asterisk, protein levels were perturbed in SCNT. In the case of others, transcript levels were 
perturbed in SCNT. 
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CHAPTER 2 FIGURES 
 
Figure 2.1. Photomicrographs showing mRNA localization of IGF1R at GD-34 (A) and GD-18 
(B), ERBB2 at GD-34 (C) and GD-18 (D), NRG2 at GD-34 (E), ITFG3 at GD-34 (F) and GD-18 
(G), ITGB4 at GD-18 (H), BCAM at GD-18 (I), ACTN4 at GD-18 (J) and IGF1 at GD-34 (K, L) in 
the bovine endometrium. Inset shows consecutive sections hybridized by sense probes. Scale 
bar: 2mm (A – J) and 200µm (K and L). Arrows on section L point to blood vessels. Section K 
emphasizes localization of IGF1 mRNA on GE and stroma surrounding GE. 
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Figure 2.1. (cont.) 
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Chapter 3: Effects of somatic cell nuclear transfer on transcripts related to 
integrin signaling during the peri-implantation period in cattle 
 
SUMMARY 
Pregnancy losses during the peri-implantation period can be up to 70% in somatic cell nuclear 
transfer (SCNT)–derived bovine pregnancies. Given the cell-cell and cell-extra cellular matrix 
(ECM) adhesion events associated with blastocyst implantation, and literature implicating a role 
for integrins in its physiology, we hypothesized that integrin-mediated cellular functions may be 
perturbed in bovine SCNT pregnancies during the peri-implantation period. To test this 
hypothesis, and to identify genes encoding integrins and ECM proteins whose transcript levels 
are temporally regulated during the peri-implantation period in cattle, transcriptomes of 
endometrial tissue and extra-embryonic tissue (EET) collected from gestation day (GD)-18 and 
GD-34 bovine pregnancies (SCNT and artificial insemination (AI)-derived pregnancies) were 
sequenced (RNAseq) and analyzed. In total, 22 and 40 genes encoding integrins and ECM 
proteins were transcribed across endometrial and EET tissues tested, respectively. Of these, 
transcript levels of 20 integrin-encoding genes and all 40 ECM protein-encoding genes were 
temporally regulated. Expression levels of the majority of these genes were up-regulated at GD-
34 compared to GD-18 in both EET and endometria. Transcript levels of 15 integrins and 19 
ECM proteins were significantly different in SCNT-derived tissues as compared to AI. Aberrant 
expression of integrin and ECM protein-related genes was largely limited to GD-18 EET and 
GD-34 inter-caruncular tissue (ICAR). Of the 13 integrin-encoding genes and 11 ECM protein-
encoding genes that were aberrantly expressed in GD-34 SCNT ICAR, nine and 10 were down-
regulated in SCNT, respectively. Our study identifies integrin and ECM protein-encoding genes 
transcribed in endometria and EET of cattle during the peri-implantation period, and 
demonstrates that the transcription of these groups of genes is temporally regulated. Our 
findings on transcript levels of genes related to integrins, ECM proteins and focal adhesions 
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suggest that integrin signaling at the conceptus-maternal interface may be compromised in 
SCNT pregnancies during the peri-implantation period in cattle. These perturbations may 
contribute to the high embryo mortality observed in bovine SCNT pregnancies during this 
period of gestation.  
INTRODUCTION 
Somatic cell nuclear transfer can be a valuable tool in agriculture and biotechnology with 
potential for multiplication of elite livestock (Campbell et al. 1996), generation of organs for 
xenotransplantation (Schneider and Seebach 2011), development of transgenic animals for 
production of recombinant proteins (Moura et al. 2011), preservation of endangered species 
(Wells and Misica 1998), and studying genetic and epigenetic mechanisms associated with 
development, aging, and carcinogenesis (Meissner and Jaenisch 2006). However, the efficiency 
of the technique is still very low (Ross and Cibelli 2010; Wilmut and Peterson 2002) among all 
species cloned to-date (Suteevun et al. 2006). In contrast to the average calving rate of 55% 
(King 1991) in artificial insemination AI-derived bovine pregnancies (hereafter denoted AI 
pregnancies), SCNT-derived bovine pregnancies (hereafter denoted SCNT pregnancies) have a 
low average calving rate of 9% (Panarace et al. 2007). Pregnancy losses during the peri-
implantation period are particularly high, and up to 70% of the initiated SCNT pregnancies may 
be lost in cattle during this period (Chavatte-Palmer et al. 2012a). Given the physiological nature 
of blastocyst implantation involving cell-cell and cell-extra cellular matrix (ECM) interactions, 
and literature implicating a role for integrins in blastocyst implantation (human; Coutifaris et al. 
1998; sheep; Johnson et al. 2001; cattle; MacIntyre et al. 2002; mice; Wang et al. 2002), we 
hypothesized that integrin signaling is perturbed in bovine SCNT pregnancies during 
implantation and contribute to the observed pregnancy losses. Of the physiological events that 
characterize the peri-implantation period, a role for integrins has been shown in the regulation 
of uterine receptivity to the blastocyst (Lessey 1997), endometrial glands (Johnson et al. 1999a; 
Lessey et al. 1996), vasculogenesis/angiogenesis (Bader et al. 1998; Sheppard 2002), 
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binucleated cell (BNC) migration in cattle (MacIntyre et al. 2002) and chorio-allantoic fusion 
(Yang et al. 1995).  
Integrins, consisting of non-covalently bound alpha and beta subunits, link cells with the 
ECM or adjacent cells (Wang et al. 2012), and transmit messages to (outside-in-signaling) and 
from (inside-out-signaling) cells. Interaction of extra-cellular domains of integrins with ECM 
proteins such as fibronectin, vitronectin, collagen, laminin, thrombospondin, fibrillin, tenascin, 
osteopontin, and fibrinogen leads to clustering of integrins giving rise to focal adhesions. These 
clusters of integrins recruit signaling molecules such as focal adhesion kinase (FAK) and 
integrin-linked kinase (ILK), and cytoplasmic proteins such as talin, paxillin, vinculin and 
alpha-actinin, that directly or indirectly anchor to the actin cytoskeleton (Hynes 2002; Plow et 
al. 2000). Integrins link the extracellular microenvironment to the actin cytoskeleton and 
activate intracellular signal transduction pathways such as AKT (McDonald et al. 2008; Shen 
and Guan 2001) and ERK1/2 (Danen and Yamada 2001; Pullikuth and Catling 2007) throgh 
focal adhesion complexes (FACs). By virtue of these properties, integrins are able to recognize 
environmental changes, transmit the message across the plasma membrane, and mediate a 
variety of cellular responses such as changes to cell shape, adhesion, migration, cell 
proliferation, differentiation, cytoskeletal rearrangement, and apoptosis/survival during a 
variety of physiological and pathological conditions (Miranti and Brugge 2002; Schwartz and 
Ginsberg 2002).  
To-date, 18 alpha and 8 beta integrin subunits have been identified in mammalian cells 
that give rise to 24 distinct heterodimer combinations (Hynes 2002; Hynes 2004). Even though 
the expression of several individual genes encoding integrins and ECM proteins in cattle have 
been studied in association with blastocyst implantation (e.g. integrin alpha-1, -3, -6, collagen iv 
and laminin; MacIntyre et al. 2002), a comprehensive evaluation of neither the transcription 
status nor the effects of implantation and SCNT on the integrin adhesome-encoding genes has 
been carried out. In the present study, we examine the transcription of genes encoding integrins, 
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ECM proteins and components of the FAC in peri-implantation stage bovine SCNT and AI 
pregnancies. We use RNAseq technology to sequence transcriptomes of endometrial tissue (CAR 
and ICAR separately) and extraembryonic tissue (EET; trophoblast and allantois separately) 
collected from AI and SCNT-derived pregnancies at gestation day (GD)-18 (pre-implantation) 
and GD-34 (post-implantation). MetaCore™ GeneGo Pathway Maps functional ontology 
enrichment analysis was then used to identify integrin/ECM/FAC-related genes whose 
transcript levels are affected by implantation and SCNT. We report expression of 22 integrin-
encoding genes and 40 ECM-protein-encoding genes in the bovine peri-implantation stage 
conceptus-maternal unit. Our findings on transcript levels of genes related to integrin signaling 
provide strong evidence to support the hypothesis that integrin signaling is compromised in 
EET and endometrial tissues derived from bovine SCNT pregnancies during the peri-
implantation period.  
RESULTS 
Pathway enrichment analysis. On the basis of MetaCore™ GeneGo Pathway Maps 
functional ontology enrichment analysis, “Integrin outside-in signaling”, “Integrin inside-out 
signaling”, “Integrin-mediated cell adhesion and migration”, “Cytoskeleton remodeling” and 
“FAK signaling” were significantly affected by SCNT in GD-18 EET. In addition, GeneGo 
Pathway Maps “Integrin outside-in signaling”, “Cytoskeleton remodeling”, and “FAK signaling” 
were affected by SCNT in GD-34 ICAR (false discovery rate (FDR) adjusted P<0.05; Tables 3.1 
and 3.2). None of the above mentioned GeneGo Pathway Maps were affected by SCNT in GD-18 
endometrial tissue, GD-34 CAR or GD-34 EET. Out of the above-mentioned five GeneGo 
Pathway Maps, all were affected by implantation in CAR and ICAR while all except “FAK 
signaling” were affected by implantation in trophoblast/chorion (FDR P<0.05; Table 3.3). 
Expression of genes encoding integrins, ECM proteins and components of the FAC. Of 
the identified 18 α (ITGA1-11, ITGA2B, ITGAD, ITGAE, ITGAL, ITGAM, ITGAV, and ITGAX) 
and eight β (ITGB1-8) integrin subunits (Hynes 2004), 22 (all except ITGA8, ITGAD, ITGAM, 
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and ITGAX mRNAs) and 20 (all except ITGA8, ITGAD, ITGAM, ITGAX, ITGA7 and ITGB8 
mRNAs) genes encoding integrins were expressed on the endometrium and EET respectively. Of 
the integrins expressed in EET, ITGB6, ITGA1, ITGB3, ITGA11, ITGA4, ITGA2B, and ITGA9 
were expressed only at GD-34, of which ITGB6, ITGB3 and ITGA9 were exclusively expressed 
on allantois. Of the expressed integrin-encoding genes, 15 were aberrantly expressed in SCNT in 
at least one tissue tested: transcript levels of genes encoding 13 (ITGA2, ITGA2B, ITGA3, 
ITGA4, ITGA5, ITGA6, ITGA7, ITGA11, ITGB2, ITGB4, ITGB5, ITGB7, ITGB8), seven (ITGA2, 
ITGA5, ITGA6, ITGAV, ITGB1, ITGB2, and ITGB7), two (ITGA2 and ITGAV) and one (ITGA7) 
integrin subunits were aberrant in SCNT pregnancies, in GD-34 ICAR, GD-18 EET, allantois and 
GD-18 CAR, respectively (FDR P<0.05; Table 3.4). When the AI vs SCNT comparison is carried 
out with all allantois samples included, transcript levels of an additional 13 integrin signaling-
related genes (ITGA6, ITGA1, ITGB3, ITGB6, FBN2, THBS4, THBS2, LAMC1, COL27A1, 
LAMB3, FGG, TLN2 and VCL; Table 3.5) were differentially expressed in SCNT allantois (FDR 
P<0.05). Transcript levels of all expressed integrin subunits except those of ITGAE and ITGAV 
were temporally regulated in one or more tissues (FDR P<0.05; Table 3.6).  
Expression of 40 genes that encode ECM proteins were identified in one or more tissues 
tested. Of those transcripts, COL8A2, COL9A2, FGG and LAMA1 were expressed exclusively on 
EET while COL4A3, COL22A1, COL5A3, COL9A3, COL13A1 and TNR were expressed 
exclusively on endometria. Of the expressed ECM components, 19 were aberrantly expressed in 
SCNT pregnancies in at least one tissue type tested. Transcript levels of genes encoding 11 
(THBS4, TNXB, THBS2, LAMB3, COL16A1, COL22A1, COL4A3, COL27A1, EMID2, COL6A3 
and LAMC3), three (LAMC2, COL11A2 and COL6A3), three (COL22A1, FGG and COL4A2), 
three (THBS4, COL11A2 and EMID2), one (LAMC3) and one (LAMA1) ECM proteins were 
aberrant in SCNT pregnancies, in GD-34 ICAR, allantois, GD-18 EET, GD-34 CAR, GD-34 
trophoblast and GD-18 CAR tissue, respectively (FDR P<0.05; Table 3.7). Transcript levels of all 
40 expressed ECM proteins were temporally regulated in one or more tissues. Transcript levels 
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of seven genes (COL22A1, LAMA1, FGG, COL11A2, LAMC2, COL4A5, and LAMB3) decreased 
from GD-18 to GD-34, while those of the other 32 increased from GD-18 to GD-34 in one or 
more tissues (FDR P<0.05; Table 3.8).  
In addition, transcript levels of most temporally regulated FAC-related proteins were 
higher at GD-34 than at GD-18 (Table 3.9). Implantation-associated gene expression differences 
were observed across all tissue types tested while SCNT-associated differences in gene 
expression were observed mainly on GD-18 EET and GD-34 ICAR. These included genes 
encoding structural components of the FAC and actin cytoskeleton such as WASL, Arp2/3, 
destrin, paxillin, alpha-actinin, talin, zyxin, filamin A and ACTB, and genes encoding kinases 
such as FAK1/PTK2 and ILK (Table 3.10).  
DISCUSSION 
We report the transcription of 22 and 40 genes encoding integrins and ECM proteins 
respectively, at the conceptus maternal interface during the peri-implantation period. These 
molecules may be important for cell-cell or cell-ECM interactions at the apical surface (e.g. 
trophoblast-endometrial luminal epithelial (LE) interactions), lateral surface (e.g. between 
trophoblast cells, LE cells or glandular epithelial (GE) cells) or basal surface (e.g. anchoring GE 
cells to ICAR stroma) of EET or endometrial cells and thereby play roles in a variety of 
physiological events including conceptus-maternal attachment, maintenance of epithelial 
integrity, ECM remodeling, binucleated cell migration, chorioallantoic fusion, endometrial 
glandular structure/function and vasculogenesis/angiogenesis.  
Temporal regulation of integrin signaling-related gene expression  
Implantation-associated differences of transcript levels suggest increased integrin 
signaling post-implantation. The majority of the integrins and ECM components whose 
expression levels were affected by implantation were up-regulated at GD-34 compared to GD-18 
in both EET and endometria. ITGA1, ITGA5, ITGA7, ITGA9, ITGA11, ITGB2, ITGB7 and ITGAL 
were consistently up-regulated at GD-34 in both CAR and ICAR of while ITGA2, ITGA6, ITGB3, 
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ITGB5, ITGB6 and ITGB8 were consistently down-regulated at GD-34 in both CAR and ICAR. 
In EET, transcript levels of ITGA4, ITGA11 and ITGA1 showed the highest increase with 456.5, 
361.2 and 79.5-fold increases at GD-34 compared to GD-18, respectively (Table 3.6; FDR 
P<0.05). ITGA4 has been implicated in chorio-allantoic fusion in mice (Yang et al. 1995); thus 
the extreme fold-change observed may reflect a similar function for the gene in cattle. All 
expressed ECM proteins (collagens, fibrillins, laminins, thrombospondins, tenascins, 
osteopontin and fibrinogen) were significantly associated with implantation in endometria 
and/or EET. In endometrial tissue, all except LAMB3, LAMC2, COL11A2, COL4A5, and 
COL22A1 were up-regulated at GD-34 compared to GD-18. In trophoblast/chorion, all except 
COL22A1, LAMA1 and FGG were up-regulated at GD-34 compared to GD-18 (FDR P<0.05; 
Table 3.8).  
Increased expression levels of integrins (up to 456.5-fold increase) and their potential 
ligands (up to 136.2-fold increase) at GD-34 are indicative of increased integrin 
activation/signaling. Integrin activation may be associated with cell adhesion, migration, 
proliferation, differentiation or survival (Calderwood et al. 2004). Given that endometrial 
samples tested include cells from the luminal epithelium, endometrial glands, CAR and ICAR 
stroma as well as blood vessels, changes in transcript levels suggestive of increased integrin 
activation may reflect cell-cell and cell-ECM interactions between the conceptus and 
endometrial luminal epithelium, increased endometrial gland proliferation (Gray et al. 2001a), 
vasculogenesis (Delafontaine et al. 2004; Mehta and Besner 2007) and/or development of CAR 
that takes place during the peri-implantation period. Similarly, on the EET, increased integrin 
activation post-implantation may be associated with increased trophoblast/allantois cell 
proliferation, binucleate cell migration (MacLaren and Wildeman 1995), chorioallantoic fusion 
and/or vasculogenesis/angiogenesis of the allantois. Others have also reported increased 
expression of various integrins and ECM components coincident with blastocyst implantation 
(Sueoka et al. 1997; Sutherland et al. 1993). However, in contrast to our findings of increased 
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ITGA1 post-implantation, another study reported down-regulation of the integrin α1 subunit 
from GD-18 through GD-24 in bovine trophoblast (MacIntyre et al. 2002). 
Cells expressing ‘unstimulated/low-affinity’ integrins are non-adherent. Upon 
stimulation, integrins undergo certain conformational changes and become ‘activated’ 
increasing their affinity towards integrin-binding ligands. Integrin activation is triggered by 
interactions between cytoplasmic tails of the beta integrin subunits and proteins of the FAC such 
as talin (TLN; Tadokoro et al. 2003). Evidence indicates that integrin activation is initiated by 
integrin–talin interactions, causing tail separation and propagation of conformational changes 
to the outside of the cell (inside-out signal transduction; Anthis et al. 2009). Consistent with the 
up-regulation of genes encoding integrins and ECM components at GD-34, TLN mRNA levels 
were increased at GD-34 in endometrium and EET at GD-34 (up to 10.6-fold). Transcript levels 
of genes encoding several proteins related to the cytoskeleton and integrin activated kinases, 
FAK (PTK2) and ILK were also increased at GD-34 in endometrium and/or EET suggesting 
increased integrin signaling post-implantation (Table 3.9).  
On the basis of the assumption that mRNA expression is informative in predicting 
protein expression levels (Guo et al. 2008), our findings collectively support the hypothesis that 
integrin activation/signaling is increased post-implantation in cattle. This observation is 
consistent with the known physiological changes that take place on endometria and EET during 
the peri-implantation period such as conceptus-maternal attachment, development of 
endometrial glands, binucleate cell migration and vasculogenesis/angiogenesis in the ICAR. 
Integrin signaling-related genes are affected by SCNT 
Expression levels of genes related to integrins, ECM proteins and FAC were aberrant in 
SCNT, mainly in GD-34 ICAR and GD-18 EET (Tables 3.4, 3.7 and 3.10). In GD-18 
endometrium, GD-34 CAR, and GD-34 EET, few or no genes related to integrin signaling were 
affected by SCNT. Detailed descriptions of SCNT-associated gene expression differences in GD-
18 trophoblast and GD-34 ICAR are provided below. 
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Aberrant expression of genes related to integrin signaling in GD-18 EET  
Aberrant expression of integrin-related genes suggests compromised integrin signaling 
in SCNT trophoblast at GD-18. All considered GeneGo Pathway Maps related to integrin 
signaling were affected by SCNT in GD-18 EET (FDR P<0.05; Table 3.1). Of the expressed 
integrin and ECM component-encoding genes, seven and three were aberrantly expressed in 
GD-18 SCNT EET, respectively. However, they were not consistently up or down-regulated. 
However, of the eight cytoskeletal components whose mRNA levels were affected by SCNT in 
GD-18 EET (actin beta, paxillin, Arp2/3, alpha-actinin, filamin A, talin, WASL and zyxin), 
transcript levels of seven genes, including TLN1, were down-regulated in SCNT (all except 
WASL). Consistent with the down-regulation of structural proteins, several intracellular kinases 
activated by integrin-ligand binding such as SRC, ILK, AKT, MAP3K and MAP2K2 were also 
down-regulated in GD-18 SCNT EET (Figure 3.1). However, expression of the gene encoding 
FAK1 (PTK2), one of the main component kinases of FACs, was up-regulated in GD-18 SCNT. 
Collectively these findings suggest compromised FAC/cytoskeleton function in SCNT. Given that 
focal adhesion formation and cytoskeletal remodeling is regulated by integrin ligation with ECM 
and subsequent integrin clustering (Humphries et al. 2006; Plow et al. 2000), the observation of 
down-regulated cytoskeletal component/kinase-encoding genes is suggestive of compromised 
integrin signaling in SCNT trophoblast.  
Decreased transcript levels of CCND2 (more than 10-fold decrease in SCNT) and CCND3 
mRNA levels in GD-18 SCNT EET suggest that G1/S transition/cell cycle progression may be 
compromised in SCNT. Studies have shown that integrin signaling regulates cyclin D1 levels via 
MAPK signaling in other biological systems (Roovers et al. 1999; Walker and Assoian 2005). 
However, in GD-18 EET, mRNA encoding cyclin D1 was not expressed while mRNAs encoding 
cyclin D2 and cyclin D3 were expressed, and both were down-regulated in SCNT. This 
observation also supports the hypothesis that integrin activation/signaling in GD-18 SCNT EET 
cells may be compromised. Under in vitro conditions, decreased integrin affinity induces 
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detachment of cells from the ECM, a phenomenon known as anoikis (apoptosis induced by 
inadequate or inappropriate cell–matrix interactions; Frisch and Screaton 2001). Even though, 
anoikis is a phenomenon observed in vitro, it is regarded as a mechanism cells use in vivo to 
maintain tissue integrity (Gilmore 2005). Therefore, transcript levels suggestive of decreased 
integrin activation may reflect a pro-apoptotic response on the GD-18 SCNT EET. Integrins have 
been shown to regulate cellular apoptotic and survival responses by multiple mechanisms (Gary 
et al. 2003; Huang et al. 2009; Reginato et al. 2003). Increased apoptosis of trophoblast cells 
has been observed in SCNT and has been suggested to contribute to SCNT failures (Chae et al. 
2006; Fletcher et al. 2007). Transcript levels of several genes encoding molecules regulating 
cellular apoptosis/survival were also aberrantly expressed in GD-18 SCNT EET (BAD, MDM2, 
TP53, FAS and FOXO3), further supporting the hypothesis of compromised integrin activation 
in GD-18 SCNT trophoblast. 
Our findings of aberrant expression levels of genes encoding integrin signaling-related 
molecules suggest that integrin signaling in SCNT trophoblast is compromised during the 
immediate pre-implantation period. Given the many cell-cell and cell-ECM interactions that 
characterize physiological events regulating blastocyst implantation, compromised integrin 
signaling may contribute to perturbed blastocyst implantation and in turn pregnancy losses in 
SCNT pregnancies.  
Aberrant expression of genes related to integrin signaling in GD-34 ICAR  
Aberrant expression of integrin-related genes suggests compromised integrin signaling 
in SCNT ICAR at GD-34. Three of the five considered GeneGo Pathway Maps (“Integrin outside-
in signaling”, “Cytoskeleton remodeling”, and “FAK signaling”) were affected by SCNT in GD-34 
ICAR. Of the 13 integrin-encoding genes and 11 ECM protein-encoding genes that were 
aberrantly expressed in GD-34 SCNT ICAR, nine and 10 were down-regulated in SCNT, 
respectively. This general down-regulation of transcripts encoding integrin-related genes in 
SCNT suggests that integrin activation/signaling in GD-34 ICAR may be compromised in SCNT. 
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Consistent with this hypothesis, transcript levels of genes encoding structural components of the 
FAC such as talin 1, talin 2, paxillin, alpha-actinin 1 and 3, filamin A, and zyxin, and functional 
molecules such as PYK2, AKT2 and MAP2K2 that act downstream of integrin ligation were also 
down-regulated in GD-34 SCNT ICAR. However, genes encoding certain molecules downstream 
of integrin activation such as ACTR3 (a protein necessary for actin polymerization), AKT3, and 
SOS1 and SOS2 were up-regulated in SCNT (Table 3.10 and Figures 3.1 and 3.2). Decreased 
transcript levels of CCND1 and CCND3 and increased transcript levels of GSK3β in GD-34 SCNT 
ICAR suggest that G1/S transition/cell cycle progression may be compromised in SCNT (Figure 
3.3). Further, similar to GD-18 EET, in which transcript levels of certain apoptosis-regulatory 
genes were affected by SCNT, expression levels of BAD, MDM2, FAS and MAP3K5 were 
significantly different in SCNT in GD-34 ICAR.  
In SCNT, the decreased transcript levels of genes encoding integrins, ECM proteins, 
components of the FAC and kinases activated by integrin ligation, and molecules regulating cell 
cycle G1/S transition are consistent with the hypothesis that integrin activation in GD-34 ICAR 
cells may be compromised. These perturbations may be manifested in luminal epithelia, stroma, 
glandular epithelia or blood vessels or any combination of these cell types in ICAR and may 
reflect perturbations in conceptus-maternal attachment, endometrial gland structure/function 
or angiogenesis. Trophoblast adhesion to ICAR tissue during the peri-implantation period has 
been reported (Guillomot et al. 1981) in ovine pregnancies and mediation of this adhesion by 
integrins has been suggested (Wan et al. 2011). Aberrant expression of integrins have been 
described in endometrial gland (Béliard et al. 1997) and vascular (Rupp and Little 2001) 
pathologies. In pigs, a species with epitheliochorial placentation similar to cattle, where 
histiotrophic nutrition plays an important role throughout gestation (Bazer et al. 2009; Geisert 
and Yelich 1997), apoptosis and disruption of developing endometrial glands was demonstrated 
in GD-30 SCNT pregnancies (Kim et al. 2011a). Therefore the observed perturbations in 
expression of genes related to integrin signaling in GD-34 SCNT ICAR tissue may reflect 
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disturbances in conceptus-maternal attachment, endometrial glandular proliferation/function 
and/or angiogenesis. Such disturbances may contribute to the high peri-implantation pregnancy 
losses observed in bovine SCNT pregnancies. 
Of the nine integrin-encoding genes and 10 ECM protein-encoding genes whose 
transcript levels were significantly decreased in SCNT ICAR, mRNA levels of seven integrin-
encoding genes (ITGA7, ITGA2B, ITGB7, ITGB2, ITGA11, ITGA5 and ITGB4) and seven ECM 
protein-encoding genes (COL16A1, COL27A1, COL6A3, EMID2, LAMC3, THBS2 and TNXB) 
increased from GD-18 to GD-34 in AI ICAR. Therefore, it could be argued that the relatively low 
expression of these genes in GD-34 SCNT ICAR may correspond to a gene expression profile of a 
gestationally less mature endometrium resulting from developmentally delayed/compromised 
SCNT conceptuses, as has been described for bovine peri-implantation stage SCNT pregnancies 
(Alexopoulos et al. 2008). However, these aberrantly decreased gene expression levels were 
observed largely in ICAR only. The three genes that were aberrantly expressed in SCNT CAR 
were up-regulated in SCNT (Table 3.7). If the observed decreases in endometrium/ICAR are in 
fact due to developmentally delayed SCNT conceptuses, gene expression levels on EET can be 
expected to reflect these differences. However integrins/ECM protein-expression in GD-34 
SCNT chorion was not different from that in AI. Therefore it is unlikely that the observed 
decrease of transcript levels related to integrin signaling in GD-34 SCNT ICAR are due to a 
developmental lag of SCNT conceptuses.  
In summary, transcripts of genes encoding integrin-related proteins are temporally 
regulated in all tissues tested, and aberrantly expressed in SCNT in GD-18 EET and GD-34 
ICAR. Transcript levels of the majority of genes encoding integrins, ECM proteins, and FAC-
components and actin cytoskeleton were higher at GD-34 than at GD-18 in both EET and 
endometria suggesting that integrin signaling in component cells increases post-implantation. 
This is consistent with known physiological changes that take place during the peri-implantation 
period (e.g. conceptus-maternal attachment, binucleate cell migration, endometrial gland 
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proliferation, blood vessel development in the EET and endometrium). Aberrant expression of 
genes encoding integrins, ECM proteins and components of the FAC in GD-18 EET and GD-34 
ICAR suggest that integrin signaling may be compromised in SCNT. These observations are 
consistent with increased apoptosis of trophoblast cells and endometrial tissue reported in 
SCNT pregnancies.  
It should be noted that kinases such as AKT and ERK1/2 (MAPK3, MAP2K2) are 
activated not only by integrins, but also by activation of growth factor receptors (Costoya et al. 
1999; Schwartz and Ginsberg 2002). Therefore the changes in transcript levels in genes 
encoding these molecules may not necessarily be directly related to integrin activation. 
However, current approaches of pathway analysis do not account for interactions between 
different pathways (Khatri et al. 2012) and it is not possible to determine the role played by 
integrins in activation of these kinases without in vitro studies. Most tissues we tested contained 
more than one cell type (e.g. glandular epithelia, luminal epithelia, endothelia, mono nucleated 
and binucleated trophoblast cells etc.). Therefore our interpretations are provided at the tissue 
level and not at the cellular level. Further, our interpretations are based on transcriptomic data. 
However, expression levels of proteins or phosphorylation status of proteins (e.g. in the case of 
MAPK cascade in ERK1/2 signaling) are generally considered better indicators of the functional 
status of gene products compared to transcript levels (Wu et al. 2009). Therefore, proteomic 
studies, with emphasis on cellular localization where necessary, are warranted to confirm our 
observations on effects of implantation and SCNT on integrin signaling.  
MATERIALS AND METHODS 
Samples collected from the same AI and SCNT-derived pregnancies described in Chapter 
2 were used for this portion of the study with the exception of the number of AI-derived 
pregnancies used.  Endometrial and EET samples from all SCNT-derived pregnancies (GD-18: 
N=10; GD-34: N=8) and five AI-derived pregnancies from each time point (GD-18: N=5; GD-34: 
N=5) were used for this study. In the case of the endometrium, CAR and ICAR areas were 
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dissected separately from the pregnant uterine horn and snap-frozen in liquid nitrogen. In the 
case of the conceptuses, only the EET were used for the study. Gestation day-18 EET were 
directly cut into segments of ~2cm in length and snap-frozen. In the case of GD-34 EET, first 
allantois and chorion were carefully dissected and separated under a stereo-microscope, and 
secondly separated allantois and chorion tissues cut into segments of ~2cm in length and snap-
frozen separately. All snap-frozen tissues were stored at -80oC until further use. 
Total RNAs used in this portion of the study was from the same sources as those used in 
the study described in Chapter 2; thus the methodology of RNA extraction is the same as that 
described in Chapter 2. Three micrograms of total RNA from each sample (CAR, ICAR, 
trophoblast, chorion and allantois separately) was used to build tagged cDNA libraries targeting 
Poly (A) + mRNA using TruSeq RNA Sample Prep Kits (Illumina®; Solexa, San Diego, CA) as 
per the manufacturer’s recommendations. Each lane on a flow cell was loaded with cDNA from 
three libraries with different tags. Sequencing of endometrial and EET transcriptomes was 
carried out using a HiSeq™ 2000 next-generation sequencing system (Illumina®; San Diego, 
CA) according to manufacturer’s recommendations. One-hundred base-long reads were 
generated with single end sequencing. A base-calling pipeline (pipeline 1.8; Sequencing Control 
Software, SCS; Illumina®) was used to process the raw fluorescent images and to call 
nucleotides. After stringent quality control measures, reads were aligned to the bovine genome 
(Baylor release Btau_4.0) using the program TopHat (version 1.2.0;  Trapnell et al. 2009) and 
reads were counted according to Ensemble annotation. Sequences with unique hits and up to 
three mismatches were used for further analyses. Subsequently, genes whose transcript levels 
were significantly associated with SCNT (AI vs SCNT comparison) and implantation (GD-18 vs 
GD-34 comparison; differentially expressed genes; DEG; FDR P<0.05; Benjamini and Hochberg 
1995) were identified using the edgeR Bioconductor package (Robinson et al. 2010). In the case 
of the AI vs SCNT comparison, the analysis was carried out for the seven tissues separately; GD-
18 CAR, GD-18 ICAR, GD-18 EET, GD-34 CAR, GD-34 ICAR, GD-34 chorion and GD-34 
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allantois.  In the case of the GD-18 vs GD-34 comparison, gene expression data in AI and SCNT 
samples were combined for each tissue type and the analysis carried out for the three tissues 
CAR, ICAR and trophoblast/chorion separately. For a gene to be considered ‘expressed’ and 
included in the analyses, an expression-threshold of a minimum 50 reads/animal for the 
particular tissue was used. For any given two-way comparison, only genes that satisfied the 
above criterion in at least one of the two tissues were included in the analysis.  
Of the GD-34 chorion and allantois samples sequenced (SCNT; N=8 and AI; N=5), it was 
observed that three and one allantois samples, respectively, from SCNT and AI pregnancies may 
have been contaminated with chorion tissue of the same conceptus. Therefore these four 
allantois samples were removed from the final analysis. 
Transcriptomes of all 14 tissues ([i] AI GD-18 CAR, [ii] SCNT GD-18 CAR [iii] AI GD-18 
ICAR, [iv] SCNT GD-18 ICAR, [v] AI GD-18 EET, [vi] SCNT GD-18 EET,  [vii] AI GD-34 CAR, 
[viii] SCNT GD-34 CAR, [ix] AI GD-34 ICAR, [x] SCNT GD-34 ICAR, [xi] AI chorion [GD-34], 
[xii] SCNT chorion [GD-34], [xiii] AI allantois [GD-34] and [xiv] SCNT allantois [GD-34]) and 
data from the seven AI vs SCNT comparisons and three GD-18 vs GD-34 comparisons were 
uploaded to Metacore™ (version 6.9 build 30881; GeneGo; St. Joseph, MI) data mining and 
pathway analysis suite. Five GeneGo Pathway Maps related to integrin signaling were identified 
(“Integrin outside-in signaling”, “Integrin inside-out signaling”, “Integrin-mediated cell 
adhesion and migration”, “Cytoskeleton remodeling” and “FAK signaling”). Because these maps 
did not include the majority of known integrins and extra-cellular matrix (ECM) proteins, a 
custom map was constructed using MapEditor™ to include all integrins, collagens, fibrillins, 
fibrinogen, laminins, osteopontin, thrombospondins and tenascins in the Metacore™ database. 
Subsequently this custom map was exported to the “Custom Maps” folder of GeneGo Pathway 
Maps. Gene IDs that mapped to network objects of this custom map were used to identify 
integrin and ECM protein-related genes that were transcribed in each tissue. However, the 
default GeneGo Pathway Maps “Integrin outside-in signaling”, “Integrin inside-out signaling”, 
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“Integrin-mediated cell adhesion and migration”, “Cytoskeleton remodeling” and “FAK 
signaling” were used for functional enrichment analyses. Functional enrichment analysis of all 
expressed genes (in each of the 14 tissues) was used to identify GeneGo Pathway Maps that were 
significantly enriched in each of the 14 tissues. Functional enrichment analysis of DEG (FDR 
P<0.05) from AI vs SCNT and GD-18 vs GD-34 comparisons were used to identify GeneGo 
Pathway Maps that were affected by SCNT and implantation respectively. In both cases, the 
default database in Metacore™ was used as background and a threshold of FDR P<0.05 was 
used to define statistical significance. 
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CHAPTER 3 TABLES 
Table 3.1. Numbers of transcripts aberrantly expressed in SCNT-derived tissues within integrin signaling-related GeneGo Pathway 
Maps at gestation day-18 
Genego Pathway Map 
No. of genes 
in pathway 
CAR   ICAR   EET 
 
 Expressed DEG§   Expressed DEG§   Expressed DEG§   
 Integrin outside-in signaling 59 57 0 
 
57 0 
 
51 19* 
  Integrin inside-out signaling 61 57 0 
 
55 0 
 
43 23* 
  Integrin-mediated cell 
adhesion  and migration 63 57 1 
 
57 0 
 
53 26* 
  Cytoskeleton remodeling 115 108 0 
 
108 0 
 
97 45* 
  FAK signaling 55 55 0   54 0   46 27*   
 § number of differentially expressed genes (DEG; FDR P<0.05) 
* indicates significant enrichment of GeneGo Pathway Map (FDR P<0.05)  
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Table 3.2. Numbers of transcripts aberrantly expressed in SCNT-derived tissues within integrin signaling-related GeneGo Pathway 
Maps at gestation day-34 
Genego Pathway Map 
No. of genes 
in pathway 
CAR   ICAR   Chorion   Allantois 
Expressed DEG§   Expressed DEG§   Expressed DEG§   Expressed DEG§ 
Integrin outside-in signaling 59 58 0 
 
58 23* 
 
53 1 
 
57 2 
Integrin inside-out signaling 61 58 0 
 
56 19 
 
45 0 
 
55 2 
Integrin-mediated cell 
adhesion and migration 63 58 0 
 
57 21 
 
54 1 
 
56 2 
Cytoskeleton remodeling 115 109 0 
 
108 43* 
 
104 1 
 
109 3 
FAK signaling 55 54 0   53 26*   51 0   53 1 
§ number of differentially expressed genes (DEG; FDR P<0.05) 
* indicates significant enrichment of GeneGo Pathway Map (FDR P<0.05)  
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Table 3.3. Numbers of transcripts temporally regulated within integrin signaling-related GeneGo Pathway Maps 
GeneGo Pathway Map 
No. of genes 
in pathway 
CAR ICAR 
Chorion/ 
Trophoblast   
Expressed DEG§ Expressed DEG§ Expressed DEG§ 
Integrin outside-in signaling 59 57 35* 57 38* 53 25* 
Integrin inside-out signaling 61 56 37* 57 39* 48 30* 
Integrin-mediated cell 
adhesion and migration 63 57 32* 56 34* 56 28* 
Cytoskeleton remodeling 115 108 62* 107 69* 106 47* 
FAK signaling 55 54 28* 54 35* 51 20 
§ number of differentially expressed genes (DEG; FDR P<0.05) 
* indicates significant enrichment of GeneGo Pathway Map (FDR P<0.05)  
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Table 3.4. Fold-changes (SCNT/AI) of transcribed integrin-encoding genes 
Gene 
Symbol 
Bos taurus 
Gene ID 
Entrez 
Gene ID 
GD-18   GD-34 
CAR* ICAR EET**   CAR ICAR** Chorion Allantois** 
ITGA1 535951 3672 1.2* 0.9 ND** 
 
0.9 1.5** 0.8 1.9** 
ITGA2 281872 3673 1.3* 1.2 2.7** 
 
1.3 2.1** 0.9 8.1** 
ITGA2B 515011 3674 1.0* 0.8 ND** 
 
1.0 0.5** 1.3 0.8** 
ITGA3 508490 3675 0.9* 1.2 0.7** 
 
1.4 0.7** 1.3 1.0** 
ITGA4 282882 3676 0.8* 0.8 ND** 
 
1.0 2.1** 0.9 0.9** 
ITGA5 281873 3678 0.9* 1.0 0.7** 
 
0.9 0.6** 2.4 1.1** 
ITGA6 535043 3655 1.0* 1.0 2.0** 
 
1.0 1.6** 1.1 1.4** 
ITGA7 506953 3679 0.6* 0.7 ND** 
 
1.3 0.5** ND ND** 
ITGA9 532127 3680 0.9* 1.1 ND** 
 
0.7 1.0** ND 0.8** 
ITGA10 506526 8515 1.0* 0.9 1.9** 
 
0.9 1.1** ND 0.9** 
ITGA11 523755 22801 1.1* 1.4 ND** 
 
0.8 0.5** 1.2 0.9** 
ITGAE 100140050 3682 1.0* 0.9 2.0** 
 
0.9 1.6** 1.0 1.0** 
ITGAL 281874 3683 0.7* 0.8 1.2** 
 
0.6 0.7** ND ND** 
ITGAV 281875 3685 1.2* 0.8 2.7** 
 
0.7 1.2** 1.1 3.0** 
ITGB1 281876 3688 1.0* 1.0 1.5** 
 
1.0 1.2** 1.2 1.2** 
ITGB2 281877 3689 0.7* 1.0 0.6** 
 
1.0 0.5** 2.9 0.7** 
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Table 3.4 (cont.) 
ITGB3 282642 3690 0.9 0.9 ND* 
 
0.7 1.0** ND 2.1 
ITGB4 506995 3691 0.9 1.2 0.8* 
 
1.4 0.7** 1.1 1.2 
ITGB5 282564 3693 0.9 1.1 0.7* 
 
0.9 0.6** 1.0 1.2 
ITGB6 282644 3694 1.2 0.9 ND* 
 
1.6 1.7** ND 1.9 
ITGB7 514031 3695 0.7 0.9 0.3* 
 
0.9 0.5** ND 0.9 
ITGB8 536286 3696 1.1 0.8 ND*   1.1 2.6** ND ND 
* FDR P<0.05; ** FDR P<0.01; ND; not detected 
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Table 3.5. Comparison of fold-changes (SCNT/AI) and P values of integrin signaling-related 
genes whose expression levels were affected by SCNT in allantois tissue 
Gene 
Symbol 
Bos taurus 
Gene ID 
Entrez 
Gene ID 
  
ICAR Chorion 
Allantois 
  
All samples 
included 
Four samples 
removed 
ITGA1 535951 3672 x 1.5** 0.8 2.0** 1.9** 
ITGA2 281872 3673 x 2.1** 0.9 8.0** 8.1** 
ITGA6 535043 3655 x 1.6** 1.1 1.7** 1.4** 
ITGAV 281875 3685 x 1.2** 1.1 3.1** 3.0** 
ITGB3 282642 3690 x 1.0** ND 1.9** 2.1** 
ITGB6 282644 3694 x 1.7** ND 2.1** 1.9** 
COL11A2 515435 1302 x 0.6** 0.9 0.5** 0.4** 
COL27A1 513668 85301 x 0.6** 0.7 1.9** 1.6** 
COL6A3 530657 1293 x 0.6** 0.9 2.4** 2.1** 
FBN2 540017 2201 x 1.2** 0.7 5.4** 2.5** 
FGG 280792 2266 x ND** 2.6 0.4** 1.0** 
LAMB3 529939 3914 x 0.4** ND 1.9** 2.0** 
LAMC1 532572 3915 x 1.1** 1.0 2.0** 1.7** 
LAMC2 511043 3918 x 0.9** 0.9 3.8** 3.5** 
THBS2 338092 7058 x 0.4** 0.7 2.4** 1.7** 
THBS4 541281 7060 x 6.3** 1.9 2.5** 2.0** 
TLN2 528252 83660 x 0.6** 0.9 2.2** 1.6** 
VCL 783645 7414 x 1.0** 1.0 1.8** 1.5** 
* FDR P<0.05; ** FDR P<0.01; ND; not detected 
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Table 3.6. Fold-changes (GD-34/GD-18) of transcribed integrin-encoding genes 
Gene 
Symbol 
Bos taurus 
Gene ID 
Entrez 
Gene ID 
CAR ICAR 
Chorion/ 
Trophoblast   
ITGA1 535951 3672 2.3** 2.2** 79.5** 
ITGA2 281872 3673 0.7** 0.6** 26.3** 
ITGA2B 515011 3674 1.6** 1.2** 1.2** 
ITGA3 508490 3675 0.8** 0.8** 2.0** 
ITGA4 282882 3676 1.3** 0.7** 456.6** 
ITGA5 281873 3678 1.8** 2.2** 0.2** 
ITGA6 535043 3655 0.8** 0.7** 1.1** 
ITGA7 506953 3679 3.2** 1.6** ND** 
ITGA9 532127 3680 3.0** 3.5** ND** 
ITGA10 506526 8515 1.3** 1.4** ND** 
ITGA11 523755 22801 2.8** 5.0** 361.2** 
ITGAE 100140050 3682 1.2** 1.0** 1.1** 
ITGAL 281874 3683 2.0** 1.9** <0.1** 
ITGAV 281875 3685 1.0** 1.1** 1.3** 
ITGB1 281876 3688 1.1** 1.1** 1.5** 
ITGB2 281877 3689 3.1** 2.7** 0.1** 
ITGB3 282642 3690 0.4** 0.5** ND** 
ITGB4 506995 3691 1.4** 1.1** 12.4** 
ITGB5 282564 3693 0.4** 0.4** 1.1** 
ITGB6 282644 3694 0.2** 0.2** ND** 
ITGB7 514031 3695 2.9** 2.5** 0.2** 
ITGB8 536286 3696 0.4** 0.5** ND** 
* FDR P<0.05; ** FDR P<0.01; ND; not detected 
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Table 3.7. Fold-changes (SCNT/AI) of transcribed ECM protein-encoding genes  
Gene 
Symbol 
Bos taurus 
Gene ID 
Entrez 
Gene ID 
GD-18   GD-34 
CAR ICAR EET   CAR ICAR Chorion Allantois 
COL11A1 287013 1301 1.1 ND ND** 
 
2.1** ND** 0.9 1.4* 
COL11A2 515435 1302 1.0 0.7 ND** 
 
3.5** 0.6** 0.9 0.4* 
COL13A1 613849 1305 1.6 1.5 ND** 
 
1.9** 0.7** ND 1.0* 
COL15A1 100139730 1306 1.0 1.1 ND** 
 
0.9** 0.7** 0.8 1.0* 
COL16A1 507010 1307 1.0 1.0 ND** 
 
1.2** 0.5** 1.1 1.0* 
COL1A1 282187 1277 0.9 1.1 0.8** 
 
0.9** 0.7** 1.0 1.1* 
COL1A2 282188 1278 0.9 1.1 0.9** 
 
0.9** 0.8** 1.0 1.1* 
COL22A1 521058 169044 0.7 0.9 0.4** 
 
1.0** 0.3** 3.1 1.0* 
COL27A1 513668 85301 1.1 1.0 ND** 
 
1.3** 0.6** 0.7 1.6* 
COL3A1 510833 1281 0.9 1.0 0.7** 
 
0.9** 0.9** 1.0 1.1* 
COL4A1 282191 1282 0.9 1.3 0.8** 
 
1.3** 0.7** 1.2 1.0* 
COL4A2 508632 1284 0.9 1.4 0.7** 
 
1.4** 0.7** 1.2 1.0* 
COL4A3 317711 1285 1.4 0.9 ND** 
 
0.6** 0.4** ND 1.0* 
COL4A5 511602 1287 1.3 0.9 0.9** 
 
1.2** 1.1** 0.9 1.2* 
COL4A6 523526 1288 1.3 1.3 ND** 
 
1.5** 0.7** 0.9 1.3* 
COL5A3 507881 50509 1.0 1.1 ND** 
 
1.5** 0.8** ND 1.0* 
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Table 3.7 (cont.) 
COL6A1 511422 1291 0.9** 1.1 1.1** 
 
1.0* 0.8** 1.1** 1.1** 
COL6A2 282194 1292 0.9** 1.1 1.3** 
 
1.0* 0.7** 1.2** 1.1** 
COL6A3 530657 1293 0.9** 1.1 1.1** 
 
0.8* 0.6** 0.9** 2.1** 
COL8A1 538564 1295 1.0** ND ND** 
 
0.9* 0.6** ND** 1.2** 
COL8A2 539415 1296 ND** ND ND** 
 
ND* ND** 1.0** 1.2** 
COL9A2 505942 1298 ND** ND ND** 
 
ND* ND** 1.2** 0.9** 
COL9A3 789493 1299 0.8** 0.7 ND** 
 
1.7* 0.6** ND** 0.8** 
EMID2 617340 136227 0.9** 1.1 ND** 
 
2.6* 0.4** 1.3** 1.0** 
FBN2 540017 2201 1.3** 0.9 ND** 
 
0.9* 1.2** 0.7** 2.5** 
FGG 280792 2266 ND** ND 2.9** 
 
ND* ND** 2.6** 1.0** 
LAMA1 506387 284217 ND** ND 1.3** 
 
ND* ND** 11.2** 0.8** 
LAMA4 529670 3910 1.1** 1.1 ND** 
 
0.9* 1.2** 1.4** 1.3** 
LAMB3 529939 3914 0.8** 1.1 ND** 
 
1.6* 0.4** ND** 2.0** 
LAMC1 532572 3915 0.9** 1.0 1.5** 
 
0.8* 1.1** 1.0** 1.7** 
LAMC2 511043 3918 1.0** 1.1 1.4** 
 
0.9* 0.9** 0.9** 3.5** 
LAMC3 518914 10319 0.6** 1.0 ND** 
 
1.5* 0.7** ND** 0.6** 
SPP1 281499 6696 2.0** ND 0.7** 
 
0.8* 0.9** 1.4** 1.0** 
THBS1 281530 7057 1.3** 1.3 1.1** 
 
0.7* 0.8** 1.9** 1.2** 
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Table 3.7 (cont.) 
THBS2 338092 7058 1.1 1.2 ND 
 
0.9** 0.4** 0.7 1.7 
THBS3 504323 7059 1.3 1.1 ND 
 
0.8** 0.7** 1.7 0.9 
THBS4 541281 7060 0.6 1.1 ND 
 
5.3** 6.3** 1.9 2.0 
TNR 526409 7143 1.0 1.5 ND 
 
0.5** 0.8** ND 1.0 
TNXB 282654 7148 0.9 1.2 ND   0.9** 0.4** 1.6 1.3 
* FDR P<0.05; ** FDR P<0.01; ND; not detected 
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Table 3.8. Fold-changes (GD-34/GD-18) of transcribed ECM protein-encoding genes 
Gene 
Symbol 
Bos taurus 
Gene ID 
Entrez 
Gene ID 
CAR ICAR 
Chorion/ 
Trophoblast   
COL11A1 287013 1301 1.3** ND** 44.8** 
COL11A2 515435 1302 0.5** 0.7** 2.2** 
COL13A1 613849 1305 1.5** 1.6** ND** 
COL15A1 100139730 1306 3.2** 3.7** 27.0** 
COL16A1 507010 1307 1.4** 1.9** 103.8** 
COL1A1 282187 1277 1.5** 2.1** 5.5** 
COL1A2 282188 1278 1.3** 1.7** 6.6** 
COL22A1 521058 169044 1.4** 0.5** 0.1** 
COL27A1 513668 85301 1.5** 2.1** 20.7** 
COL3A1 510833 1281 1.2** 1.6** 5.6** 
COL4A1 282191 1282 2.0** 2.3** 1.1** 
COL4A2 508632 1284 2.5** 2.8** 1.1** 
COL4A3 317711 1285 1.7** 1.7** ND** 
COL4A5 511602 1287 1.2** 0.8** 21.9** 
COL4A6 523526 1288 1.6** 1.6** 55.2** 
COL5A3 507881 50509 2.1** 3.0** ND** 
COL6A1 511422 1291 1.3** 1.6** 28.1** 
COL6A2 282194 1292 1.4** 1.8** 21.5** 
COL6A3 530657 1293 1.5** 2.2** 27.0** 
COL8A1 538564 1295 5.8** 6.0** ND** 
COL8A2 539415 1296 ND** ND** 27.5** 
COL9A2 505942 1298 ND** ND** 15.4** 
COL9A3 789493 1299 0.8** 1.6** ND** 
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Table 3.8 (cont.) 
EMID2 617340 136227 2.6** 2.1** 44.2** 
FBN1 281154 2200 1.9** 2.3** 18.3** 
FBN2 540017 2201 2.0** 2.5** 136.2** 
FGG 280792 2266 ND** ND** 0.5** 
LAMA1 506387 284217 ND** ND** 0.1** 
LAMA4 529670 3910 1.6** 2.2** 67.8** 
LAMB3 529939 3914 1.0** 0.7** ND** 
LAMC1 532572 3915 1.6** 1.9** 2.1** 
LAMC2 511043 3918 0.5** 0.7** 2.8** 
LAMC3 518914 10319 2.3** 1.9** ND** 
SPP1 281499 6696 8.3** 5.3** 9.1** 
THBS1 281530 7057 1.4** 1.4** 7.7** 
THBS2 338092 7058 2.0** 1.9** 8.0** 
THBS3 504323 7059 2.0** 1.7** 17.8** 
THBS4 541281 7060 5.8** 6.4** 39.6** 
TNR 526409 7143 2.5** 3.1** ND** 
TNXB 282654 7148 2.3** 2.9** 17.1** 
* FDR P<0.05; ** FDR P<0.01; ND; not detected 
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Table 3.9. Fold-changes (GD-34/GD-18) of genes encoding FAC-associated proteins 
Gene 
Symbol 
Bos taurus 
Gene ID 
Entrez 
Gene ID 
CAR ICAR 
Chorion/ 
Trophoblast   
ACTB 280979 60 1.3** 1.2** 0.8** 
ACTN1 524770 87 1.4** 1.4** 1.5** 
ACTN4 522269 81 1.3** 1.3** 0.9** 
ACTR2 538486 10097 0.8** 0.9** 1.2** 
ACTR3 281597 10096 0.7** 0.7** 1.3** 
ACTR3B 616404 57180 1.0** 1.0** 0.6** 
ARPC1A 508402 10552 1.3** 1.3** 0.8** 
ARPC2 540838 10109 0.9** 1.0** 1.1** 
ARPC3 506596 10094 1.0** 0.9** 1.0** 
ARPC4 539459 10093 1.0** 1.0** 0.9** 
CAV1 281040 857 1.1** 1.0** 24.5** 
CFL2 539332 1073 1.1** 1.0** 0.7** 
DSTN 513267 11034 1.0** 1.0** 0.7** 
FLNA 281165 2316 2.1** 2.6** 0.6** 
ILK 540207 3611 1.4** 1.5** 0.9** 
NCL 497013 4691 1.0** 1.1** 0.9** 
PTK2  506270 5747 0.9** 1.0** 2.1** 
PXN 517456 5829 1.3** 1.2** 0.9** 
TLN1 783470 7094 1.6** 1.6** 0.9** 
TLN2 528252 83660 1.6** 1.5** 10.6** 
VCL 783645 7414 1.3** 1.6** 1.2** 
WASL 281577 8976 0.6** 0.6** 1.6** 
ZYX 768226 7791 2.0** 2.0** 0.7** 
* FDR P<0.05; ** FDR P<0.01 
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Table 3.10. Fold-changes (SCNT/AI) of genes encoding FAC-associated proteins 
Gene 
Symbol 
Bos taurus 
Gene ID 
Entrez 
Gene ID 
GD-18   GD-34 
CAR ICAR EET   CAR ICAR Chorion Allantois 
ACTB 280979 60 0.9 1.1 0.6**  0.9 0.9* 1.1 1.0 
ACTN1 524770 87 0.8 1.1 0.8**  0.9 0.7** 1.0 1.2 
ACTN3 539375 89 ND ND ND**  1.1 0.4** ND ND 
ACTN4 522269 81 0.9 1.1 0.6**  1.0 0.7** 1.1 1.1 
ACTR3 281597 10096 1.0 1.0 1.5**  1.4 1.5** 1.1 0.9 
ARPC4 539459 10093 0.9 1.0 0.6**  0.9 1.2** 1.0 1.0 
CAV1 281040 857 1.0 1.1 ND**  1.1 1.6** 1.7 1.0 
FLNA 281165 2316 0.9 1.1 0.7**  0.9 0.7** 1.3 1.3 
ILK 540207 3611 0.9 1.1 0.6**  0.8 0.9** 1.1 1.0 
PTK2  506270 5747 0.9 1.0 1.9**  1.0 0.8** 0.9 1.3 
PXN 517456 5829 1.0 1.2 0.6**  1.4 0.6** 1.1 0.9 
TLN1 783470 7094 0.9 1.2 0.7**  1.0 0.7** 1.2 1.2 
TLN2 528252 83660 1.0 1.2 1.1**  1.0 0.6** 0.9 1.6 
VCL 783645 7414 1.0 1.1 1.3**  0.8 1.0** 1.0 1.5 
WASL 281577 8976 1.1 0.9 2.2**  1.6 1.3** 1.0 1.2 
ZYX 768226 7791 0.9 1.1 0.6**   1.1 0.6** 1.2 1.1 
* FDR P<0.05; ** FDR P<0.01; ND; not detected 
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CHAPTER 3 FIGURES
 
Figure 3.1. Effects of SCNT on transcript levels of genes categorized in the GeneGo Pathway Map 
“Integrin-mediated cell adhesion and migration”. Red and blue thermometers indicate genes 
whose expression levels are aberrantly up-regulated and down-regulated in SCNT compared to 
that in AI, respectively (FDR P<0.05). Numbers “1” and “2” of thermometers represent 
significantly different gene expression levels in GD-34 ICAR and GD-18 EET, respectively. 
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Figure 3.2. Effects of SCNT on transcript levels of genes categorized in the GeneGo Pathway 
Map “Integrin outside-in signaling”. Red and blue thermometers indicate genes whose 
expression levels are aberrantly up-regulated and down-regulated in SCNT compared to that in 
AI, respectively (FDR P<0.05). Numbers “1” and “2” of thermometers represent significantly 
different gene expression levels in GD-34 ICAR and GD-18 EET respectively. 
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Figure 3.3. Effects of SCNT on transcript levels of genes categorized in the GeneGo Pathway 
Map “FAK signaling”. Red and blue thermometers indicate genes whose expression levels are 
aberrantly up-regulated and down-regulated in SCNT compared to that in AI, respectively (FDR 
P<0.05). Numbers “1” and “2” of thermometers represent significantly different gene expression 
levels in GD-34 ICAR and GD-18 EET, respectively. 
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Chapter 4: Effects of somatic cell nuclear transfer on transcripts related to 
IGF and EGF signaling during the peri-implantation period in cattle 
 
SUMMARY 
Somatic cell nuclear transfer (SCNT)–derived bovine pregnancies are characterized by clinico-
pathological features such as Large Offspring Syndrome, placental abnormalities and 
hydroallantois, and loss of up to 70% of the initiated pregnancies during the peri-implantation 
period. Because of the growth and metabolism-related functions of insulin-like growth factor 
(IGF) and epidermal growth factor (EGF) families, we hypothesized that IGF and EGF signaling 
are perturbed in bovine SCNT pregnancies during the peri-implantation period. To test this 
hypothesis, and to identify genes encoding IGF and EGF signaling-related proteins whose 
transcript levels are temporally regulated during the peri-implantation period in cattle, 
transcriptomes of endometrial tissue and extra-embryonic tissue (EET) collected from gestation 
day (GD)-18 and GD-34 bovine pregnancies (SCNT and artificial insemination-derived 
pregnancies) were sequenced (RNAseq) and analyzed. Our study identifies genes encoding IGF 
and EGF family-related ligands, receptors, binding proteins and downstream effector molecules 
transcribed in endometria and EET in cattle during the peri-implantation period, and suggests 
that their transcription is temporally regulated. Our findings on aberrant transcription of genes 
related to IGF and EGF signaling suggest that IGF1 and EGF/ERBB receptor activation and 
several IGF and/or EGF-mediated molecular and cellular functions such as glucose uptake, cell 
cycle progression, cell survival, MTOR signaling, protein synthesis and energy metabolism are 
perturbed in bovine SCNT pregnancies during the peri-implantation period. Our findings 
provide new insights to current understanding of the effects of SCNT on cellular metabolism and 
growth. These perturbations may contribute to the high embryo mortalities and other clinico-
pathological features observed in bovine SCNT pregnancies during this period of gestation.  
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INTRODUCTION 
Cloning via somatic cell nuclear transfer (SNCT) can be a valuable tool in agricultural 
and biotechnological endeavors with potential for multiplication of elite livestock (Campbell et 
al. 1996), generation of organs for xenotransplantation (Schneider and Seebach 2011), 
development of transgenic animals for production of recombinant proteins (Moura et al. 2011) , 
preservation of endangered species (Wells and Misica 1998), and studying genetic and 
epigenetic mechanisms associated with development, aging, and carcinogenesis (Meissner and 
Jaenisch 2006). However, the efficiency of the technique is still very low (Ross and Cibelli 2010) 
among all species cloned to-date (Suteevun et al. 2006). Macrosomia (Large Offspring 
Syndrome; LOS), placental abnormalities (placentomegaly, large but few placentomes, placental 
edema) and hydroallantois are some of the most common clinico-pathological features 
associated with SCNT-derived pregnancies (hereafter denoted SCNT pregnancies) in cattle 
(Chavatte-Palmer et al. 2002; Hill et al. 1999; Walker et al. 1996).  
Given the above characteristic clinico-pathological features observed with SCNT 
pregnancies (e.g. macrosomia, placentomegaly), genes known to regulate embryonic, fetal and 
placental development such as those of the insulin-like growth factor (IGF) family have been 
implicated in its pathophysiology (Moore et al. 2007; Ravelich et al. 2004). A recent report 
suggests a role for the epidermal growth factor (EGF) family, particularly in the endometrial 
response during blastocyst implantation of the SCNT-derived conceptus (Mansouri-Attia et al. 
2009).  
IGFs are anabolic (Fowden 2003; Jones and Clemmons 1995) and exert insulin-like 
effects such as increasing cellular glucose uptake, increasing lipid, glycogen, and protein 
synthesis and cell proliferation (Chi et al. 2000; Fowden and Forhead 2009; Maki 2010). IGFs 
mediate these cellular functions by activating downstream signal transduction pathways 
phosphoinositide 3-Kinase/v-AKT murine thymoma viral oncogene homolog (PI3K/AKT) and 
extracellular-signal-regulated kinase (ERK). For example, IGF1R activation (i) affects glucose 
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uptake by regulating transcription and/or translocation of glucose transporters to the plasma 
membrane via the PI3K/AKT pathway (Copland et al. 2007; Díaz et al. 2009; Wilson et al. 
1995), (ii) enhances glycogen synthesis via AKT-mediated inhibitory phosphorylation of 
glycogen synthase kinase 3 (GSK3; Cross et al. 1995), (iii) enhances cellular protein synthesis 
via AKT/MTOR-mediated relief of the inhibition on  the rate limiting step on translation 
initiation (Topisirovic et al. 2005), and (iv) enhances cell cycle progression via AKT-mediated 
relief of cyclin D degradation by GSK3 (Chang et al. 2003) or via ERK1/2-mediated 
transcription of a variety of genes that drive cell proliferation (Chitnis et al. 2008). By virtue of 
above-mentioned molecular functions, IGFs promote cellular mitosis, differentiation, migration, 
aggregation and inhibition of apoptosis in the placenta (Ravelich et al. 2004). Further, it has 
been suggested that IGF1 acts as a nutrient sensor that ensures fetal growth is commensurate 
with the maternal nutrient supply, and that IGF2 acts as a driver of feto-placental mass 
accumulation (Fowden 2003).  
The EGF family of growth factors are also implicated in cellular growth through 
proliferation, differentiation, and apoptosis (Bryant et al. 2004) in a variety of cell types 
(Johnstone et al. 2005; Jorissen et al. 2003) including those of the placenta (Johnstone et al. 
2005). They have been shown to stimulate proliferation and/or migration of trophoblast cells in 
cattle (Dilly et al. 2010) and human (Han et al. 2010; Qiu et al. 2004), and to exert anti-
apoptotic effects on human trophoblast cells (Garcia-Lloret et al. 1996; Levy et al. 2000). 
Activated ERBB receptors exert their functions by activating signal transduction pathways 
including but not limited to PI3K/AKT, ERK1/2 pathways (Jorissen et al. 2003; Koyama et al. 
2003).  
Even though several studies have looked at the effects of SCNT on transcription of genes 
encoding IGF ligands (IGF1 and IGF2; Ravelich et al. 2004; Sawai 2009), IGF receptors (IGF1R 
and IGF2R; Moore et al. 2007; Yang et al. 2005), and several IGFBPs (IGFBP1-4; Li et al. 2007; 
Ravelich et al. 2004; Sawai 2009), a comprehensive evaluation of neither the transcription 
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status nor the effects of implantation and SCNT on IGF signaling-related genes, in particular 
signal transduction pathways induced by IGF1R activation, has been carried out. Expression 
levels of genes related to EGF ligands, receptors and downstream effectors with regard to SCNT 
pregnancies have also not been studied in detail. In the present study, we examine the transcript 
levels of genes encoding IGF and EGF-related ligands, receptors and binding proteins, and that 
of genes encoding PI3K/AKT and ERK1/2-related molecules in peri-implantation stage bovine 
SCNT and artificial insemination (AI)-derived pregnancies. We use RNAseq technology to 
identify transcripts expressed on endometrial tissue (caruncle; CAR and inter-caruncle; ICAR 
separately) and extraembryonic tissue (trophoblast/chorion and allantois separately) collected 
from AI and SCNT-derived pregnancies at gestation day (GD)-18 (pre-implantation) and GD-34 
(post-implantation). MetaCore™ GeneGo Pathway Maps were used for functional ontology 
enrichment analysis to identify IGF/EGF signaling-related genes whose transcript levels are 
aberrant in SCNT pregnancies. The above experimental design together with RNAseq 
technology provides strong evidence to support the hypotheses that IGF and EGF signaling and 
in turn cellular functions mediated by these growth factor families are perturbed in SCNT 
pregnancies during the peri-implantation period in cattle. Further, we report that genes 
encoding the mammalian target of rapamycin (MTOR) and 5' adenosine monophosphate-
activated protein kinase (AMPK), two central sensors/regulators of cellular energy status, are 
aberrantly expressed in SCNT conceptuses. 
RESULTS 
GeneGo pathway maps enrichment analysis. On the basis of MetaCore™ GeneGo 
Pathway Maps functional ontology enrichment analysis, “IGF-1 receptor signaling”, “EGFR 
signaling pathway”, “ERBB-family signaling”, “AKT signaling” and “ERK1/2 signaling pathway” 
were significantly affected by SCNT in GD-18 EET and GD-34 ICAR tissues (Tables 4.1 and 4.2). 
The three GeneGo Pathway Maps “IGF-1 receptor signaling”, “EGFR signaling pathway” and 
“AKT signaling” were significantly affected by implantation in CAR, ICAR and 
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trophoblast/chorion while the GeneGo Pathway Maps “ERBB-family signaling” and “ERK1/2 
signaling pathway” were affected by implantation in CAR and ICAR but not in 
trophoblast/chorion (false discovery rate adjusted; FDR P<0.05; Table 4.3). Of the genes 
categorized under these five GeneGo Pathway Maps, expression levels of 54 genes were affected 
by SCNT in GD-18 EET and GD-34 ICAR tissues (FDR P<0.05; Table 4.4), and transcript levels 
of 63, 78 and 42 were affected by implantation in CAR, ICAR and trophoblast/chorion 
respectively (FDR P<0.05; Table 4.5). 
Expression levels of genes encoding IGF family-related ligands, receptors and binding 
proteins are affected by SCNT during the peri-implantation period. IGF1 mRNA expression 
was only detected in endometrial tissue. Neither GD-18 nor GD-34 EET tissues expressed IGF1 
mRNA. IGF2, IGF1R and IGF2R mRNA were expressed in all tissues tested. The gene encoding 
INSR was not expressed in any of the tested tissues. Of the IGFBP encoding mRNAs, IGFBP2 – 
5 were expressed in all tissues, while IGFBP1 was not expressed in any of the tissues and 
IGFBP6 was expressed in all tissues except GD-18 trophoblast. A relatively more heterogeneous 
spatio-temporal pattern of expression was observed for the genes encoding IGF2 mRNA binding 
proteins: IGF2BP1 was expressed in all EET tissue and GD-34 NT CAR, IGF2BP2 was expressed 
in all tissues except GD-18 EET and GD-34 CAR, and IGF2BP3 was expressed in all EET tissues 
and GD-18 CAR.  
Transcript levels of genes encoding IGF2R, IGF2BP1, IGF2BP3, IGFBP3, IGFBP4, and 
IGFBP6 were significantly affected by SCNT in one or more tissues (FDR P<0.05; Table 4.4). In 
addition, transcript levels of genes encoding IGF2, IGF2BP1, and IGFBP2 tended to be different 
between SCNT and AI in one or more tissues (FDR P<0.1). In addition, transcript levels of genes 
encoding IGF1R, IGF2, IGFBP2–6, IGF2BP1 and IGF2BP2 were significantly associated with 
implantation in one or more tissues (FDR P<0.05; Table 4.5).  
Expression levels of genes encoding EGF family-related ligands and receptors were also 
affected by SCNT during the peri-implantation period. Of the ligands belonging to the EGF 
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family of growth factors, amphiregulin (AREG), betacellulin (BTC), heparin-binding EGF-like 
growth factor (HB-EGF), neuregulin 1 (NRG1), and neuregulin 2 (NRG2) encoding genes were 
expressed in at least one tissue while EGF, epiregulin (EREG), NRG3, NRG4, and TGF-alpha-
encoding genes were not expressed in any of the tissues tested. Of the receptors belonging to the 
EGF family of growth factors, EGFR-, ERBB2- and ERBB3-encoding genes were expressed in 
one or more tissues while ERBB4 was not expressed in any of the endometrial or EET tissues 
tested (Table 4.4).  
Transcript levels of NRG2, EGFR, and ERBB2 were significantly affected by SCNT in one 
or more tissues (FDR P<0.05; Table 4.4). In addition, transcript levels of BTC, and ERBB3 
tended to be different between SCNT and AI in certain tissues (FDR P<0.1). Transcript levels of 
BTC, HB-EGF, NRG1, NRG2, and ERBB3 were significantly affected by implantation in one or 
more tissues (FDR P<0.05; Table 4.5). 
Expression levels of genes encoding downstream effectors of IGF and EGF receptor 
activation are affected by SCNT during the peri-implantation period. Of the genes encoding 
the two insulin receptor substrate family of proteins annotated in cattle (IRS1 and IRS4), IRS1 
was expressed in all tissues while IRS4 was not expressed in any of the tissues. The genes 
encoding adaptor molecules Src homology collagen (SHC), growth factor receptor-bound 
protein 2 (GRB2), growth factor receptor-bound protein 7 (GRB7), SH2/SH3 adaptor protein 
(NCK) adaptor protein 1 (NCK1) and 14-3-3 proteins that couple activated growth factor 
receptors to downstream signaling pathways were also expressed in all tissues. Of these adaptor 
molecule-encoding genes, IRS1, GRB7, NCK1 and SHC1 were differentially expressed in one or 
more tissues collected from SCNT pregnancies (FDR P<0.05; Table 4.4).  
When the AI vs SCNT comparison is carried out with all allantois samples included, 
transcript levels of an additional nine IGF and EGF signaling-related genes (MTOR, IRS1, AKT3, 
RAPGEF2, GSK3B, ERBB3, IGFBP3, BCL2L1 and IGF2BP2; Table 4.6) were differentially 
expressed in SCNT allantois (FDR P<0.05). In addition, transcript levels of several constituent 
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molecules of PI3K/AKT and ERK1/2 signal transduction pathways were significantly affected by 
SCNT and implantation (listed in tables 4.4 and 4.5, respectively). 
DISCUSSION 
Insulin-like growth factor 1 mRNA was not expressed in EET. However, others have 
demonstrated the expression of IGF1 mRNA in EET of peri-implantation-stage bovine 
conceptuses using qRT-PCR (Moore et al. 2007). Therefore, the non-detection of IGF1 mRNA 
on bovine EET in this particular experiment may be due to the lower sensitivity of the RNA-seq 
technology compared to qRT-PCR (Klopfleisch and Gruber 2012). However, mRNAs of IGF1R, 
IGF2 and IGF2R were expressed in all tissues. Given the autocrine and paracrine mechanisms of 
growth factor action postulated to mediate conceptus-placental growth (Schultz and Heyner 
1993; Simmen and Simmen 1991), IGF1R expressed on EET may be targets for IGF2 from the 
EET itself (autocrine) or IGF1 and/or IGF2 from maternal sources (paracrine/endocrine).  
For ease of understanding, component genes of the GeneGo Pathway Maps considered in 
the analysis were categorized as those encoding proteins related to IGF1R activation, 
EGFR/ERBB activation, PI3K activation, AKT activation, ERK1/2 signaling, cell cycle G1/S 
transition, apoptosis/survival and protein synthesis (Table 4.7). Aberrant expression of 
transcripts belonging to each of the above molecular/cellular functions in SCNT pregnancies will 
be discussed separately. 
IGF and EGF signaling-related genes are affected by SCNT 
One of the most striking findings in the AI vs SCNT comparison was the observation that 
differential expression of transcripts related to IGF and EGF/ERBB signaling molecules were 
almost exclusive to GD-18 EET and GD-34 ICAR tissues. Consistent with this observation, the 
three GeneGo Pathway Maps “IGF-1 receptor signaling”, “EGFR signaling pathway”, and 
“ERBB-family signaling” were affected by SCNT only in GD-18 EET and GD-34 ICAR (FDR 
P<0.05). Transcript levels of any of the genes categorized in the above GeneGo Pathway Maps 
were not affected by SCNT in GD-18 CAR, GD-18 ICAR, GD-34 CAR or GD-34 trophoblast. A 
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few genes were differentially expressed in allantois; however none of the three GeneGo Pathway 
Maps were significantly affected. The same pattern was true for the GeneGo Pathway Maps 
“AKT signaling” and “ERK1/2 signaling pathway”, two signal transduction pathways induced 
upon IGF1R/EGFR/ERBB activation.  
Differential expression of genes related to IGF and EGF families in GD-18 EET  
Of the genes categorized under the GeneGo Pathway Maps “IGF-1 receptor signaling”, 
“EGFR signaling pathway”, “ERBB-family signaling”, “AKT signaling” and “ERK1/2 signaling 
pathway”, 101 genes satisfied the criteria used for the AI vs SCNT comparison in GD-18 EET. Of 
these, transcript levels of 54 genes were affected by SCNT (N=29 genes were up-regulated and 
N=25 genes were down-regulated in SCNT; Table 4.4). 
Effects of SCNT on transcripts-related to IGF1R and ERBB activation in GD-18 EET. No 
differences in expression levels were observed for genes encoding IGF ligands or IGF1R/2R. 
However, three genes encoding two IGFBPs and one IGF2BP were aberrantly expressed: 
IGFBP3 (fold-change SCNT/AI = 2.39) and IGF2BP3 (fold-change SCNT/AI = 2.01) were 
increased, and IGFBP4 was decreased (fold-change SCNT/AI = 0.59) in GD-18 SCNT 
trophoblast. In contrast to our findings, another study that compared IGFBP3 mRNA levels 
between SCNT and AI GD-15 blastocysts found that IGFBP3 was down-regulated in SCNT 
(Sawai 2009). However, it is not clear if RNA extraction was carried out using the EET alone or 
the whole conceptus. Another study that looked at IGFBP3 protein expression at later stages of 
bovine pregnancy reported that it was higher in placentomes collected from SCNT pregnancies 
(both trophoblast cells and maternal cells) than those from AI pregnancies (Ravelich et al. 
2004). Assuming the typical function of these binding proteins, the decreased IGFBP4 and 
increased IGF2BP3 levels may act to increase IGF1R activation subsequently leading to a growth 
stimulatory effect in GD-18 SCNT trophoblast. In contrast, the increased IGFBP3 mRNA levels 
may lead to reduced IGF1R activation. Given the contrasting nature of these effects, it is not 
clear if IGF1R activation is increased or decreased in SCNT trophoblast compared to AI. 
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Similarly, directions of fold-changes of the two EGF receptors whose transcript levels were 
affected by SCNT, EGFR (2.18-fold up in SCNT) and ERBB2 (1.75-fold down in SCNT), were not 
consistent and it is therefore not clear if EGFR activation is increased or decreased in SCNT. 
Effects of SCNT on transcripts-related to PI3K/AKT signal transduction in GD-18 EET. 
Transcript levels of all four class IA phosphoinositide 3-kinase encoding genes that were 
expressed in GD-18 trophoblast were different in SCNT. Expression levels of PIK3CA, PIK3CB, 
and PIK3R1 were increased (2.11 – 3.62-fold increase) while that of PIK3R2 was decreased (2-
fold decrease) in GD-18 SCNT trophoblast. In addition, PTEN was significantly increased (2.45-
fold increase) in GD-18 SCNT trophoblast. Collectively these results suggest that PI3K activation 
may be increased in SCNT compared to AI in GD-18 EET. Transcript levels of the gene encoding 
GRB2-associated binder-1 (GAB1), which has been shown to provide docking sites for PI3K 
regulatory subunits and thereby mediate downstream activation of PI3K (Wickrema et al. 1999), 
were also increased in GD-18 SCNT EET. These results support the hypothesis that PI3K 
enzyme activity may be elevated in GD-18 SCNT EET tissue. In contrast, decreased expression 
levels of AKT2, HSP90, which encodes a protein that protects AKT from dephosphorylation by 
the phosphatase PP2A (Sato et al. 2000), and ILK, which has been shown to phosphorylate and 
activate the AKT pathway (McDonald et al. 2008), suggest that the AKT activation may be 
decreased in SCNT compared to AI in GD-18 EET (Figure 4.1). 
Among the differentially expressed genes encoding molecules of the ERK1/2 signaling 
pathway, some are increased and others are decreased in GD-18 SCNT EET. Transcript levels of 
SOS1, SOS2, N-RAS, K-RAS and B-RAF were increased while those of SHC1, SHC2, A-RAF, 
MAP2K2, and MAPK3 were decreased in GD-18 SCNT EET compared to GD-18 AI EET. Of the 
major targets of activated ERKs, RPS6KA1, ELK1, SRF, and HSF1 were down-regulated while 
RPS6KA3 and CREB1 were up-regulated in GD-18 SCNT EET compared to that in GD-18 AI 
EET. Given the inconsistent nature of the directions of fold-changes, it is not clear if ERK1/2 
signaling is increased or decreased in SCNT (Figure 4.2).  
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Effects of SCNT on transcripts-related to PI3K/AKT and ERK1/2 signaling-mediated 
cellular processes, cell cycle progression, apoptosis/survival, protein synthesis and cellular 
metabolism in GD-18 EET. Increased MTOR and RPS6KB1, and decreased TSC2 and 4E-BP1 
(EIF4EBP1) mRNA levels in SCNT suggest increased activation of the MTOR pathway in GD-18 
SCNT EET (Figure 4.3). Further supporting the hypothesis that MTOR signaling may be 
perturbed in the pre-implantation SCNT trophoblast, transcript levels of three other MTOR 
signaling-related genes that were not categorized under the considered GeneGo Pathway Maps 
were also aberrantly expressed in SCNT: MTOR associated protein, LST8 homolog (MLST8; 
2.6-fold down-regulated), regulatory associated protein of MTOR, complex 1 (RAPTOR) 
independent companion of MTOR, complex 2 (RICTOR; 3.2-fold up-regulated) and TSC1 (2.2-
fold up-regulated).  
In mammalian cells, MTOR is considered a central regulator of cellular growth and 
metabolism. MTOR functions as a multichannel processor that activates different downstream 
effectors responding to different inputs derived from distinct environmental cues. Four 
upstream regulators of MTOR have been described: (i) growth factors, (ii) nutrients, (iii) energy, 
and (iv) stress (Ramanathan and Schreiber 2009; Wullschleger et al. 2006). The MTOR 
pathway responds to these stimuli via different pathways: (i) growth factors (e.g. IGF, EGF and 
platelet derived growth factor) via the PI3K/AKT pathway, (ii) nutrients via tuberous sclerosis 
proteins (TSC1; hamartin and TSC2; tuberin)/Ras homolog enriched in brain (RHEB) axis, (iii) 
energy levels via AMP-activated protein kinase (AMPK), and (iv) stress/hypoxia via DNA-
damage-inducible transcript 4  (DDIT4) and hypoxia-inducible factor 1 (HIF1; Wullschleger et 
al. 2006). When above environmental signals are favorable for growth, MTOR signaling 
promotes a shift toward anabolic processes stimulating cellular growth and proliferation 
(Gibbons et al. 2009; Lane and Breuleux 2009; Schmelzle and Hall 2000). Several genes related 
to above pathways were also aberrantly expressed in SCNT. For example, transcripts encoding 
protein kinase, AMP-activated, alpha 1 catalytic subunit (PRKAA1; a gene encoding the AMPK 
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alpha subunit; 2.4-fold increase), ataxia telangiectasia mutated (ATM; a protein involved in 
IGF-mediated activation of AMPK; Suzuki et al. 2004; 3.4-fold increase) and HIF1α (2.2-fold 
increase) were aberrantly expressed in SCNT.  
Up-regulation of above-mentioned MTOR signaling-related genes, AMPK, ATM and 
HIF1α in SCNT also suggests perturbed cellular energy metabolism and cellular stress/hypoxia 
in GD-18 SCNT trophoblast cells. AMPK is considered a sensor of cellular energy levels and a 
master regulator of cellular metabolism (Potter et al. 2010). It is switched on by cellular stresses 
that interfere with ATP production (e.g. hypoxia, glucose deprivation, ischemia; regulated by the 
ATP:AMP ratio) or by stresses that increase ATP consumption (e.g. muscle contraction). Further 
supporting the above hypothesis of perturbed energy metabolism/cellular glucose/ATP levels in 
GD-18 SCNT EET, GLUT1 (SLC2A1) and GLUT3 (SLC2A3), two glucose transporters regulated 
by IGF1 (Copland et al. 2007; Wilson et al. 1995), were down-regulated in SCNT. It has been 
shown that insulin mediated expression of GLUT1 is mediated via AKT/MTOR pathway in other 
systems (Zhou et al. 2008a). Collectively, above findings further strengthen the hypothesis that 
MTOR signaling in GD-18 SCNT EET is perturbed. These perturbations may reflect 
disturbances in growth and metabolism of trophoblast cells at GD-18. These findings of 
differential transcription of genes related to MTOR signaling provide new insights to current 
understanding of effects of SCNT on cellular metabolism and growth. 
Two of the best characterized downstream pathways of MTOR activation involve protein 
translation regulators S6K1-RPS6K and 4E-BP1 (Wullschleger et al. 2006). Increased RPS6KB1 
and decreased EIF4EBP1 levels suggest enhanced cellular protein synthesis. Consistent with 
hypothesis, transcripts encoding eukaryotic translation initiation factor 4 gamma, 3 (EIF4G3; 
2.6-fold increase) and eukaryotic translation initiation factor 4A2 (EIF4A2; 2.6-fold increase), 
components of the eukaryotic translation initiation factor 4 complex, were up-regulated. It has 
been shown that IGF1 stimulates global cellular protein synthesis by inducing changes in the 
phosphorylation and association state of PI3K/AKT/MTORC1 signaling pathway (Burgos and 
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Cant 2010). Therefore these transcript levels suggestive of increased MTOR activation and 
protein synthesis may reflect altered IGF1R activation in SCNT trophoblast cells. Another group 
demonstrated aberrant expression of 4E-BP1 levels in EET collected from GD-26 swine SCNT 
conceptuses (Chae et al. 2009). Interestingly, 4E-BP1 levels were increased in SCNT EET, in 
contrast to the decreased mRNA levels we observed in SCNT. The authors suggested that 
increased 4E-BP1 levels may be a result of altered IGF levels in SCNT pregnancies. 
Decreased expression of CCND2 (10.4-fold decreased in SCNT) and CCND3, genes 
whose protein products regulate G1/S transition in the cell cycle, suggest that cell cycle 
progression may be compromised in SCNT trophoblast. Expression levels of genes encoding 
pro-apopt0tic (BAD, P53, FAS, FOXO3) and anti-apoptotic (MDM2) proteins were also affected 
by SCNT in GD-18 EET; however, their directions of fold-changes were not consistent and it is 
not clear if the cumulative effect is pro-apoptotic or anti-apoptotic in SCNT. Previous studies 
have reported hypoplasia, increased apoptosis and shedding of trophoblast cells from fetal villi 
(Fletcher et al. 2007), and/or reduced numbers of binucleate cells (Fletcher et al. 2007; BNC; 
Hashizume et al. 2002; Loi et al. 2006; Palmieri et al. 2007) in ovine and bovine SCNT 
pregnancies. The observed differences in expression levels of genes regulating cell cycle 
progression and apoptosis in the GD-18 SCNT EET may reflect these perturbations. 
In summary, transcripts related to IGF1R activation, ERBB/EGFR activation, MTOR 
activation, PI3K/AKT and ERK1/2 signaling, are aberrantly expressed in GD-18 SCNT EET. On 
the basis of the assumption that mRNA expression is informative for predicting protein 
expression levels (Guo et al. 2008), the above findings suggest that IGF and EGF signaling are 
perturbed in GD-18 SCNT EET during the peri-implantation period in cattle. In addition, 
findings on transcript levels also suggest that cellular functions potentially regulated by IGF and 
EGF signaling, G1/S transition, survival/apoptosis, glucose uptake, protein synthesis and 
cellular energy metabolism may be perturbed in SCNT trophoblast cells during this period of 
gestation. Given the highly proliferative nature of the elongating EET at this stage of gestation, 
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perturbations in above-mentioned cellular/molecular functions mediated via IGF/EGF 
signaling in trophoblast cells may contribute to disturbances in blastocyst growth and/or 
implantation and in turn peri-implantation losses in SCNT pregnancies. To our knowledge, this 
is the first report of differential expression of transcripts encoding AMPK and MTOR, two 
molecules that are considered central regulators of cellular energy metabolism, in SCNT 
pregnancies. These results support and extend observations made by other researchers that 
energy metabolism in SCNT conceptuses may be disturbed (Everts et al. 2008; Garry et al. 1996; 
Ravelich et al. 2004).  
Differential expression of genes related to IGF and EGF families in GD-34 ICAR 
Of the genes categorized under the GeneGo Pathway Maps “IGF-1 receptor signaling”, 
“EGFR signaling pathway”, “ERBB-family signaling”, “AKT signaling” and “ERK1/2 signaling 
pathway”, 116 genes satisfied the criteria used for the AI vs SCNT comparison in GD-34 ICAR. 
Of these, transcript levels of 54 genes were affected by SCNT (N=26 genes were up-regulated 
and N=28 genes were down-regulated in SCNT).  
Effects of SCNT on transcripts-related to IGF1R activation in GD-34 endometria. No 
differences in expression levels were observed for genes encoding IGF ligands. However, 
transcript levels of IGF2R and IGFBP6 were decreased in SCNT. Decreased IGF2R (a scavenger 
of IGF2) and IGFBP6 (preferentially binds and sequesters IGF2; Jones and Clemmons 1995) can 
lead to increased IGF2 ligand availability and increased IGF1R activation. Of the EGF family of 
growth factors, NRG2 was down-regulated in SCNT. 
Effects of SCNT on transcripts-related to PI3K/AKT signaling in GD-34 endometria. 
Transcript levels of five genes encoding molecules related to PI3K enzyme activation were 
aberrant in GD-34 SCNT ICAR. Expression levels of PIK3CA, PIK3CB, and PIK3R3 were 
increased (1.9 – 2.8-fold increase) while that of PIK3R2 was decreased (1.7-fold decrease) in 
GD-34 SCNT ICAR. In addition, PTEN was significantly increased (2.3-fold increase) in SCNT. 
Collectively these results suggest that PI3K enzyme activation may be increased in SCNT 
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compared to AI in GD-34 ICAR. Of the genes related to AKT activation, transcript levels of AKT2 
and HSP90 decreased and transcript levels of AKT3, PPP2CA and PPP2CB were increased in 
SCNT. Transcripts PPP2CA and PPP2CB encode the protein phosphatase 2A catalytic subunits 
alpha and beta that dephosphorylate and inactivate AKT while HSP90 protects AKT against 
PPP2A mediated dephosphorylation (Sato et al. 2000). Collectively, the above observations 
suggest that AKT activation may be decreased in SCNT compared to AI in GD-34 ICAR. 
Effects of SCNT on transcripts-related to ERK1/2 signaling in GD-34 endometria. Of 
the differentially expressed genes encoding molecules of the ERK1/2 signaling pathway, 
transcript levels of some were increased and others were decreased in SCNT.  Transcript levels 
of SOS1, SOS2, N-RAS, K-RAS and B-RAF were increased while those of IRS1, SHC2 and 
MAP2K2 were decreased in GD-34 SCNT ICAR compared to GD-34 AI ICAR. Given the 
inconsistent nature of the directions of fold-changes, it is not clear if ERK1/2 signaling is 
increased or decreased in SCNT.  
Effects of SCNT on transcripts-related to PI3K/AKT and ERK1/2 signaling-mediated 
cellular processes glucose uptake, cell cycle progression, apoptosis/survival and protein 
synthesis in GD-34 ICAR. Transcript levels of four genes related to G1/S transition were affected 
by SCNT in GD-34 ICAR. Levels of CCND1, CCND2 and CDKN1A were decreased while that of 
GSK3β was increased in SCNT. Collectively, the above data suggest that G1/S cell cycle 
progression may be compromised in SCNT ICAR at GD-34. Expression levels of genes encoding 
pro-apopt0tic (BAD, FAS, ASK1) and anti-apoptotic (MDM2) proteins were also affected by 
SCNT; however, their directions of fold-changes were not consistent and it is not clear if the 
cumulative effect is pro-apoptotic or anti-apoptotic in SCNT. Decreased TSC2 and EIF4EBP1 
mRNA levels in GD-34 SCNT ICAR suggest perturbed activation of the MTOR pathway and 
cellular protein synthesis. However, MTOR mRNA levels were not affected by SCNT in GD-34 
ICAR. Further supporting the hypothesis that MTOR signaling in GD-34 SCNT ICAR is 
perturbed, transcript levels of MTOR-related genes MLST8 (1.7-fold down-regulated) and 
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RICTOR (2.6-fold up-regulated) were differentially expressed. In addition, differential 
transcript levels of GLUT4 (SLC2A4; 2-fold decrease), PRKAA2 (AMPK subunit encoding gene; 
2.9-fold increase) and HIF1α (2.2-fold increase), genes whose protein products are involved in 
activation of MTOR, support the hypothesis that MTOR signaling may be perturbed in SCNT. 
Consistent with decreased EIF4EBP1 suggestive of increased protein synthesis, transcript levels 
of the gene encoding eukaryotic translation initiation factor 4e (eTIF4e), a component of the 
eukaryotic translation initiation factor 4 complex, was also up-regulated in SCNT. Transcript 
levels suggestive of increased protein synthesis are consistent with the observations suggestive 
of increased IGF1R and PI3K enzyme activation.  
A recent study reported the expression of MTOR pathway-related molecules (mRNAs 
and/or proteins) MTOR, TSC2, RHEB, EIF4EBP1, MLST8, RAPTOR, RICTOR and TSC1 in 
endometrial luminal epithelia, glandular epithelia and trophoblast cells of peri-implantation 
stage ewes (Gao et al. 2009). They also showed that the transcript levels of RHEB, EIF4EBP1 
and MLST8 in uterine luminal and glandular epithelia increased with advancing days of 
pregnancy. It was also demonstrated that endometrial transcription of RHEB and EIF4EBP1 
were regulated by progesterone and IFNτ, and progesterone respectively. Given that RHEB is 
the only known activator of MTOR protein (Gao et al. 2009), these results suggest that the 
implanting conceptus may regulate the MTOR pathway on maternal endometrial epithelia via 
IFNτ. Two other studies from the same group showed that select amino acids and glucose 
coordinately activate AKT1-MTOR and RPS6K-RPS6 cell signaling pathways to stimulate 
cellular protein synthesis, hypertrophy, hyperplasia, and migration of primary ovine 
trophectoderm (oTr) cells isolated from GD-15 conceptuses. These in vitro findings suggest that 
select amino acids and glucose in histiotroph may regulate hypertrophy, hyperplasia, and 
migration of trophoblast cells via the MTOR pathway in vivo (Kim et al. 2011b; Kim et al. 
2011c). Therefore, on the one hand, the implanting conceptus regulates endometrial MTOR 
pathway/cellular protein synthesis via IFNτ; on the other, endometrial histiotroph, a secretory 
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product of endometrial epithelial cells rich in select nutrients, regulates trophoblast cell 
development via the MTOR pathway. Results from above studies collectively suggest that MTOR 
signaling in conceptuses and endometria, in response to a multitude of stimuli, including 
hormones, cytokines, and nutrients, likely mediates interactions between the uterus and 
conceptus that are required for growth and development during the peri-implantation period of 
pregnancy (Bazer et al. 2011; Gao et al. 2009). Therefore, our findings on differential 
transcription of genes related to MTOR signaling in GD-18 SCNT EET and GD-34 SCNT ICAR 
suggest that this pathway, which likely mediates interactions between the uterus and conceptus 
by integrating a multitude of environmental cues such as growth factors, nutrients, energy status 
and cellular stress, is perturbed in SCNT pregnancies during the peri-implantation period in 
cattle. 
In summary, genes that were differentially expressed in GD-34 SCNT ICAR suggest that 
IGF1R activation, PI3K enzyme activation and cellular protein synthesis may be increased and 
that AKT signaling and G1/S transition may be compromised in SCNT ICAR at GD-34. This 
transcription profile is very similar to that of the GD-18 SCNT EET. Inter-caruncular tissue is a 
mixture of a multitude of cell types: luminal epithelia, stromal cells, endometrial glands and 
blood vessels. Given that IGF and PI3K/AKT signaling have been implicated in endometrial 
gland proliferation (Eritja et al. 2010; Taylor et al. 2001; Wathes et al. 1998) and 
angiogenesis/vascular remodeling in the uterus and other tissues (Herr et al. 2003; Shankar et 
al. 2008), and that perturbations in endometrial glands (Kim et al. 2011a) and placental 
vasculature (Palmieri et al. 2008) have been reported in SCNT pregnancies, the observed gene 
expression differences in SCNT may reflect disturbances in endometrial glandular 
proliferation/secretion and/or blood vessel development. Given the importance of ICAR during 
this pre-placental phase of gestation in providing histiotrophic nutrition (Bazer 1975) as well as 
a surface for attachment for the conceptus (Guillomot et al. 1981), perturbations in above-
mentioned cellular/molecular functions mediated via IGF/EGF signaling in ICAR tissue may 
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contribute to increased peri-implantation losses observed in SCNT pregnancies. In light of 
recent findings implicating a role for MTOR signaling in conceptus-maternal cross-talk, 
histiotrophic nutrition and trophoblast elongation (Bazer et al. 2011; Gao et al. 2009; Kim et al. 
2011c), our findings of aberrant expression of genes related to the PI3K/AKT/MTOR pathway 
and energy metabolism in SCNT pregnancies provide new insights to core metabolic pathways 
that may be affected by SCNT.  
IGF and EGF signaling-related genes are temporally regulated 
All five GeneGo Pathway Maps considered in the analysis were associated with 
implantation in endometrium while three were associated with implantation in 
trophoblast/chorion (FDR P<0.05; Table 4.3).  
Effects of implantation on transcripts related to IGF1R activation. Endometrial 
transcript levels of genes related to IGF receptors and binding proteins affected by implantation 
suggest that IGF1R activation may be decreased in GD-34 endometrium compared to GD-18. 
Decreased levels of IGF1R, IGF2BP2 and IGF2BP3 mRNA and increased levels of IGF2R, 
IGFBP2, IGFBP3, IGFBP4, and IGFBP6 mRNA in CAR and/or ICAR (Table 4.5) are consistent 
with decreased IGF1R activation. IGFBPs generally bind and sequester IGF ligands (Jones and 
Clemmons 1995), and increased levels of IGFBP proteins have been shown to decrease IGF1R 
phosphorylation (Laursen et al. 2007; Yan et al. 2006). Decreased IGF2BP2 and IGF2BP3 (Liao 
et al. 2005), whose gene-products are considered translational activators of IGF2, are consistent 
with decreased IGF2 ligand production. Increased transcript levels of the gene encoding IGF2R, 
a scavenger of IGF2 (Jones and Clemmons 1995), can also lead to decreased IGF1R activation by 
IGF2. Collectively, transcript levels of the above mentioned genes suggest that IGF1R activation 
may be decreased in GD-34 CAR and ICAR compared to GD-18. The only IGF-related gene 
whose transcript levels suggest an increase of IGF1R activation from GD-18 to GD-34 was that of 
IGFBP5 in CAR; however this was in contrast to what is reflected by the other eight IGF-related 
genes. 
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In contrast, IGF1R activation-related genes whose transcript levels were affected by 
implantation in trophoblast/chorion suggest increased IGF1R activation in GD-34 chorion 
compared to GD-18 EET. Increased IGF2 (7.4-fold) and IGF2BP2 (22.9-fold; a translational 
activator of IGF2; Liao et al. 2005) mRNA levels and decreased IGF2BP1 (a translational 
inhibitor of IGF2; Nielsen et al. 1999) mRNA levels suggest increased IGF2 ligand availability 
for IGF1R activation. In contrast, decreased IGF1R and increased IGF2R, IGFBP2 and IGFBP6 
mRNA levels at GD-34 may result in decreased IGF1R activation (Table 4.5); however, these 
may be compensatory responses to increased IGF ligand availability. For example, it is well 
established in other systems that IGF1R levels are negatively regulated by increasing IGF ligand 
levels (Chi et al. 2000; Rosenfeld and Hintz 1980). 
Effects of implantation on transcripts related to EGFR/ERBB activation. Endometrial 
transcript levels of genes encoding several EGF family ligands (BTC, NRG2, NRG1, and HBEGF) 
and receptors (EGFR and ERBB3) were affected by implantation, however the directions of fold-
changes were not consistent. However, in chorion, consistently increased expression of NRG1 
(7.3-fold) and EGFR (2.4-fold) suggest increased EGFR/ERBB activation at GD-34 compared to 
GD-18 (Table 4.5). 
Effects of implantation on transcripts related to PI3K/AKT and ERK1/2 signaling. 
PI3K/AKT and ERK1/2 signal transduction pathways are two of the major intracellular 
signaling pathways induced upon IGF1R and EGFR/ERBB activation. In the case of the 
trophoblast/chorion, transcript levels of two genes related to PI3K signaling were affected by 
implantation (PIK3CA and PIK3CD), and both of them were increased at GD-34 (up to 7.6-fold; 
Table 4.5) suggesting that PI3K enzyme activity may be increased in chorion compared to GD-18 
trophoblast. Consistent with the above, AKT3 mRNA levels were also increased in chorion (14.9-
fold). Collectively, the above observations suggest that PI3K/AKT signaling may be increased in 
GD-34 chorion compared to GD-18 trophoblast. These gene expression differences suggestive of 
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increased PI3K/AKT signal transduction at GD-34 are consistent with those suggesting 
increased IGF2 ligand availability and EGFR activation of GD-34 chorion. 
In the case of the endometrium, transcript levels of the majority of genes related to PI3K 
activation were decreased at GD-34 (PIK3CA, PIK3CB, PIK3R1, PIK3R3 and PTEN), while that 
of AKT2 was increased. Similarly, in the case of ERK1/2 signaling-related genes, endometrial 
expression levels of several genes were affected by SCNT (MAP2K2, MAPK3, SOS1, SOS2, N-
RAS, K-RAS, B-RAF, and A-RAF); however, their directions of fold-change were not consistent. 
For example, transcript levels of SOS1, SOS2, N-RAS, K-RAS and B-RAF were decreased while 
those of SHC1, MAP2K2, and MAPK3 were increased at GD-34. A common observation in 
transcript levels related to these two pathways on the endometrium was that the expression 
levels of upstream elements (PI3K-related genes in the AKT pathway, and SOS1, SOS2, N-RAS, 
K-RAS and B-RAF in the ERK1/2 pathway) were generally decreased while those of the 
downstream kinases (AKT2, MAP2K2, and MAPK3) were increased at GD-34. The apparent 
decrease in expression levels of genes encoding upstream elements of the PI3K/AKT and 
ERK1/2 pathways in the endometrium is consistent with observations suggesting decreased 
post-implantation IGF1R activation. 
Effects of implantation on transcripts related to PI3K/AKT and ERK1/2 signaling-
mediated cellular processes cell cycle G1/S transition, apoptosis/survival and protein 
synthesis. IGF1R and/or EGFR/ERBB activation, acting via AKT and ERK1/2 signaling 
pathways, mediate a wide variety of cellular processes such as cell cycle progression via  G1/S 
transition (by inhibiting GSK3 mediated cyclin D degradation; Chang et al. 2003),  anti-
apoptotic/pro-survival responses, and protein synthesis (by relieving the inhibition on the rate 
limiting step of translation initiation via the AKT/mTOR pathway; Shiojima and Walsh 2002; 
Topisirovic et al. 2005). Transcript levels of several genes regulating cell cycle progression 
(CCND1–3, GSK3α, GSK3β), apoptosis/survival proteins (pro-apopt0tic BAD, P53, FAS, ASK1 
and anti-apoptotic BCL2L1, MDM2), and cellular protein synthesis (4E-BP1, TSC2, RPS6KB1, 
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RHEB and MTOR) were affected by implantation in endometrium and/or EET. However, the 
directions of fold-changes of individual genes did not consistently support up-regulation or 
down-regulation of a particular cellular function in most cases (Figure 4.4): for example, 
increased transcript levels of genes encoding 4E-BP1, TSC2 and decreased transcript levels of 
RHEB at GD-34 compared to GD-18 are suggestive of decreased post-implantation protein 
translation, however, decreased MTOR levels do not support this hypothesis. 
In summary, differences of transcript levels between the two time points in chorion 
suggest that IGF2 ligand production, EGFR activation and PI3K/AKT signaling in GD-34 
chorion may be increased compared to GD-18 trophoblast. These observations may be related to 
proliferation of the trophoblast, binuclear cell differentiation and migration, chorio-allantoic 
fusion etc. that characterize the post-implantation chorion. In contrast, differences of transcript 
levels between the two time points in endometrium suggest that IGF1R activation and PI3K 
activation may be decreased post-implantation. Implantation involves events that impose acute 
metabolic demands on endometrial cells (e.g. ECM remodeling; Korgun et al. 2003). Therefore 
metabolic demands on endometrial cells at GD-34 may be lower than that at GD-18. Decreased 
IGF1R and PI3K activation are consistent with this notion. Increased transcript levels of genes 
encoding 4E-BP1, TSC2 and decreased transcript levels of RHEB at GD-34 compared to GD-18 
are suggestive of decreased post-implantation protein translation, and further support this 
hypothesis of decreased metabolic demands on the early post-implantation endometrium.  
It should be noted that, in certain cases, directions of fold-changes regulating the same 
cellular function/pathway were not consistent and it was not possible to predict the cumulative 
effect of all affected genes. For example, in general PI3K enzyme activation culminates in AKT 
activation. But in several comparisons in this study, PI3K-related genes were up-regulated while 
AKT-related genes were down-regulated (e.g. GD-34 SCNT ICAR). Such observations could be 
attributed to several reasons. First, CAR, ICAR and trophoblast/chorion tissue comprise of 
different cell types with different specialized functions (e.g. glandular epithelia, blood vessels, 
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stromal cells, mono-nucleated trophoblast cells, binucleated trophoblast cells etc.) and 
presumably different levels of signaling pathway activation. However, transcript levels 
measured in this study reflects a mean value for a given transcript expressed in all cell types. 
Secondly, the degree of receptor/pathway activation may be regulated at a post-
transcriptional/post-translational level and therefore may not be reflected in the transcriptome. 
Thirdly, the same pathway may be activated by different mechanisms (Franke et al. 2003). For 
example, AKT can be activated independent of PI3K (e.g. via ILK; Yoganathan et al. 2000). Thus 
in the example above, activation of PI3K and AKT may be induced from two different sources. 
It should also be noted that intra-cellular signal transduction pathways such as AKT 
signaling and ERK1/2 signaling are activated by not only IGF1R and EGFR activation, but also 
by activation of other growth factor receptors such as growth hormone receptor (Costoya et al. 
1999), leptin receptor (Goetze et al. 2002; Trinko et al. 2011) and platelet derived growth factor 
(PDGF; Xiong et al. 2010). Therefore the changes in transcript levels in genes encoding 
molecules of these pathways may not necessarily be directly related to IGF1R and EGFR/ERBB 
activation. Supporting this hypothesis, GeneGo Pathway Maps “Growth hormone signaling via 
PI3K/AKT and MAPK cascades”, “Leptin signaling via PI3K-dependent pathway” and “PDGF 
signaling via MAPK cascades” were also significantly affected by SCNT in both GD-18 EET and 
GD-34 ICAR. However, current approaches of pathway analysis are designed to analyze a 
snapshot of a biological system by assuming that each pathway is independent of the others at a 
given time and do not account for inter-pathway dependence (Khatri et al. 2012). These 
observations suggest that the differential expression of genes related to IGF and EGF signaling 
in SCNT may be part of a physiological response involving other growth factor families as well.  
Most tissues we tested contained more than one cell type (e.g. glandular epithelia, 
luminal epithelia, endothelia, mono nucleated and binucleated trophoblast cells etc.). Therefore 
our interpretations are provided at the tissue level and not at the cellular level. Further, our 
interpretations are based on transcriptomic data. However, expression levels of proteins or 
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phosphorylation status of proteins (e.g. in the case of MAPK cascade in ERK1/2 signaling) are 
generally considered better indicators of the functional status of gene products compared to 
transcript levels (Wu et al. 2009). Therefore, proteomic studies, with emphasis on cellular 
localization where necessary, are warranted to confirm our observations on perturbed IGF/EGF 
signaling in SCNT pregnancies. 
MATERIALS AND METHODS 
Production of AI and SCNT-derived pregnancies, sample collection, RNA extraction, 
RNA sequencing, statistical analysis, thresholds used to define expressed genes and 
differentially expressed genes (DEG; Benjamini and Hochberg 1995; FDR P<0.05) and 
importing of expression data to Metacore™ (version 6.9 build 30881; GeneGo; St. Joseph, MI) 
were described in chapters 2 and 3. 
Gene IDs that mapped to network objects categorized under the GeneGo Pathway Maps 
“IGF-1 receptor signaling”, “EGFR signaling pathway”, “ERBB-family signaling”, “AKT 
signaling” and “ERK1/2 signaling pathway” were used to identify IGF and EGF family-related 
genes transcribed in different tissues. Functional enrichment analysis of all expressed genes (in 
each of the 14 tissues) was used to identify GeneGo Pathway Maps that were significantly 
enriched in each of the 14 tissues. Functional enrichment analysis of DEG (FDR P<0.05) from 
AI vs SCNT and GD-18 vs GD-34 comparisons were used to identify GeneGo Pathway Maps that 
were affected by SCNT and implantation, respectively. In both cases, the default database in 
Metacore™ was used as background and a threshold of FDR P<0.05 was used to define 
statistical significance. Most of the above canonical pathways were complex in nature and 
consisted of genes related to different cellular processes and molecular functions. Therefore, for 
ease of understanding, component genes of the five GeneGo Pathway Maps considered in the 
analysis were categorized as those encoding proteins related to IGF1R activation, EGFR/ERBB 
activation, PI3K activation, AKT activation, ERK1/2 signaling, cell cycle G1/S transition, 
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apoptosis/survival and protein synthesis (Table 4.7), and effects of implantation and SCNT on 
these sub-networks discussed separately. 
Certain genes that are related to IGF and/or EGF signaling were not included in the 
considered GeneGo Pathway Maps by default (e.g. IGF2BP1 – 3, IGF2R, ATM, PRKAA1, 
PRKAA2, SLC2A1, SLC2A3 and SLC2A4). However, these genes were identified based on 
literature review and their expression data discussed where relevant. 
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CHAPTER 4 TABLES 
Table 4.1. Numbers of transcripts aberrantly expressed in SCNT-derived tissues within growth factor signaling-related GeneGo 
Pathway Maps at gestation day-18 
Genego Pathway Map 
No. of genes 
in pathway 
CAR   ICAR   EET 
Expressed DEG§   Expressed DEG§   Expressed DEG§ 
IGF-1 receptor signaling 60 60 0 
 
60 0 
 
52 30* 
EGFR signaling pathway 56 53 0 
 
53 0 
 
47 25* 
ERBB-family signaling 37 36 0 
 
36 0 
 
29 17* 
AKT signaling 49 49 0 
 
49 0 
 
44 24* 
ERK1/2 signaling pathway 25 23 0   23 0   21 13* 
§ number of differentially expressed genes (DEG; FDR P<0.05) 
* indicates significant enrichment of GeneGo Pathway Map (FDR P<0.05) 
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Table 4.2. Numbers of transcripts aberrantly expressed in SCNT-derived tissues within growth factor signaling-related GeneGo 
Pathway Maps at gestation day-34 
Genego Pathway Map 
No. of genes 
in pathway 
CAR   ICAR   Chorion   Allantois 
Expressed DEG§   Expressed DEG§   Expressed DEG§   Expressed DEG§ 
IGF-1 receptor signaling 60 60 0 
 
60 31* 
 
56 0 
 
58 0 
EGFR signaling pathway 56 53 0 
 
53 26* 
 
51 0 
 
53 1 
ERBB-family signaling 37 36 0 
 
36 20* 
 
33 0 
 
34 1 
AKT signaling 49 49 0 
 
49 30* 
 
47 0 
 
48 0 
ERK1/2 signaling pathway 25 23 0   23 9*   20 0   23 1 
§ number of differentially expressed genes (DEG; FDR P<0.05) 
* indicates significant enrichment of GeneGo Pathway Map (FDR P<0.05) 
 
 
 
 
  
  
123 
 
Table 4.3. Numbers of transcripts temporally regulated within growth factor signaling-related GeneGo Pathway Maps 
GeneGo Pathway Map 
No. of genes 
in pathway 
CAR   ICAR   
Chorion/ 
Trophoblast   
Expressed DEG§   Expressed DEG§   Expressed DEG§ 
IGF-1 receptor signaling 60 60 31* 
 
60 40* 
 
56 20* 
EGFR signaling pathway 56 53 29* 
 
53 36* 
 
50 22* 
ERBB-family signaling 37 36 20* 
 
36 27* 
 
32 12 
AKT signaling 49 49 26* 
 
49 33* 
 
47 16* 
ERK1/2 signaling pathway 25 23 17*   23 17*   20 6 
§ number of differentially expressed genes (DEG; FDR P<0.05) 
* indicates significant enrichment of GeneGo Pathway Map (FDR P<0.05) 
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Table 4.4. Fold changes (SCNT/AI) of the cumulative list of genes from combining all GeneGo Pathway Maps 
Gene 
Symbol 
Bos taurus 
Gene ID 
Entrez 
Gene ID 
GD-18   GD-34 
CAR ICAR EET   CAR ICAR Chorion Allantois 
AKT2 534923 208 0.9 1.1 0.4** # 1.0 0.7** 0.9 1.1 
AKT3 100137872 10000 1.0 0.9 ND** # 0.9 1.7** 1.0 1.5 
ARAF 540421 369 1.0 1.0 0.5** # 0.9 0.7** 1.0 0.9 
AREG 538751 374 ND ND ND** # 2.9 ND** ND ND 
ATM§ 526824 472 1.2 0.9 3.4** # 1.2 2.3** 1.3 1.5 
BAD 615013 572 0.9 1.1 0.4** # 1.4 0.6** 1.1 0.8 
BCL2L1 282152 598 0.9 1.0 0.7** # 1.1 0.8** 1.0 0.8 
BRAF 536051 673 1.2 0.9 1.9** # 1.0 2.1** 1.1 1.5 
BTC 280737 685 1.1 0.9 ND** # ND 1.8** ND ND 
CASP9 100140945 842 1.0 1.0 0.9** # 0.9 1.0** 0.8 0.8 
CCND1 524530 595 1.2 1.4 ND** # 1.1 0.6** ND 1.0 
CCND2 615414 894 1.0 1.2 0.1** # 0.8 0.5** 1.2 1.0 
CCND3 540547 896 0.9 1.0 0.4** # 1.2 0.7** 0.9 0.8 
CDKN1A 513497 1026 1.0 1.1 0.7** # 1.0 0.6** 1.0 1.8 
CDKN1B 512613 1027 1.0 1.0 1.5** # 1.3 1.1** 0.9 0.8 
CHUK 281073 1147 1.1 0.9 2.5** # 1.2 2.0** 1.0 1.0 
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Table  4.4 (cont.) 
CREB1 281713 1385 1.2 0.9 2.9** # 0.8 2.2** 1.1 1.3* 
DOK2 514616 9046 0.7 0.9 ND** # 1.3 0.4** ND 0.6* 
DUSP1 539175 1843 1.0 1.1 0.9** # 1.0 0.9** 0.9 0.9* 
EGFR 407217 1956 1.1 1.1 2.2** # 0.7 1.1** 1.0 2.4* 
EIF4EBP1 509613 1978 0.9 1.3 0.5** # 1.4 0.6** 0.9 0.9* 
ELK1 786886 2002 1.0 1.0 0.6** # 1.0 0.7** 1.0 1.0* 
ERBB2 505709 2064 0.9 1.0 0.6** # 1.1 0.8** 1.1 0.9* 
ERBB3 785655 2065 0.8 1.0 1.1** # 1.0 1.4** 1.0 1.5* 
FOS 280795 2353 0.9 1.1 1.3** # 0.7 0.5** 0.7 0.8* 
FOXO3 535530 2309 0.9 1.2 2.7** # 0.9 0.9** 1.2 1.5* 
GAB1 540085 2549 0.9 0.8 2.2** # 1.0 1.7** 1.2 1.1* 
GRB10 407210 2887 0.9 1.0 0.9** # 0.8 0.8** 1.0 1.2* 
GRB2 535298 2885 1.0 1.1 1.0** # 0.9 1.1** 1.0 1.0* 
GRB7 508847 2886 0.8 1.0 0.5** # 1.3 0.7** 1.0 1.1* 
GSK3A 536561 2931 1.0 1.1 0.6** # 0.9 0.8** 1.1 0.9* 
GSK3B 790875 2932 1.1 1.0 1.4** # 0.8 1.9** 1.0 1.6* 
HBEGF 522921 1839 0.9 1.3 ND** # 1.2 0.7** 0.4 0.7* 
HSP90AA1 281832 3320 0.9 1.1 1.1** # 1.0 1.2** 1.0 0.9* 
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Table  4.4 (cont.) 
HSP90AB1 767874 3326 0.9 1.1 0.8** # 0.9** 1.1** 1.0 1.0 
HSP90B1 282646 7184 1.0 1.0 0.8** # 0.9** 1.3** 1.1 1.1 
IGF1 281239 3479 1.5 1.2 ND** # 1.0** 0.8** ND ND 
IGF1R 281848 3480 0.9 1.0 0.9** # 1.0** 0.8** 1.6 1.4 
IGF2 281240 3481 0.9 1.1 0.6** # 1.2** 0.9** 1.2 1.0 
IGF2BP1§ 516853 10642 ND ND 0.7** # 7.4** ND** 1.1 1.2 
IGF2BP2§ 519028 10644 1.2 1.2 ND** # ND** 1.3** 0.9 1.5 
IGF2BP3§ 539650 10643 1.3 ND 2.0** # ND** ND** 0.9 0.9 
IGF2R§ 281849 3482 1.0 1.2 1.0** # 1.5** 0.7** 1.1 1.0 
IGFBP2 282260 3485 1.0 1.1 0.7** # 1.0** 0.7** 4.5 0.7 
IGFBP3 282261 3486 0.9 1.3 2.4** # 1.0** 0.8** 1.1 1.6 
IGFBP4 282262 3487 0.9 1.1 0.6** # 1.0** 0.8** 1.3 0.7 
IGFBP5 404185 3488 0.8 1.2 1.6** # 1.4** 0.8** 1.1 1.4 
IGFBP6 404186 3489 0.9 1.1 ND** # 1.1** 0.6** 1.1 1.0 
IKBKB 281854 3551 0.9 1.0 0.8** # 1.2** 0.6** 1.2 1.1 
ILK 540207 3611 0.9 1.1 0.6** # 0.8** 0.9** 1.1 1.0 
IRS1 538598 3667 0.9 1.2 1.3** # 1.1** 0.5** 1.1 1.8 
JAK2 525246 3717 1.2 0.9 4.5** # 1.2** 2.2** 1.2 1.1 
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Table  4.4 (cont.) 
JUN 280831 3725 1.0 1.1 1.1** # 0.9 0.6** 0.9 1.0 
KRAS 541140 3845 1.3 0.9 2.9** # 1.7 2.6** 1.3 1.3 
MAP2K1 533199 5604 1.0 0.9 1.1** # 1.2 0.9** 0.9 1.1 
MAP2K2 510434 5605 1.0 1.1 0.5** # 1.1 0.6** 1.0 0.9 
MAP2K4 526469 6416 1.0 1.1 1.7** # 0.9 1.1** 1.0 1.2 
MAP2K7 787278 5609 0.9 1.0 0.7** # 1.2 0.7** 1.1 0.9 
MAP3K14 508367 9020 0.8 1.0 ND** # 1.3 0.7** ND 1.3 
MAP3K5 537380 4217 1.1 0.9 2.0** # 0.9 1.5** 1.0 1.3 
MAPK3 531391 5595 0.9 1.0 0.5** # 0.8 0.8** 1.2 0.8 
MAPK9 534125 5601 1.0 1.0 2.7** # 1.0 1.5** 1.0 1.2 
MDM2 540378 4193 1.1 0.9 2.9** # 1.2 2.5** 1.1 1.2 
MET 280855 4233 1.0 0.8 2.3** # 1.0 2.8** 1.0 1.2 
MMP2 282872 4313 1.0 1.1 1.4** # 0.9 0.7** 1.1 1.2 
MMP9 282871 4318 ND ND ND** # ND ND** ND 0.3 
MRAS 540803 22808 1.1 1.1 1.1** # 0.9 0.8** 0.9 1.2 
MTOR 100139219 2475 1.0 1.1 1.6** # 0.8 1.0** 1.1 1.9 
MYC 511077 4609 1.0 1.1 0.9** # 0.9 0.6** 1.1 0.8 
NCK1 536154 4690 1.1 0.9 2.5** # 1.4 1.5** 1.1 1.0 
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Table  4.4 (cont.) 
NFKB1 616115 4790 1.0 1.0 1.6** # 0.9 0.8** 0.9 1.4 
NFKB2 526392 4791 0.9 1.1 0.5** # 1.2 0.6** 1.1 1.1 
NFKBIA 282291 4792 0.9 1.1 0.8** # 1.0 0.7** 0.9 0.8 
NFKBIB 525408 4793 0.8 1.1 0.4** # 1.3 0.5** 1.0 0.9 
NFKBIE 506727 4794 0.9 1.1 0.6** # 1.2 0.6** 1.0 1.0 
NRAS 506322 4893 1.0 0.9 2.1** # 0.9 1.7** 1.0 1.1 
NRG1 281361 3084 1.1 0.9 ND** # 0.6 0.6** 0.6 0.6 
NRG2 783452 9542 1.0 1.0 0.8** # 1.5 0.5** 0.9 ND 
PAK1 533729 5058 0.9 0.9 0.9** # 0.9 1.7** 1.0 1.0 
PCNA 515499 5111 1.0 1.0 1.3** # 1.1 1.4** 0.9 0.8 
PIK3CA 282306 5290 1.1 0.8 3.6** # 1.2 2.2** 1.2 1.3 
PIK3CB 517948 5291 1.0 0.9 2.1** # 1.3 2.8** 1.1 1.0 
PIK3CD 504531 5293 0.7 0.9 ND** # 0.9 0.7** 1.0 1.0 
PIK3R1 282307 5295 0.9 0.9 3.5** # 0.9 1.4** 1.1 1.2 
PIK3R2 282308 5296 1.0 1.2 0.5** # 1.3 0.6** 1.2 0.9 
PIK3R3 286865 8503 0.9 1.1 ND** # 0.9 1.9** ND 0.8 
PLCG1 281987 5335 1.0 1.1 1.2** # 1.1 0.7** 1.5 1.1 
PPP2CA 282320 5515 1.0 1.0 1.4** # 1.2 1.5** 1.0 1.0 
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Table  4.4 (cont.) 
PPP2CB 524361 5516 1.1 0.9 1.2** # 1.3 2.2** 1.0 1.0* 
PRKAA1§ 540404 5562 1.0 0.9 2.4** # 1.2 1.5** 1.2 1.2* 
PRKAA2§ 538954 5563 1.3 0.9 ND** # ND 2.9** 0.9 ND* 
PRKCA 282001 5578 0.9 1.0 0.6** # 1.1 0.8** 0.8 1.2* 
PRKCB 282325 5579 1.0 0.9 ND** # 0.9 1.1** ND 1.3* 
PRKCD 505708 5580 0.9 1.1 1.0** # 0.8 1.0** 0.9 1.0* 
PRKCE 507041 5581 1.0 1.0 3.7** # 0.7 1.0** 1.0 1.5* 
PRKCG 282002 5582 ND ND 0.7** # ND ND** 1.4 1.0* 
PRKCQ 505901 5588 1.1 0.9 3.5** # 0.7 0.9** 0.6 1.0* 
PTEN 540786 5728 1.2 1.0 2.5** # 1.2 2.3** 1.2 1.1* 
RAC1 281440 5879 0.9 1.0 0.7** # 1.0 1.0** 1.0 1.0* 
RAF1 521196 5894 0.9 1.0 0.7** # 1.0 0.8** 1.0 1.0* 
RAP1A 282031 5906 1.0 1.0 2.0** # 1.5 1.7** 1.1 0.8* 
RAPGEF2 100139484 9693 0.9 0.9 2.1** # 0.9 1.2** 1.1 1.6* 
RAPGEF3 535383 10411 1.0 1.2 0.3** # 1.2 0.7** ND 0.4* 
RAPGEF4 537312 11069 0.9 0.8 ND** # 0.6 1.2** ND ND* 
RASA1 282032 5921 1.2 0.9 2.5** # 1.3 2.0** 1.2 1.0* 
REL 509135 5966 1.2 0.8 ND** # 1.4 2.0** 1.0 ND* 
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Table  4.4 (cont.) 
RELA 508233 5970 0.9 1.2 0.6** # 1.2 0.7** 1.1 1.0 
RELB 522670 5971 0.9 1.0 0.5** # 1.2 0.6** 1.1 1.5 
RHEB 528204 6009 1.0 0.9 1.2** # 1.0 0.9** 0.9 0.9 
RPS6KA1 533908 6195 0.8 1.0 0.6** # 1.0 0.8** 1.1 0.9 
RPS6KA2 517953 6196 1.0 1.2 ND** # 1.1 0.6** ND 1.1 
RPS6KA3 511190 6197 1.1 0.8 3.4** # 1.0 2.1** 1.1 1.4 
RPS6KB1 404181 6198 1.1 0.9 1.9** # 0.9 1.5** 1.1 1.2 
SHC1 507196 6464 0.9 1.1 0.6** # 1.0 0.8** 1.1 0.9 
SHC2 533455 25759 1.0 1.1 ND** # 1.5 0.4** ND ND 
SHC4 524734 399694 ND ND ND** # ND ND** ND 1.0 
SLC2A1§ 282356 6513 0.9 1.1 0.6** # 1.8 1.1** 1.1 1.0 
SLC2A3§ 282358 6515 1.0 1.0 0.7** # 1.2 1.3** 1.1 1.3 
SLC2A4§ 282359 6517 0.9 1.2 ND** # 1.3 0.5** ND ND 
SOS1 537682 6654 1.2 0.9 2.4** # 0.9 2.0** 1.1 1.3 
SOS2 100138040 6655 1.2 0.9 2.9** # 0.9 1.9** 1.1 1.2 
SRC 535742 6714 1.0 1.1 0.6** # 1.0 0.9** 1.1 1.1 
STAT1 510814 6772 0.9 1.0 1.8** # 0.8 1.3** 1.1 1.0 
STAT3 508541 6774 0.9 1.1 1.8** # 0.8 1.2** 0.9 1.1 
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Table  4.4 (cont.) 
TP53 281542 7157 1.0 1.0 0.6** # 0.9 1.0** 1.1 0.8 
TRAP1 514472 10131 1.0 1.1 0.5** # 1.1 0.6** 1.1 0.9 
TSC2 504985 7249 0.9 1.0 0.6** # 1.0 0.7** 1.3 1.0 
YWHAB 286863 7529 0.9 1.0 1.0** # 0.9 1.2** 0.9 1.0 
YWHAE 282125 7531 0.9 1.0 0.9** # 1.0 1.2** 1.0 1.0 
YWHAZ 287022 7534 1.0 1.1 1.8** # 0.8 1.7** 1.1 1.0 
* FDR P<0.05; ** FDR P<0.01; ND; not detected 
§ indicates genes that were not included in the considered GeneGo Pathway Maps by default, but were manually included based on 
their relationship to the signal transduction pathways based on literature review 
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Table 4.5. Fold changes (GD-34/GD-18) of the cumulative list of genes from combining all 
GeneGo Pathway Maps 
Gene 
Symbol 
Bos taurus 
Gene ID 
Entrez 
Gene ID 
CAR ICAR 
Chorion/ 
Trophoblast   
AKT2 534923 208 1.4** 1.4** 0.9** 
AKT3 100137872 10000 1.4** 1.3** 14.9** 
ARAF 540421 369 1.4** 1.4** 0.8** 
AREG 538751 374 ND** ND** ND** 
ATM 526824 472 0.6** 0.5** 1.2** 
BAD 615013 572 1.6** 1.5** 0.8** 
BCL2L1 282152 598 0.8** 0.9** 1.0** 
BRAF 536051 673 0.7** 0.6** 1.0** 
BTC 280737 685 0.2** 0.3** ND** 
CASP9 100140945 842 1.0** 0.9** 1.3** 
CCND1 524530 595 1.8** 1.9** ND** 
CCND2 615414 894 1.2** 1.7** 1.1** 
CCND3 540547 896 0.8** 0.7** 0.9** 
CDKN1A 513497 1026 0.9** 1.0** 1.2** 
CDKN1B 512613 1027 0.9** 0.8** 1.8** 
CHUK 281073 1147 0.8** 0.7** 1.7** 
CREB1 281713 1385 0.8** 0.7** 1.1** 
DOK2 514616 9046 2.2** 2.0** ND** 
DUSP1 539175 1843 1.4** 1.4** 1.3** 
EGFR 407217 1956 1.1** 1.5** 2.4** 
EIF4EBP1 509613 1978 2.1** 2.5** 0.6** 
ELK1 786886 2002 1.3** 1.2** 0.6** 
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Table 4.5 (cont.) 
ERBB2 505709 2064 1.2** 1.2** 1.1** 
ERBB3 785655 2065 0.4** 0.8** 0.9** 
FOS 280795 2353 2.3** 2.9** 2.8** 
FOXO3 535530 2309 1.1** 1.0** 1.1** 
GAB1 540085 2549 0.7** 0.6** 1.7** 
GRB10 407210 2887 1.8** 2.0** 0.8** 
GRB2 535298 2885 1.0** 1.1** 1.1** 
GRB7 508847 2886 0.8** 0.7** 1.6** 
GSK3A 536561 2931 1.5** 1.4** 0.8** 
GSK3B 790875 2932 0.8** 0.7** 1.1** 
HBEGF 522921 1839 1.3** 1.5** ND** 
HSP90AA1 281832 3320 0.9** 0.9** 1.0** 
HSP90AB1 767874 3326 1.0** 1.1** 0.8** 
HSP90B1 282646 7184 1.1** 1.2** 1.0** 
IGF1 281239 3479 1.1** 1.2** ND** 
IGF1R 281848 3480 0.7** 0.7** 0.4** 
IGF2 281240 3481 1.0** 1.1** 7.4** 
IGF2BP1 516853 10642 ND** ND** 0.5** 
IGF2BP2 519028 10644 0.4** 0.6** 22.9** 
IGF2BP3 539650 10643 0.5** ND** 0.8** 
IGF2R 281849 3482 2.2** 1.6** 1.6** 
IGFBP2 282260 3485 1.9** 2.0** 0.2** 
IGFBP3 282261 3486 4.1** 4.3** 6.8** 
IGFBP4 282262 3487 1.5** 1.9** 1.3** 
IGFBP5 404185 3488 0.6** 0.7** 2.2** 
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Table 4.5 (cont.) 
IGFBP6 404186 3489 1.2** 1.4** 3.5** 
IKBKB 281854 3551 1.1** 1.0** 0.6** 
ILK 540207 3611 1.4** 1.5** 0.9** 
IRS1 538598 3667 1.0** 1.0** 0.6** 
JAK2 525246 3717 0.7** 0.7** 3.8** 
JUN 280831 3725 1.4** 1.5** 1.5** 
KRAS 541140 3845 0.6** 0.6** 1.0** 
MAP2K1 533199 5604 1.0** 0.9** 1.1** 
MAP2K2 510434 5605 1.6** 1.6** 1.0** 
MAP2K4 526469 6416 1.0** 1.0** 0.8** 
MAP2K7 787278 5609 1.2** 1.1** 0.9** 
MAP3K14 508367 9020 1.5** 1.4** ND** 
MAP3K5 537380 4217 1.0** 0.8** 2.2** 
MAPK3 531391 5595 1.6** 1.6** 0.5** 
MAPK9 534125 5601 0.9** 0.9** 2.8** 
MDM2 540378 4193 0.6** 0.4** 2.5** 
MET 280855 4233 0.2** 0.3** 2.2** 
MMP2 282872 4313 1.5** 1.9** 4.7** 
MMP9 282871 4318 ND** ND** ND** 
MRAS 540803 22808 1.9** 2.2** 1.6** 
MTOR 100139219 2475 1.2** 1.4** 1.0** 
MYC 511077 4609 1.9** 1.9** 0.9** 
NCK1 536154 4690 0.8** 0.7** 1.5** 
NFKB1 616115 4790 1.2** 1.3** 1.4** 
NFKB2 526392 4791 1.4** 1.4** 0.9** 
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Table 4.5 (cont.) 
NFKBIA 282291 4792 1.1** 1.1** 0.8** 
NFKBIB 525408 4793 1.6** 1.5** 0.7** 
NFKBIE 506727 4794 1.5** 1.7** 0.7** 
NRAS 506322 4893 0.7** 0.7** 1.2** 
NRG1 281361 3084 0.8** 0.9** 7.3** 
NRG2 783452 9542 1.4** 2.1** 1.2** 
PAK1 533729 5058 0.5** 0.4** 0.6** 
PCNA 515499 5111 1.2** 1.0** 1.0** 
PIK3CA 282306 5290 0.7** 0.5** 2.7** 
PIK3CB 517948 5291 0.5** 0.4** 0.9** 
PIK3CD 504531 5293 2.5** 2.4** 7.6** 
PIK3R1 282307 5295 0.7** 0.7** 0.9** 
PIK3R2 282308 5296 1.6** 1.5** 0.9** 
PIK3R3 286865 8503 0.4** 0.5** ND** 
PLCG1 281987 5335 1.2** 1.2** 1.2** 
PPP2CA 282320 5515 0.8** 0.7** 1.1** 
PPP2CB 524361 5516 0.9** 0.7** 0.8** 
PRKAA1 540404 5562 0.6** 0.5** 1.3** 
PRKAA2 538954 5563 0.3** 0.4** 7.1** 
PRKCA 282001 5578 1.5** 1.4** 0.5** 
PRKCB 282325 5579 1.1** 1.1** ND** 
PRKCD 505708 5580 1.0** 1.1** 1.2** 
PRKCE 507041 5581 1.4** 1.2** 4.7** 
PRKCG 282002 5582 ND** ND** 0.6** 
PRKCQ 505901 5588 1.3** 1.2** 1.8** 
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Table 4.5 (cont.) 
PTEN 540786 5728 0.7** 0.6** 1.1** 
RAC1 281440 5879 1.1** 1.2** 0.9** 
RAF1 521196 5894 1.0** 1.0** 0.8** 
RAP1A 282031 5906 0.7** 0.6** 1.2** 
RAPGEF2 100139484 9693 0.8** 0.8** 0.7** 
RAPGEF3 535383 10411 1.9** 2.0** ND** 
RAPGEF4 537312 11069 2.2** 2.7** ND** 
RASA1 282032 5921 0.7** 0.6** 1.3** 
REL 509135 5966 1.2** 0.8** 2.0** 
RELA 508233 5970 1.3** 1.3** 0.9** 
RELB 522670 5971 1.4** 1.4** 1.4** 
RHEB 528204 6009 0.7** 0.6** 0.8** 
RPS6KA1 533908 6195 1.3** 1.7** 0.5** 
RPS6KA2 517953 6196 2.5** 2.4** ND** 
RPS6KA3 511190 6197 0.8** 0.8* 0.9** 
RPS6KB1 404181 6198 0.9** 0.8** 0.6** 
SHC1 507196 6464 1.3** 1.5** 0.9** 
SHC2 533455 25759 1.9** 2.1** ND** 
SHC4 524734 399694 ND** ND** ND** 
SLC2A1 282356 6513 0.4** 0.4** 0.8** 
SLC2A3 282358 6515 3.8** 4.1** 0.7** 
SLC2A4 282359 6517 1.6** 1.5** ND** 
SOS1 537682 6654 0.9** 0.7** 1.2** 
SOS2 100138040 6655 0.8** 0.6** 1.8** 
SRC 535742 6714 0.9** 0.9** 0.7** 
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Table 4.5 (cont.) 
STAT1 510814 6772 0.4** 0.5** 2.8** 
STAT3 508541 6774 1.4** 1.4** 4.4** 
TP53 281542 7157 1.3** 1.3** 0.7* 
TRAP1 514472 10131 1.0** 1.1** 0.5** 
TSC2 504985 7249 1.4** 1.3** 1.0** 
YWHAB 286863 7529 1.0** 1.0** 1.0** 
YWHAE 282125 7531 0.9** 0.9** 0.9** 
YWHAZ 287022 7534 1.0** 1.0** 1.1** 
* FDR P<0.05; ** FDR P<0.01; ND; not detected 
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Table 4.6. Comparison of fold-changes (SCNT/AI) and P values of IGF and EGF signaling-
related genes whose expression levels were affected by SCNT in allantois tissue 
Gene 
Symbol 
Bos taurus 
Gene ID 
Entrez 
Gene ID 
  
ICAR Chorion 
Allantois 
  
All samples 
included 
Four samples 
removed 
AKT3 100137872 10000 x 1.7** 1.0 1.9** 1.5* 
BCL2L1 282152 598 x 0.8** 1.0 0.7** 0.8* 
EGFR 407217 1956 x 1.1** 1.0 3.0** 2.4* 
ERBB3 785655 2065 x 1.4** 1.0 1.7** 1.5* 
GSK3B 790875 2932 x 1.9** 1.0 1.7** 1.6* 
IGF2BP2 519028 10644 x 1.3** 0.9 1.7** 1.5* 
IGFBP3 282261 3486 x 0.8** 1.1 1.6** 1.6* 
IRS1 538598 3667 x 0.5** 1.1 2.0** 1.8* 
MTOR 100139219 2475 x 1.0** 1.1 2.1** 1.9* 
RAPGEF2 100139484 9693 x 1.2** 1.1 1.9** 1.6* 
RAPGEF3 535383 10411 x 0.7** ND 0.4** 0.4** 
* FDR P<0.05; ** FDR P<0.01; ND; not detected 
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Table 4.7. Molecular functions and cellular processes included in IGF and EGF signaling-related GeneGo Pathway Maps 
Cellular/Molecular Function  Genes 
IGF1R activation  IGF1, IGF2, IGF1R, IGF2R§, IGFBP2-6, IGF2BP1-3§ 
EGFR/ERBB activation  NRG1, NRG2, AREG, BTC, HBEGF, ERBB1-4  
PI3K activation PIK3CA, PIK3CB, PIK3CD, PIK3R1, PIK3R2, PIK3R3, PTEN  
AKT signaling AKT2, AKT3, SHP90, PPP2CA, PPP2CB 
ERK1/2 signaling SOS1–2, NRAS, KRAS, MRAS, ARAF, BRAF, CRAF, MEK1–2, ERK1-2  
G1/S transition  CCND1, CCND2, CCND3, GSK3α, GSK3β  
Apoptosis  BAD, BCL2L1, MDM2, P53, FAS, ASK1  
Protein synthesis  4E-BP1, TSC2, RPS6KB1, RHEB, MTOR  
§ indicates genes that were not included in the considered GeneGo Pathway Maps by default, but were manually included based on 
their relationship to the signal transduction pathways based on literature review 
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CHAPTER 4 FIGURES 
 
Figure 4.1. Effect of SCNT on transcript levels of genes categorized under the GeneGo Pathway 
Map “AKT signaling”. Red and blue thermometers indicate genes whose expression levels are 
up-regulated and down-regulated in SCNT compared to that in AI, respectively (FDR P<0.05). 
Numbers “1” and “2” of thermometers represent significantly different gene expression levels in 
GD-34 ICAR and GD-18 EET, respectively. 
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Figure 4.2. Effect of SCNT on transcript levels of genes categorized under the GeneGo Pathway 
Map “ERK1/2 signaling pathway”. Red and blue thermometers indicate genes whose expression 
levels are up-regulated and down-regulated in SCNT compared to that in AI, respectively (FDR 
P<0.05). Numbers “1” and “2” of thermometers represent significantly different gene expression 
levels in GD-34 ICAR and GD-18 EET, respectively. 
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Figure 4.3. Effect of SCNT on transcript levels of genes categorized under the GeneGo Pathway 
Map “IGF-1 receptor signaling pathway”. Red and blue thermometers indicate genes whose 
expression levels are up-regulated and down-regulated in SCNT compared to that in AI, 
respectively (FDR P<0.05). Numbers “1” and “2” of thermometers represent significantly 
different gene expression levels in GD-34 ICAR and GD-18 EET, respectively. 
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Figure 4.4. Effect of implantation on transcript levels of genes categorized under the GeneGo 
Pathway Map “IGF1-receptor signaling”. Red and blue thermometers indicate genes whose 
expression levels are higher and lower at GD-34 compared to that at GD-18, respectively (FDR 
P<0.05). Numbers “1”, “2”, and “3” of thermometers represent significantly different gene 
expression levels in CAR, ICAR and chorion/trophoblast, respectively. 
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Chapter 5: Overall summary and conclusion 
Given the cellular functions mediated by cell adhesion, IGF signaling and EGF signaling, 
and known clinico-pathological features of somatic cell nuclear transfer (SCNT)-derived 
pregnancies, we hypothesized that these signaling pathways are perturbed in SCNT pregnancies 
during the peri-implantation period in cattle. To test this compound hypothesis, we analyzed 
transcriptomes of endometrial tissue and extra-embryonic tissue (EET) collected from gestation 
day (GD)-18 and GD-34 bovine pregnancies (SCNT and artificial insemination (AI)-derived 
pregnancies) using RNAseq, and endometrial transcription of 16 preselected genes using 
quantitative real time-PCR and/or in situ hybridization. We identified all genes encoding 
integrins, ECM proteins, IGF and EGF-related ligands, receptors and binding proteins, and 
PI3K/AKT and ERK1/2 signaling-related proteins that are transcribed in endometria and EET. 
Findings of our study suggest that IGF signaling, EGF signaling and cell adhesion are perturbed 
in SCNT pregnancies during the peri-implantation period. Our findings also suggest that above 
molecular/cellular functions are temporally regulated during the peri-implantation period in 
cattle. 
Temporal regulation of transcripts related to integrin and growth factor signaling. Our 
findings suggest that integrin, IGF1R, EGFR/ERBB, PI3K, AKT, and ERK1/2 signaling are 
temporally regulated during the peri-implantation period in cattle. Observations based on 
variations of transcript levels suggest that: (i) IGF1R, EGFR/ERBB, and PI3K/AKT activation is 
increased at GD-34 in chorion, (ii) IGF1R and PI3K activation is decreased in CAR and ICAR at 
GD-34, and (iii) integrin activation/signaling is increased at GD-34 in CAR, ICAR and chorion, 
compared to GD-18. These gene expression patterns are generally consistent with the known 
physiological changes that take place in endometria and EET during the peri-implantation 
period. For example, increased integrin signaling at GD-34 is consistent with increasing cell-cell 
and cell-ECM interactions that take place during conceptus-maternal attachment, 
hyperplasia/hypertrophy of endometrial glands and vasculogenesis/angiogenesis on 
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endometria, and binucleate cell differentiation and migration. The only findings contradictory to 
above physiological changes are the observations suggesting decreased IGF1R and PI3K 
activation in the endometrium at GD-34. It has been suggested that implantation is a process 
with high metabolic demands that can largely be met by the utilization of glucose (Korgun et al. 
2003). Therefore, the apparent decrease in IGF1R and PI3K activation at GD-34 may reflect 
decreased growth/metabolic demands following the period of implantation. 
Aberrant expression of transcripts related to integrin and growth factor signaling. On 
the basis of aberrant gene expression in SCNT-derived tissues, findings from our study suggest 
that integrin, IGF1R, EGFR/ERBB, PI3K, AKT, and ERK1/2 signaling are perturbed in bovine 
SCNT pregnancies during the peri-implantation period. Observations suggest that, in GD-18 
EET and/or GD-34 ICAR tissues: (i) integrin activation/signaling is compromised, (ii) AKT and 
ERK1/2 signaling are compromised and (iii) IGF1R activation, PI3K activation and MTOR 
pathway are enhanced in SCNT. In addition, transcript levels also suggest that cellular functions 
regulated by growth factor signal transduction pathways are also affected by SCNT. For 
example, perturbed transcript levels in GD-18 EET and GD-34 tissues in SCNT are consistent 
with: (i) compromised G1/S transition, (ii) increased protein synthesis, (iii) compromised IGF-
mediated glucose uptake, and (iv) perturbed cellular energy metabolism. Consistent with these 
observations, GeneGo Processes “Translation - Regulation of initiation” and “Cell cycle - G1-S 
Growth factor regulation” were among the top five most affected GeneGo Processes by SCNT in 
GD-18 EET (FDR P<0.05). These observations are consistent with the known pathophysiology 
of SCNT pregnancies. For example, compromised integrin activation, AKT and ERK1/2 
signaling, G1/S transition and glucose uptake are consistent with reported pathologies of SCNT 
EET such as increased hypoplasia, apoptosis and shedding of trophoblast cells from fetal villi 
(Fletcher et al. 2007), and reduced numbers of binucleated cells (Fletcher et al. 2007; BNC; 
Hashizume et al. 2002; Loi et al. 2006; Palmieri et al. 2007). Further, consistent with our 
observations, aberrant expression of protein synthesis-related genes has been reported in SCNT 
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conceptuses in other species as well (Chae et al. 2009). Others have also suggested that energy 
metabolism in SCNT conceptuses may be disturbed (Garry et al. 1996; Ravelich et al. 2004) and 
our results (particularly aberrant expression of genes encoding MTOR and AMPK, two central 
sensors and regulators of cellular energy levels, in SCNT) provide strong evidence to support 
this hypothesis. 
Effects of SCNT on IGF/EGF integrin signaling are limited to GD-18 EET and GD-34 
ICAR. On the basis of MetaCore™ GeneGo Pathway Maps functional ontology enrichment 
analysis, IGF1R signaling, EGFR/ERBB signaling and integrin-mediated signaling are 
significantly affected by SCNT in GD-18 EET and GD-34 ICAR. The observations that above 
functions are affected by SCNT in EET, but not in endometrium at GD-18, and in ICAR but not 
in any other tissue at GD-34, have not been reported earlier. The relatively unaltered 
endometrial transcriptome of GD-18 endometria in-spite of a heavily altered transcriptome in 
GD-18 EET may be due to several reasons. For example, it may reflect an acute onset to the gene 
expression perturbations in EET shortly before or at the onset of blastocyst implantation. It is 
generally believed that the demand of the embryo on maternal resources is insignificant until 
implantation (Niemann et al. 2008). Therefore, GD-18 may represent a physiological stage of 
the endometrium that is relatively unresponsive for changes on the EET with regards to the 
cellular functions of concern. Even though gene expression perturbations related to IGF/EGF 
signaling and cell adhesion were not observed, genes related to other physiological functions 
during the pre-implantation period such as maternal recognition of pregnancy (e.g. interferon 
responsive genes) were found to be aberrantly expressed on GD-18 SCNT endometrium (data 
not shown).  
Another notable observation was the relatively stable transcriptome of the SCNT chorion 
at GD-34 compared to the heavily altered transcriptome of the SCNT EET at GD-18. Embryonic 
death is “regarded as a normal way of eliminating unfit genotypes” (Bishop 1964). Therefore 
we hypothesize that the ‘unfit’ GD-18 SCNT conceptuses with heavily altered transcriptomes, 
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presumably as a result of incomplete epigenetic reprogramming (Niemann et al. 2008), may 
have been eliminated at or after implantation, and only the relatively normal SCNT conceptuses 
may have survived to GD-34, and thus the relatively normal transcriptomes of chorion. 
The stable transcriptomes of GD-34 CAR in spite of a strongly altered transcriptome in 
GD-34 ICAR may be due to the more active functional role played by ICAR at this pre-
placentomal phase of gestation. In addition to adhering to the trophoblast during the peri-
implantation period (Guillomot et al. 1981), the ICAR plays an important role in providing 
histiotrophic nutrition to the conceptus by harboring endometrial glands and blood vasculature. 
Therefore the observed gene expression perturbations in GD-34 ICAR tissue may reflect 
disturbances in not only conceptus-maternal attachment, but also endometrial glandular 
proliferation/function and/or angiogenesis. During this early-post-implantation period of 
gestation, where placentomes have not yet formed, endometrial luminal fluid (ULF) derived 
from endometrial glandular secretions serve as the major source of nutrients to the developing 
conceptus (Bazer 1975). The findings that the blastocyst implantation takes place adjacent to 
endometrial glandular openings in humans (Hamilton and Boyd 1960), endometrial glands 
undergo extensive hyperplasia and hypertrophy during the peri-implantation period (Samuel et 
al. 1977; Stewart et al. 2000) and that early conceptuses communicate with endometrial glands 
(Johnson et al. 2003a; Spencer et al. 2004a) emphasize the importance of endometrial glands 
during the peri-implantation period. Collectively, the above observations suggest that 
endometrial glands play an important role during the peri-implantation period and emphasize 
the functional importance of ICAR in implantation. In contrast to ICAR tissue, CAR is avascular 
and aglandular during this period of gestation (Robinson et al. 2000). Further, firm attachment 
of endometrial CAR and chorioallantoic cotyledons resulting in the formation of placentomes 
does not commence till ~GD-35 (Chavatte-Palmer et al. 2012b). Therefore CAR may not be 
functionally as important as ICAR at this stage of gestation; this may be the reason why gene 
expression perturbations in SCNT were observed on ICAR and not on CAR at GD-34.  
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Several studies have also shown the involvement of genes related to integrins (Johnson 
et al. 1999b; Lessey et al. 1996) and IGF/EGF families (Gray et al. 2001a; Wathes et al. 1998) in 
endometrial gland development/function. For example, GE proliferation in neonates (Gray et al. 
2001a) and secretory activity during the peri-implantation period (Wathes et al. 1998) has been 
proposed to be under the regulation of IGF1R signaling. Another group showed that mRNA for 
osteopontin (SPP1/OPN), a ligand for integrin αvβ3, was exclusively expressed on GE and not 
LE in ovine endometria, during the GD-13 to GD-19 period they studied. Further they went on to 
show that the osteopontin protein was secreted in the endometrial glandular secretion in peri-
implantation stage ewes, and proposed that secreted osteopontin may act as a ligand for integrin 
αvβ3 on luminal epithelium and/or trophoblast and thereby mediate conceptus-maternal 
attachment (Johnson et al. 1999b). In addition, our observation that ITFG3 mRNA localizes to 
GE and not LE (chapter 2) also suggests a role for integrin-signaling in endometrial glandular 
structure/function during the studied period. Collectively, the above observations support the 
hypothesis that integrin signaling and growth factor signaling play a role in endometrial gland 
function during the peri-implantation period. Further, there is also evidence to support the 
hypothesis that genes related to these two signaling pathways may be perturbed in SCNT. For 
example, our demonstration of aberrant expression of IGF1R and ERBB2 transcripts in SCNT 
ICAR and their predominant (if not exclusive) localization to glandular epithelia at GD-34 (see 
chapter 2) suggests that the aberrant expression of these two genes may be related to perturbed 
endometrial glandular function in SCNT pregnancies. The observation of apoptosis and 
disruption of endometrial glands in GD-30 swine SCNT pregnancies (Kim et al. 2011a) further 
supports the notion that endometrial glandular function may be perturbed in SCNT. 
Collectively, above observations suggest that integrins and IGF/EGF signaling may play an 
important role in endometrial gland proliferation/function during the peri-implantation period 
and that they may be perturbed in SCNT pregnancies. This perturbation may be reflected as 
disturbed integrin and IGF/EGF signaling in ICAR tissues from SCNT pregnancies.  
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The relatively unaffected transcriptome of GD-34 EET in spite of a heavily affected 
transcriptome in GD-34 ICAR is more difficult to explain. Perturbations observed in GD-18 EET 
may have been initiated by aberrant epigenetic reprogramming as has been described for SCNT 
(Kang et al. 2001; Ohgane et al. 2004). However, perturbations observed in GD-34 ICAR have to 
be in response to disturbances from the SCNT conceptus. Of the genes categorized under the 
GeneGo Pathway Maps considered in chapters 3 and 4, expression of only a single gene was 
affected by SCNT in chorion (LAMA1) while expression of a total of seven genes (EGFR, 
RAPGEF3, ITGAV, ITGA2, COL11A2, LAMC2 and COL6A3) were affected by SCNT in allantois. 
Therefore, even though the considered GeneGo Pathway Maps were not significantly affected by 
SCNT in allantois, the few genes that are aberrantly expressed in the allantois may lead to a 
paracrine signal that triggers a cascade of responses from the GD-34 ICAR. Alternatively, the 
conceptus-signal that triggers these changes in SCNT ICAR may come from the embryo and not 
from EET; in this experiment, we did not study the transcriptome of the embryo. Another 
possibility is that the signals originated in the chorion, but was from an unrelated pathway. The 
only GeneGo Pathway Maps that were significantly affected by SCNT in chorion were 
“Alternative complement pathway”, “Lectin induced complement pathway”, “Classical 
complement pathway” and “Polyamine metabolism”.  
Allantois may play a role in feto-maternal cross-talk at GD-34  
As mentioned earlier (Chapter 3 – Materials and Methods), gene expression data from 
four allantois samples (SCNT; N=3 and AI; N=1) were eliminated from the analysis on the basis 
of possible contamination with chorion tissue from the same conceptus. When the AI vs SCNT 
comparison was carried out with these four allantois samples excluded, transcript levels of seven 
genes (EGFR, RAPGEF3, ITGAV, ITGA2, COL11A2, LAMC2 and COL6A3; Tables 3.5 and 4.6) 
were affected by SCNT (FDR P<0.05), and none of the considered GeneGo Pathway Maps were 
affected by SCNT. However, when the AI vs SCNT comparison is carried out with these four 
allantois samples included, transcript levels of an additional nine IGF and EGF signaling-related 
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genes (MTOR, IRS1, AKT3, RAPGEF2, GSK3B, ERBB3, IGFBP3, BCL2L1 and IGF2BP2; Table 
4.6) and 13 integrin signaling-related genes (ITGA6, ITGA1, ITGB3, ITGB6, FBN2, THBS4, 
THBS2, LAMC1, COL27A1, LAMB3, FGG, TLN2 and VCL; Table 3.5) were aberrantly expressed 
in SCNT allantois (FDR P<0.05). Despite showing comparable SCNT/AI fold-changes (Tables 
3.5 and 4.6), these 22 genes were likely not detected as significantly affected by SCNT in the 
former analysis likely due to the decreased discriminatory power resulting from smaller sample 
size. In addition, when data from all allantois samples were included, the MetaCore™ GeneGo 
Pathway Maps “Integrin inside-out signaling”, “Cytoskeleton remodeling” and “FAK signaling” 
were significantly affected by SCNT (FDR P<0.05) in allantois. 
Therefore, it is possible that the aberrant transcript levels observed in genes related to 
IGF, EGF, and integrin signaling in GD-34 SCNT ICAR may be triggered by an aberrant signal 
originating from structurally and/or functionally compromised SCNT allantois tissues. The fact 
that transcript levels of the above-mentioned 29 IGF/EGF and integrin signaling-related genes 
were affected by SCNT only in allantois and not in chorion is also consistent with this 
hypothesis. In total, levels of 1413 and 93 transcripts were significantly affected by SCNT in 
allantois and chorion, respectively (expression levels of 23 transcripts were affected by SCNT in 
both tissues). This large difference of the number of aberrantly expressed genes in SCNT also 
supports the hypothesis that allantois may be more affected by SCNT than the chorion at this 
stage of gestation, and that the aberrant gene expression levels observed in GD-34 SCNT ICAR 
may be in response to these perturbations in allantois.  
Even though the allantois is physically separated from the endometrium by the chorion, 
results from studies in pigs (Ducsay et al. 1982; Renegar et al. 1982) and sheep (Gray et al. 
2005; Song et al. 2006) suggest that components of histiotroph are transported to the fetus 
through the chorioallantoic circulation. On visual inspection, GD-34 bovine conceptuses showed 
well developed allantoic blood vessels (Figure 5.1) that had established connections with the 
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fetal circulation via umbilical vessels (Figure 5.2). Therefore, it is possible that perturbations of 
allantoic structure/function are conveyed to the endometrium via this route at GD-34. 
Of the total of 29 IGF, EGF, and integrin signaling-related genes whose transcript levels 
were affected by SCNT in allantois, transcript levels of 25 genes were up-regulated in SCNT. All 
six aberrantly expressed integrins were were up-regulated in SCNT. Of these, ITGA2 (San 
Antonio et al. 2009), ITGAV (Ahnert and Kirsten 2007), ITGA6 (Lee et al. 2006), ITGA1 (Senger 
et al. 2002), and ITGB3 (Brooks et al. 1998) have been implicated in angiogenesis. Nine 
vertebrate integrin heterodimers have been implicated in blood vessel formation, namely α1β1, 
α2β1, α4β1, α5β1, αvβ1, αvβ3, αvβ5, αvβ8 and α6β4 (reviewed by Serini et al. 2006) and the 
above-mentioned five genes encode one or more integrin subunits that make up these 
heterodimers. Some of the ECM component-encoding genes that were up-regulated in SCNT 
allantois such as fibrillins (Xu et al. 2011), laminins (Simon-Assmann et al. 2011), 
thrombospondins (Iruela-Arispe et al. 2004) and collagens (Mundel and Kalluri 2007) have also 
been implicated in angiogenesis. Perturbations of placental vascular architecture has been 
implicated in the low efficiency of SCNT pregnancies (Campos 2010). Therefore, the observed 
gene expression perturbations may reflect compromised chorioallantoic circulation, or given the 
up-regulation in expression of most aberrantly expressed genes, a general compensatory 
mechanism to increase angiogenesis. Consistent with this hypothesis, the GeneGo Process 
Networks “Regulation of angiogenesis” and “Blood vessel morphogenesis” were significantly 
affected by SCNT (FDR P<0.05). Alternatively, one or more of these molecules may play a role 
in chorio-allantoic fusion in cattle as has been demonstrated for certain integrins like ITGA4 in 
other species (Yang et al. 1995), or in maintaining the structural integrity of allantoic connective 
tissue that anchor the blood vessels.  
In addition, consistent with the aberrant expression of genes related to MTOR signaling 
in GD-34 SCNT ICAR, MTOR (2-fold increase), RICTOR (2.1-fold increase) and TSC1 (1.9-fold 
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increase) were up-regulated in SCNT allantois, when all allantois samples were included in the 
AI vs SCNT comparison. 
Previous studies that investigated effects of SCNT on EET during the peri-implantation 
period in cattle (GD-25; Hashizume et al. 2002; Moore et al. 2007) did not study transcript 
levels of the chorion and allantois separately. Our findings strongly suggest that effects of SCNT 
on chorion and allantois are different during the early post-implantation period. Therefore we 
suggest that future studies examine these two tissues with distinct physiological functions 
separately for optimal understanding of the cellular/molecular functions perturbed in SCNT 
pregnancies during the peri-implantation period.  
Integrin-growth factor receptor cross-talk 
It should also be noted that intra-cellular signal transduction pathways such as AKT 
signaling and ERK1/2 signaling are activated by not only IGF1R and EGFR activation, but also 
by integrins. Integrin-growth factor receptor crosstalk is implicated in coordinating signals from 
growth factors and the ECM to support cell proliferation, migration, and invasion in vivo 
(Eliceiri 2001). Growth factors generally have an acute and more robust induction while integrin 
binding to ECM has a milder induction of signal transduction pathways with slower kinetics 
(Danen and Yamada 2001). Further, it has been shown that integrin-ligand binding can enhance 
growth factor induced signal transduction. However, these interactions may be cell-type specific 
and are not universal (Schwartz and Baron 1999; Short et al. 1998). Therefore the observed 
differential expression of genes encoding AKT and ERK signaling-related molecules may be 
triggered by differences in growth factor receptor signaling, integrin-signaling or both. 
In addition to integrins and IGF and EGF, AKT signaling and ERK1/2 signaling are also 
induced by activation of other growth factor receptors such as growth hormone receptor 
(Costoya et al. 1999), leptin receptor (Goetze et al. 2002; Trinko et al. 2011) and platelet derived 
growth factor (PDGF; Xiong et al. 2010) receptor. Therefore the observed differential expression 
of genes encoding AKT and ERK signaling-related molecules may be triggered by differences in 
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any of the growth factor receptor signaling molecules mentioned above. Supporting this 
hypothesis, GeneGo Pathway Maps “Growth hormone signaling via PI3K/AKT and MAPK 
cascades”, “Leptin signaling via PI3K-dependent pathway” and “PDGF signaling via MAPK 
cascades” were also significantly affected by SCNT in both GD-18 EET and GD-34 ICAR. These 
observations suggest that the aberrant expression of genes related to IGF and EGF signaling in 
SCNT may be only a part of a broader physiological response involving other growth factor 
families as well. 
On the basis of qRT-PCR analysis carried out using 12 preselected genes, transcript 
levels of four IGF and EGF signaling-related genes were aberrantly expressed in SCNT 
endometria (IGF1R; GD-34 CAR and ICAR, IGFBP6; GD-34 CAR and ICAR, NRG2; GD-34 
CAR, ERBB2; GD-34 ICAR; FDR 0.05; Table 2.4). Of these, only IGFBP6 was aberrantly 
expressed in SCNT on the basis of RNAseq (GD-34 ICAR; Table 4.4). The SCNT/AI fold-changes 
were consistent for IGFBP6 in the two studies (GD-34 ICAR; qRT-PCR fold-change 0.72, 
RNAseq fold-change 0.62). The failure of RNAseq to identify transcript levels of the other three 
genes as statistically significantly different between AI and SCNT can be attributed to 
differences of strategies used in the two experiments. Firstly, the number of samples analyzed by 
qPCR and RNAseq were different. In the case of qRT-PCR, samples collected from all AI (GD-
18; N=10, GD-34; N=10) and SCNT (GD-18; N=11, GD-34; N=8) animals were tested. In the 
case of RNAseq, samples from all SCNT animals were tested; however samples from only five AI 
animals were tested from each time point, resulting in lower statistical power of the RNAseq 
analysis compared to the qRT-PCR analysis.  Secondly, the statistical models used for analyzing 
data were different. In the case of qRT-PCR, data from all tissues were analyzed together using 
analysis of variance (ANOVA) where the model statements included gestation length (day; GD-
18 and GD-34), tissue type (tissue; CAR and ICAR), treatment group (group; AI and SCNT), and 
qPCR plate (plate; plate 1 and 2) as fixed effects and two-way interactions (day*tissue, 
group*tissue and day*group). Twelve contrast statements were used to test for differences of 
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each pair-wise comparison for each target gene. However, in the case of RNAseq data, tissues 
relevant for each comparison (e.g. GD-18 AI CAR and GD-18 SCNT CAR transcriptomes to test 
for genes whose expression levels are affected by SCNT in GD-18 CAR tissue; GD-34 AI chorion 
and GD-34 SCNT chorion transcriptomes to test for genes whose expression levels are affected 
by SCNT in GD-34 chorion tissue) were analyzed separately using a t-test. Thirdly, RNAseq is 
also considered a technique with lower sensitivity than qRT-PCR (Klopfleisch and Gruber 2012). 
Collectively, these three reasons may have contributed to the failure of RNAseq to identify 
transcript levels of IGF1R, ERBB2 and NRG2 as significantly different between AI and SCNT.  
As demonstrated by the limited in situ hybridizations carried out, some genes are 
transcribed in all constituent cells (e.g. NRG2 expression was observed in LE, GE, sub-epithelial 
stroma, deep stroma and endothelia; Figure 2.1.E) while others show tightly regulated cell-type-
specific transcription patterns (e.g. ITFG3 expression was observed only in GE; Figure 2.1.F-G). 
Therefore, further studies are necessary to identify the exact localization of the considered 
molecules during the peri-implantation period.  
It should be emphasized that interpretations from this study based on pathway analysis 
of transcriptomic data may not accurately reflect the in vivo protein-protein/biochemical 
reactions. Generally, protein expression levels, and in some cases (e.g. MAPK cascade in ERK1/2 
signaling), the phosphorylation status of expressed proteins are better indicators of the 
functional status of gene products compared to transcript levels (Wu et al. 2009). However, 
transcriptomic studies are conducted on the basis of the key assumption that mRNA expression 
is informative in predicting protein expression levels (Guo et al. 2008). While findings of some 
studies support this assumption (Ørntoft et al. 2002; Schlemmer et al. 2004), others have 
reported relatively poor correlations in mRNA and protein expression levels (Chen et al. 2002). 
The poor correlations are thought to be due to post-transcriptional/translational modifications 
(e.g. transcriptional splicing, post-transcriptional splicing, translational modifications, 
translational regulation and protein complex formation), variations in in vivo half lives of 
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proteins (e.g. variations in protein degradation rates), and errors and noise in both protein and 
mRNA-quantification methodologies (Greenbaum et al. 2003; Guo et al. 2008). All 
interpretations from this study are also based on the assumption that transcript levels correlate 
to protein expression levels at the conceptus-maternal interface.  
Most tissues that we tested were also composed of multiple cell types. For example, ICAR 
tissue contains luminal epithelia, glandular epithelia, endothelial cells, smooth muscle cells of 
blood vessels and stromal cells etc. The extracted total RNA samples contain RNA from all these 
different cell types. Therefore our interpretations are based at the tissue level rather than at the 
cellular level. Even though, interpretations at the tissue level may not be as informative as those 
at the cellular level, they still emphasize the importance of the role played by IGF, EGF and 
integrin signaling during implantation and how they are perturbed in SCNT. Therefore, 
proteomic and metabolomic studies, involving localization studies where necessary, are 
warranted to confirm our observations, and to better understand the conceptus-maternal 
signaling mechanisms that are perturbed in SCNT pregnancies.  
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CHAPTER 5 FIGURES 
 
Figure 5.1. Gestation day-34 bovine conceptus collected from an AI-derived pregnancy. The 
black arrow points to the embryo. The allantoic circulation and its connection to the embryo via 
the umbilical vessels can be appreciated. 
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Figure 5.2. Gestation day-34 bovine embryo collected from an AI-derived pregnancy. The black 
arrow points to umbilical vessels. 
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